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In contrast to mammals, adult zebrafish are able to regenerate motor neurons and 
regain swimming ability within 6 weeks after a spinal cord injury. During this 
regenerative process, a range of developmental signals such as dopamine and 
serotonin are found to be re-deployed. This makes the research of embryonic signals 
become essential for the promotion of regeneration in the future. In my research, I 
am interested in identifying genes that are important for motor neuron development 
and motor axon differentiation. I also aimed to study the ability of zebrafish larvae to 
regenerate spinal motor neurons, and whether they can be used to study the essential 
developmental cues and the mechanisms underlying successful functional recovery. 
 
Motor axons grow out of the spinal cord in a motor neuron subtype specific manner 
and innervate different muscle groups to facilitate locomotor movements. To find 
genes and important pathways involved in motor neuron generation and axon 
development in zebrafish, we conducted an ENU-induced mutagenesis screen in 
islet-1:GFP transgenic zebrafish, in which a subset of dorsally projecting motor 
neurons are labelled. We have discovered 6 mutants displaying delayed or inhibited 
appearance of secondary motor neurons and/or motor axon deficits among 111 F2 
families screened. Through subsequent mutant phenotypical analysis, I focused my 
study in two mutant lines manifesting a lack of islet-1:GFP motor neurons, and an 
absence of islet-1:GFP motor axons. I used various molecular markers to characterise 
the mutant phenotypes and observed several additional anatomical defects. I also 
initiated the study of causative mutation analysis based on the candidate gene list 
generated from Next Generation Sequencing (NGS). To gain an insight of the genes’ 
role in motor neuron development and axonal differentiation, I started functional 
analyses in order to confirm genes that are responsible for the observed motor 
neuron/axon phenotypes, and I have achieved some promising preliminary results.  
 
Motor neurons are generated from the motor neuron progenitor domain (pMN). This 
neurogenesis process sharply declines at 48 hours post-fertilisation (hpf), while pMN 




mechanical lesion in the spinal cord of zebrafish larvae, we demonstrated that they 
are capable of regenerate new motor neurons and achieve full functional recovery 
within 48 hours following the injury, sharing similar mechanisms to that of the adult 
zebrafish. I further studied oligodendrocyte generation and found that pMN domain 
is able to switch from oligodendrogenesis to motor neuron generation after a spinal 
lesion. This demonstrates the high plasticity of the pMN domain. Interestingly, the 
generation of dorsal Pax2-positive interneurons was not altered after the lesion, 
suggesting that the regenerative potential differs in different progenitor domains. 
This study showed that the motor neuron regenerative process in zebrafish larvae is 
robust and they can be used for studying motor neuron regeneration. 
 
Taken together, the discovery of the genes from our screen will provide insights to 
the developmental cues that are involved in motor neuron generation and axon 
growth. Furthermore, spinal cord lesion in larval zebrafish larvae is established as a 
regenerative model that can be utilized to dissect the roles and mechanisms of these 







Motor neurons are the cells in the spinal cord that communicate with muscles and are 
responsible for all movement. In humans, motor neuron diseases and spinal cord 
injuries often cause a loss of these neurons which cannot be replaced, and 
consequently lead to life-long paralysis and death. In contrast to mammals, adult 
zebrafish are able to regenerate spinal motor neurons and regain their ability to swim 
within weeks of an injury. This process requires the reactivation of the signals that 
are important for producing motor neurons during the development of embryos. 
More importantly, these signals are found to promote the generation of motor 
neurons in human stem cells, demonstrating that studies in zebrafish may be 
applicable to humans. If we understand the developmental signals and pathways that 
are essential for making motor neurons, we might be able to promote the 
regeneration of motor neurons in the future in injury and disease. In my research, I 
study (1) which genes control the generation of motor neurons and their path to 
contact muscle targets; (2) whether we can use larval zebrafish as an animal model to 
study the essential signals and mechanisms underlying successful functional 
recovery. 
 
In order to dissect the underlying gene pathways for motor neuron generation, I 
performed a screen for gene defects that lead to abnormal development of motor 
neurons. Zebrafish were chemically treated to produce random gene defects. In the 
screen, I have successfully discovered 6 mutant fish lines manifesting abnormal 
motor neuron and axon development. I focused my study in two mutants displaying a 
lack of motor neurons and an absent of motor axons. I investigated the anatomy of 
these two mutants and found various defects. I started investigating which genes are 
responsible for the observed abnormalities in the motor neurons.  
 
Previous work within the research group has found that larval zebrafish are able to 
remake new motor neurons after a spinal cord injury like the adult zebrafish, and the 
regenerative process is robust and fast as they regain full functional recovery within 





Taken together, the discovery of these genes will shed light on important signals 
during the development of the nervous system, and by establishing larval zebrafish 
as a regenerative model organism, we can apply these discovered developmental 
cues in the lesioned zebrafish larvae to study their roles in promoting motor neuron 
regeneration. The findings may ultimately be used to regenerate spinal cell types in 
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Chapter  1      General  Introduction    
 
Overall aims of my PhD 
In contrast to mammals, zebrafish possess a high regenerative capacity of the central 
nervous system. It has shown that adult zebrafish are able to regenerate motor 
neurons after a spinal cord injury, and embryonic signals such as dopamine and 
serotonin are found to be reactivated during the regenerative process (Reimer et al. 
2008; Reimer et al. 2013; Barreiro-Iglesias et al. 2015). This makes the studies of 
developmental cues become essential for the promotion of regeneration in the future. 
I wondered what controls motor neuron development – which genes and signalling 
pathways participate in the generation of motor neurons during development? Also, I 
wondered whether larval zebrafish would be able to regenerate motor neurons 
following injury like the adults, and could be used as a model organism to dissect 
developmental signals and mechanisms underlying successful functional 
regeneration. In chapter 3 of this thesis, 1) I described an unbiased genetic screen to 
look for genes that are important for motor neuron and axon differentiation; 2) I 
characterised the mutants displaying motor neuron and axon phenotypes discovered 
in a screen, and I investigated the potential candidate genes that are responsible for 
the mutant phenotypes observed. In chapter 4, I analysed the lesion-induced spinal 
motor neuron regeneration in zebrafish larvae and the regenerative potential of 
different cell types.  
 
In the following introduction part, I will introduce briefly the formation of zebrafish 
spinal cord, the generation of motor neurons and the known signalling pathways 
involved in this process. I will discuss the regenerative ability of mammals and 
zebrafish, and elucidate the features of the zebrafish as a model in connecting 
research on neurodevelopment with disease research.  
 
1.1  Development  of  zebrafish  spinal  cord  
1.1.1  The  formation  of  neural  tube  
In central nervous system (CNS), brain and spinal cord are derived from the neural 




zebrafish embryogenesis, from there three germ layers are formed: endoderm, 
mesoderm and ectoderm (Stifani 2014). The mesoderm gives rise to a narrow rod 
structure called notochord. The nervous system such as brain and spine are derived 
from the ectoderm. The initial structure of the neural tube is a flat sheet of the 
ectodermal epithelium cells that thickens into a columnar shape called neural plate 
(Kimmel et al. 1995) (Fig 1.1). During neurulation, epithelial cells in the neural plate 
infolds at the midline to create a fish-specific structure, the neural keel (Araya et al. 
2016). The neural keel develops to form a more cylindrical-like structure called the 
neural nod, which cavitates at the ventro-dorsal midline to generate a lumen and 
form the neural tube (Kimmel et al. 1995; Araya et al. 2016). The neural tube sits 
dorsal to the notochord. The caudal part of the neural tube later develops into the 
spinal cord (Yamada et al. 1993). The inner layer (ependymal layer) adjacent to the 
lumen is known as the ventricular zone. The central canal of the spinal cord is 
continuous with the ventricular zones of the brain (Gilbert 2000). The ventricular 
zone is lined with multi-ciliated neuroepithelial cells. Neuroepithelial cells generate 
ependymal cells, neuroblasts and glioblasts that divide into neurons and glia cells. 
Therefore, neuroepithelial cells are the stem cells/progenitor cells in the CNS 
(Patestas & Gartner 2013). For the purpose of this thesis, stem cells refer to self-
renewable undifferentiated cells that give rise to different neural cell types. 
Progenitor cells refer to specified stem cells that differentiate into specific cell types. 
For instance, motor neuron progenitor cells develop into motor neurons. In the 
injured spinal cord, ependymal cells act as stem cells in response to injury 
(Panayiotou & Malas 2013). Motor neurons that reside in the ventral part of the 
spinal cord are generated from ventral neuroepithelial cells, while other types of 
neurons that lie in more dorsal areas of the cord are derived from more dorsal parts 






Fig   1.1   Zebrafish   neurulation.   In  zebrafish,  an   initial  epithelium   layer   thickens   to  
form  the  neural  plate.  Epithelial  cells  in  the  neural  plate  converges  at  the  midline  to  
form  a  neural  keel  and  then  subsequently  a  neural  rod.  Through  cavitation,  a  lumen  
opens  from  ventral   to  dorsal  midline  of  the  neural  rod  which  then  transforms  into  a  
neural  tube.  Adapted  from  (Lowery  &  Sive  2004).  
 
 
1.1.2  Formation  of  the  motor  neuron  progenitor  domain  (pMN)    
Multiple molecules and transcription factors are reported to be involved in the 
organization of cells in neural tube to create distinct cell-type specific progenitor 
zones. Notably, sonic hedgehog (Shh) is found to provide positional information for 
the generation of different neuron types and stereotypical patterning along the neural 
tube (Francius & Clotman 2014). Shh is first secreted by notochord and later 
expressed by floor plate from the ventral spinal cord (Yamada et al. 1993). The floor 
plate of the spinal cord is positioned dorsal to the notochord. It consists of a layer of 




the ventral to dorsal axis of the neural tube, Shh displays a ventral-high to dorsal-low 
level concentration gradient which controls the fate of interneurons and motor 
neurons (Yamada et al. 1993; Pfaff & Kintner 1998; Francius & Clotman 2014), 
whereas other molecules such as Bone Morphogenetic Proteins (BMPs) and Wnt 
secreted from the roof plate in the dorsal neural tube show a ventral-low to dorsal-
high level gradient that contribute to the generation of sensory interneurons (Fig 1 A; 
Stifani 2014; Shirasaki & Pfaff 2002). This polarized signal expression of Shh, 
together with homeodomain (HD) transcription factors, divide neuronal progenitor 
into five cell-type specific progenitor domains in ventral spinal cord: p0, p1, p2, 
pMN, p3 (Fig 1 B,  Stifani 2014). Depending on their interaction with Shh, HD 
factors can be divided into two classes (Stifani 2014; Davis-Dusenbery et al. 2014). 
Class I is repressed by Shh, which includes Irx3, Dbx1, Dbx2, and Pax6. On the 
contrary, Shh induces Class II factors such as Nkx6.2, Nkx6.1, Nkx2.2, and Olig2 
which belongs to basic helix-loop-helix (bHLH) family. The cross-repressive 
interaction between class I and class II transcription factors following the graded Shh 
signalling level define the boundaries of each progenitor domain, while the restricted 
combination of two classes refine the neuronal type produced from each progenitor 
zone. For example, the pMN domain forms in the ventral part of the neural tube 
where the level of Shh is high and exposure is long. pMN cells uniquely co-express 
homeodomain proteins Nkx6.1, Pax6 and Olig2 and give rise to motor neurons 
(Reimer et al. 2009). Each progenitor domain specifies distinct neuronal types that 
are bilaterally distributed along the dorso-ventral axis of the spinal cord. p0, p1, p2 






Fig  1.2  Shh  gradient   and   the  patterning  of  neuronal   subtypes  on   the  ventral  
neural   tube.   (A)  Schematic  cross  section  of  neural   tube.  shh  shows  a  high   to   low  
level  concentration  gradient  from  ventral  to  dorsal  neural  tube.  (B)  Interaction  of  two  
classes  of  HD  factor  with  Shh  in  determine  5  progenitor  zones.  (C)  Each  progenitor  
domain  gives  rise  to  a  distinct  cell  type.  Motor  neurons  are  generated  from  the  pMN  
domain  of  the  ventral  spinal  cord.  Adapted  and  modified  from  Stifani  (2014).  
 
 
1.1.3  From  progenitor  cells  to  mature  motor  neurons  
The progress from the formation of the pMN domain to the maturation of motor 
neurons that project motor axons into periphery is regulated by various signals and 
transcription factors. The fate of progenitor cells in pMN zone is in part determined 
by Olig2 transcription factor inducing differentiation of first motor neurons and later 
oligodendrocytes (Francius & Clotman 2014; Allan & Thor 2003; Briscoe & Novitch 
2008). In mammals such as mouse, Olig2 interacts with another bHLH protein 
Neurogenin2 (Neurog2) to promote motor neuron generation. When Neurog2 is 
down regulated, Olig2 acts with Nkx2.2 and Sox10 to give rise to oligodendrocytes 
(Allan & Thor 2003). After progenitor cells exit from cell cycles, they acquire and 
consolidate motor neuron identity by expressing LIM-HD factors downstream of 
Olig2 (Shirasaki & Pfaff 2002; Allan & Thor 2003). For instance, a homeobox gene 
– motor neuron and pancreas homeobox 1 (mnx1; also known as hb9) is expressed 
primarily in post-mitotic motor neurons (Francius & Clotman 2014). A LIM 
homeobox gene islet-1 is initially expressed in all early post-mitotic cells but later 
restricted in a subtype of motor neurons (Pfaff & Kintner 1998). Therefore, Hb9 and 
Islet-1 have been used as early markers for motor neurons. Fully differentiated motor 
neurons are cholinergic and express choline acetyltransferase (ChAT) enzyme 
(Shirasaki & Pfaff 2002).  
 
During development, motor neurons that share similar functions group together to 
form motor neuron pools (Stifani 2014). Based on the locations and axon 
connections, motor neurons can be categorized into two general classes: Upper class 
motor neurons located in the cortex of the brain that extend axons into the spinal cord; 




type of neurons that grow axons out of the CNS into the skeletal muscles in the 
periphery (Davis-Dusenbery et al. 2014). The zebrafish has two main types of spinal 
motor neurons according to the time of birth and innervated muscle types. They are 
primary motor neurons and secondary motor neurons (Patrick J. Babin et al. 2014). 
Three identifiable primary motor neurons per hemisegment control fast muscle fibres. 
The rostral, middle and caudal primary motor neurons innervate muscles in ventral-
lateral, dorsal and ventral part of the body, respectively. Secondary motor neurons 
are born later than the primary motor neurons. They are a type of abundant cells with 
small somas that extend axons to innervate both fast and slow muscle fibres.  
 
As part of the neuronal differentiation programme, post-mitotic motor neurons 
initiate axon outgrowth and their stereotypical pathfinding (Shirasaki & Pfaff 2002). 
Motor axons at first follow a common pathway to grow ventrally as they leave the 
spinal cord. Once they reach the horizontal myeseptom, the axonal growth cones of 
motor neurons follow specific guidace cues and choose their distinc pathway to 
project into the perihery. Coordinated locomotor movements rely on the correct 
connection between motor aoxns and their final skeletalmuscle targets. Based on 
their eventual projection targets, Bonanomi & Pfaff (2010) divided motor axons into 
two general categories: dorsally projecting axons and ventrally projecting axons. For 
example, in chicks, motor neurons at medial motor column (MMC) extend axons 
dorsally to innervate the dermomyotome, whereas axons of lateral motor column 
(LMC) neurons project ventro-laterally to the limbs (Bonanomi & Pfaff 2010; Jessell 
2000). In zebrafish spinal cord, based on the motor neuron types, there are two main 
types of motor axons - primary motor axons and secondary motor axons (Myers et al. 
1986). Both types of motor axons extend dorsal and ventral projections for muscle 
innervation.  
 
The exit points of motor axons from the spinal cord and the recognition of the correct 
targets at different locations in the periphery are regulated by different transcription 
factors (Eisen 1994). A combination of LIM homeodomain (LIM-HD) transcription 
factors expressed in post-mitotic motor neurons first acts as a determinant of motor 




decision making code in axon pathway selection (Appel et al. 1995). For example, 
LIM-HD gene lim3 and islet-1 are expressed in dorsally and ventro-laterally 
projecting primary motor neurons, whereas lim3 and islet-2 expression are detected 
in primary motor neurons that project ventrally. Axon guidance molecules are also 
regulated by LIM-HDs. Zhong et al (2012) found that chondrolectin (chodl) gene 
downstream of LIM-HD is expressed in primary motor neurons. Knockdown of 
chodl leads to a specific phenotype of shorter CaP motor axons at the horizontal 
myoseptum, suggesting the role of chodl in the target recognition for axon 
pathfinding (Zhong et al. 2012).  
 
In summary, the effects of polarised signals such as Shh, Wnt and BMPs on the 
unspecified epithelium cells along the ventro-dorsal axis of the neural tube, in 
collaboration with HD transcription factors and bHLH factors to define pMN domain 
specifies the fate of progenitor cells. When progenitor cell proliferation is complete, 
progenitor cells acquire motor neuron identity by expressing LIM-HD factors such as 
Hb9 and Islet-1. Further regulation of LIM-HD genes consolidates the motor neuron 
subtypes and initiate cell-type specific axonogenesis. 
 
1.2  Neurodegeneration  –  disease  and  injury  
Motor neuron disease (MND) is one of the most common forms of 
neurodegenerative disease. It manifests as a progressive neuronal death – especially 
of lower motor neurons in the spinal cord and brainstem, and upper motor neurons in 
the brain motor cortex, which leads to progressive muscle weakening and eventually 
failure of the respiratory system (Shaw 1999). Motor neuron disease is incurable, and 
current treatments are mainly symptomatic. For instance, genetic mutations in the 
gene encoding the enzyme Cu/Zn superoxide dismutase 1 (SOD1) were identified to 
account for 20% of family inherited MND (Shaw 1999); mutation of the survival of 
motor neuron 1 (smn1) gene was found to associate with spinal muscular atrophy 
(SMA), in which lower motor neurons located in the anterior horn of the spinal cord 
were selectively degenerated (Kolb & Kissel 2011). Environmental factors such as 
oxidative stress and glutamate excitotoxicity were also found to increase the 




et al (1997) showed that in both sporadic and familial amyotrophic lateral sclerosis 
(ALS) patients, the level of immunostaining for 8-hydroxy-2’-deoxyguanosine 
(OH8dG) was significantly increased in the spinal cord of both types of ALS patients. 
OH8dG is a marker for oxidative free radical damage to nuclear DNA (Ferrante et al. 
1997). Excessive Ca+ influx though the glutamate receptor AMPA (alpha-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid) was found contribute to excitotoxic 
death of neurons in motor neuron cultures from mouse spinal cord (van Den Bosch et 
al. 2000).  However, the precise genetic and neurobiological mechanisms underlying 
the motor neuron injury, and why some populations of motor neurons are more 
vulnerable to the disease are still uncertain.  
 
Another common form of neurological disorder that leads to motor neuron death is 
spinal cord injury (SCI). Every year 1,000 of people suffer spinal cord injury in the 
UK and Ireland. The traumatic injury of the spinal cord damages the vasculature, 
leading to glutamate excitotoxicity, inflammation as well as a cascade of cell death 
of motor neurons and interneurons, as well as oligodendrocytes (Thuret et al. 2006). 
In the injured spinal cord, a glia scar composed of astrocytes, microglia and glia 
progenitor cells forms after the injury. Cells in the scar secrete molecular inhibitors 
that prevented axons from sprouting across the injury site, causing disrupted 
descending and ascending axon tracts which eventually result in the degeneration of 
the caudal axons (Thuret et al. 2006; Silva et al. 2014). Moreover, the loss of 
oligodendrocytes often causes demyelination, which subsequently affects the 
remaining axons. These chains of events contribute to the poor functional recovery 
post-injury, and often leads to disabilities, neurological deficit and even 
complications of the other systems. The aim of spinal cord injury research is to find 
out what can be done to interfere with the degenerative process, and to promote the 
regeneration of motor neurons and axons, therefore to provide an effective therapy 
for functional recovery. However, this cannot be achieved without understanding the 
mechanisms underlying the motor neuron degeneration and regeneration. To do this, 
it is necessary to establish an animal model with robust regenerative capacity, as the 





1.3  Regeneration:  An  overview  
1.3.1  Regeneration  paradigm     
Poss (2010) and Vervoort (2011) classified regeneration into two general types: 
homeostatic regeneration and injury-induced regeneration. Homeostatic 
regeneration (physiological regeneration) is the regular physiological turnover of 
limited numbers of cells due to natural cell death and ageing, or a replacement of 
body parts such as teeth during the life-cycle (Vervoort 2011). Injury-induced 
regeneration (restorative regeneration) is the repair of tissues caused by an insult 
such as amputation, ablation or disease (Poss 2010). For the purpose of this thesis, 
the term regeneration refers to injury-induced regeneration. 
 
Regeneration is a biological phenomenon involving a series of events including 
initiation by injury, activation of quiescent tissue to generate new cells in response 
toinsult, as well as maintenance and integration of these cells into a functional 
network. Different experimental paradigms and injury models have been used for 
regeneration study. Mechanical injury and chemically-induced injury are commonly 
used injury models. Mechanical injury is usually induced by surgical procedures 
such as transection, cryoinjury, stab lesion and so forth. Transection is inflicted by 
using a sharp instrument such as an injection gauge, micro-scissors or a scalpel to 
make a partial or full disassociation between the rostral and caudal side of the 
structure (Cheriyan et al. 2014). It has been used extensively for the study of spinal 
cord regeneration in many animal models including mice and zebrafish (Lukovic et 
al. 2015; Becker et al. 1997; Reimer et al. 2008). Transection model is easy to 
reproduce, however, it can be difficult to apply consistent partial injury (Cheriyan et 
al. 2014). Cryoinjury involves an acutely damage to tissue or organ by applying a dry 
ice-cooled steel probe or copper filament. This method is precise and experimentally 
controllable. lez-Rosa & Mercader (2012) established a cryoinjury technique to 
induce myocardial infraction in adult zebrafish heart. Injury induces cell death via 
apoptosis or necrosis, which is similar to the cell death mechanism found in 
myocardial infraction (Chablais & Jaźwińska 2012). The chemically induced injury 
model is often performed by the injection or direct exposure of a chemical agent or a 




oligodendrocytes (Torkildsen et al. 2008). Administration of cuprizone in mice lead 
to oligodendrocytes apoptosis and demyelination, which are the clinical features of 
multiple sclerosis (Torkildsen et al. 2008). This model has been used and well 
characterised for multiple sclerosis research. It has been shown that alterations in 
surrounding environment as well as regenerative response varies depending on the 
nature of the injury. Hardy et al (2016) compared different muscle injury models that 
are commonly used for the study of skeletal muscle regeneration in mice, such as 
freeze injury (cryoinjury), chemical and toxin models. The study found a massive 
loss of muscle stem cells following the chemical/toxin-induced injury compared with 
freeze injury. Moreover, freeze injury caused muscle damage is usually focal, 
whereas chemical/toxin model has an impact on the entire muscle (Hardy et al. 2016). 
Therefore, one must have a careful consideration based on the goals and expected 
outcomes of the study when it comes to the selection of an optimal injury model. 
 
In response to injury, new cells are re-produced during regeneration and tissue repair. 
Newly regenerated cells arise from either resident stem cells/progenitor cells, or 
through de-differentiation or trans-differentiation of tissue cells (Tanaka & Reddien 
2011). Stem cells are self-renewable and can produce one or more cell types. 
Progenitor cells are the precursors of a mature cell type. An example of stem 
cell/progenitor based regeneration is planarians. Study has shown that adult dividing 
pluripotent stem cells, neoblasts, are the source for new cells and contribute to 
blastema formation in amputated planarians (Tanaka & Reddien 2011). Blastema is a 
growth zone consisting of a mass of accumulated proliferative progenitor cells that 
eventually form newly re-produced structures. Different types of tissue regeneration 
involve specific lineage-restricted progenitors. In vertebrate, satellite cells are the 
skeletal muscle progenitors and express Pax3 and Pax7 markers (Kang & Krauss 
2010). In regenerative myogenesis, quiescent satellite cells are reactivated upon 
injury and fuse into impaired muscle fibres (Kang & Krauss 2010). Regenerative 
spinal motor neurons are derived from a distinct population of cells located in ventral 
motor neuron progenitor domain (Reimer et al. 2009). New cells can also be 
regenerated through de-differentiation. De-differentiation is a process by which 




differentiate within its own lineage (Jopling et al. 2011). Using 4-hydroxy-tamoxifen 
(4-OHT)-inducible Cre/lox system, Jopling et al (2010)  lineage-traced regenerating 
cardiomyocytes in zebrafish heart. The study found pre-existing cardiomyocytes 
undergo limited de-differentiation to drive heart muscle cell regeneration. This 
proliferation of terminally differentiated cardiomyocytes correlates with the change 
in plk1 gene expression (Jopling et al. 2010). Another route to regeneration is via 
trans-differentiation. Trans-differentiation is an irreversible switch of a cell lineage 
into another new cell type (Jopling et al. 2011; Shen et al. 2003). For example, 
vertebrate radial glial cells are originated from ectodermal tissues, whereas muscle 
and cartilage are derived from mesoderm (Echeverri & Tanaka 2002). During axolotl 
tail regeneration, radio glial cells are found not only contribute to the functional 
repair of the spinal cord, but also convert their cell phenotype to muscle cells to 
promote the regeneration of surrounding tissues (Echeverri & Tanaka 2002). 
 
1.3.2  Regeneration  and  development  
Development and regeneration in animals is the result of complicated genetic 
interactions and regulatory networks. Studies have shown similar mechanisms 
underlie development and regeneration (Key 2016; Wilken & Reh 2016; Mercola et 
al. 2011). For instance, there is a re-access of embryonic programmes and 
reactivation of developmental gene expression during the cell damage repair in 
regeneration (Tanaka & Ferretti 2009; Wang et al. 2007; Burton & Finnerty 2009). 
Transcription factor Pax6 is expressed in developing retinal progenitors and retinal 
neurons (Karl et al. 2008). In mice retina, a majority of newly regenerated retinal 
progenitor cells express Pax6 marker following a N-methyl-D-aspartic acid (NMDA) 
induced damage. In chicks, fish and Xenopus, Pax6 is also detected in retinal 
neuronal progenitors during retinal growth and found to be re-expressed during lens 
regeneration (Fischer & Reh 2001; Hitchcock et al. 1996; Henry et al. 2008). 
Proneural genes such as Ascl1 regulate the specification and differentiation of neural 
progenitor cells during retina formation (Castro et al. 2011). Ascl1a expression can 
be detected in proliferating Müller glial cells after retinal injury in chick and 
zebrafish (Fausett et al. 2008). In mice retina, stimulation of Ascl1converted 




Reh 2016). In vertebrate limb and tail development, mesenchymal progenitor cell 
proliferation necessary for limb formation is regulated by Wnt/β-catenin signalling 
(Kawakami et al. 2006). This developmental signal is reactivated after Xenopus tail 
and zebrafish caudal fin amputation and promotes regeneration (Lin & Slack 2008; 
Kawakami et al. 2006). It has shown that wnt10a can activate Wnt/β-catenin 
signalling during limb development (Stoick-Cooper et al. 2007). Following fin 
amputation, wnt10a was upregulated from 3 to 6 days after injury. Blockage of 
Wnt/β-catenin signalling resulted in decreased blastema progenitor proliferation, 
whereas enhanced Wnt/β-catenin signalling augments fin regeneration. In the 
developing cerebellum, fibroblast growth factor (FGF) genes are expressed and 
involved in many neurogenesis processes such as neuronal precursor production, 
granule cell proliferation, differentiation and migration in the brain (Yaguchi et al. 
2009). In differentiating cerebellum, FGF signalling is required for the cerebellum 
neuronal cells regeneration and anterior hindbrain re-patterning after the cerebellum 
ablation in zebrafish (Koster & Fraser 2006). Sox2 belongs to the SoxB1 family and 
is expressed in neural stem cells as well as progenitor cells in adult brain (Gaete et al. 
2012). In Xenopus larvae, Sox2 cells are also observed in the ependymal zone of the 
developing and regenerative spinal cord (Muñoza et al. 2015; Gaete et al. 2012). 
Gaete et al (2012) detected an increased level of both sox2 mRNA and Sox2 protein 
in ventral ependymal canal in the injured spinal cord of Xenopus tadpoles. Sox2 cells 
are activated and proliferate in response to spinal cord transection (Gaete et al. 2012). 
They also migrate to the ablation gap to contribute to axonal regeneration (Gaete et 
al. 2012). Block Sox2 function leads to disrupted spinal cord repair, supporting the 
positive role of Sox2 in spinal cord and tail regeneration in tadpoles. Taken together, 
there is a recapitulation of embryonic signals during the regeneration. Also, many of 
these genes are evolutionally conserved and therefore likely to share similar 
regeneration mechanisms across species. 
 
However, studies also show differences exist between the genetic requirement for 
development and regeneration (Vervoort 2011; Burton & Finnerty 2009). Mizuno 
et al (1999) compared the expression of three classes of crystallin genes (αA, βB1 




embryonic Xenopus lens, positive signals for the expression of all three αA, βB1, and 
γ-crystallin genes can be detected simultaneously in lens placode at embryonic 
development stage 26-27, and later expressed in lens fibre cells. However, during the 
lens regeneration, only αA and βB1-crystallin signals were observed at Freeman’s 
stage 3 before lens fibre differentiation can be distinguished. The expression of γ-
crystallin was detected after the beginning of the lens fibre differentiation at 
Freeman’s stage 4 (Mizuno et al. 1999). This indicates that although similar 
developmental genes were reactivated, the requirement for the timing of crystallin 
genes expression could be different during the lens regeneration. In Nematostella, 
the Hox-like gene anthox6 is expressed in pharyngeal during larval development. 
However, anthox6 signal is not detected during physa regeneration (Burton & 
Finnerty 2009). A member of FGF family Fgf20, which is not required for limb 
development during embryogenesis, has been identified to be able to regulate 
blastema formation and initiate fin regeneration in zebrafish (Whitehead et al. 2005; 
Vervoort 2011). These studies demonstrate that at least some partial distinct 
mechanisms are involved in regeneration.  
 
To learn how to reactivate these intrinsic regeneration programs in future research, 
the challenge lies in exploring and systematically comparing the similarities and 
differences between the two processes. 
  
1.3.3  Regeneration  across  species  
Regeneration occurs at different levels such as a cell type, an organ, a body structure 
or even a whole organism (Rinkevich & Rinkevich 2013; Tanaka & Reddien 2011). 
There is a great diversity of regenerative capability exhibit across species. Some 
organisms can regrow a whole body, others only have some form of ability to replace 
a body part, or are even incapable of regeneration (Bely & Nyberg 2010). It also 
varies in the same animal in different body parts. For instance, a lizard can 
regenerate a new tail but fails to regrow a limb (Alibardi & Toni 2005). Regeneration 
differs at different stages of life-cycle amongst animals. Salamander limb 
regeneration occurs throughout the life, whereas regeneration in animals like chicks 





While regeneration in some simple invertebrate organisms such as Drosophila 
melanogaster and C. elegans is poor, planaria and hydras possess powerful 
regenerative abilities (Alvarado & Tsonis 2006). Planarians are fresh water 
flatworms and have been used as an animal model to study regeneration (Baguna 
2001). Planarians regenerate through the proliferation of pre-existing pluripotent 
stem cells (Tanaka & Reddien 2011). They are able to regenerate all cell types and 
regrow body parts including the head and tail. Remarkably, even an entire animal can 
be regenerated from a small piece of body fragment. Hydras have very simple body 
structure: a foot, a polarized body axis and a head (Alvarado & Tsonis 2006). They 
also can regenerate hydra polyps from a tiny piece of tissue or even from dissociated 
cells (Poss 2010). Three types of stem cells are found to play a role in the hydra 
regenerative process: ectodermal epithelial cells, endodermal epithelial cells, and 
interstitial stem cells (Tanaka & Reddien 2011). It has shown that pre-existing 
interstitial cells might be able to transdifferentiate to another cell type during 
regeneration. Hydra orthologues of developmental genes and signalling pathways 
such as Hox genes, Wnt and FGF have been identified during the regeneration 
process (Alvarado & Tsonis 2006).  
 
Although not be able to regenerate the whole organism, amphibians such as newts 
and salamanders can regrow limbs, tail, heart and spinal cord (Mchedlishvili et al. 
2012; Alvarado & Tsonis 2006). In newts, epithelial cells cover the wound and 
provide signals for the cells to re-enter the cell cycle, to proliferate and differentiate 
into new cells. FGFs and SHH signalling are found to be reactivated during the 
limb regeneration. Salamanders are capable of regenerating retina, optic tectum and 
muscles. The formation of blastemal cells, a cluster of de-differentiated cells, 
contributes to their epimorphic regeneration (Mchedlishvili et al. 2012; Becker & 
Becker 2015).  
 
A Xenopus tadpole tail consists of a spinal cord, a notochord and segmented 
myotomes with surrounding tissues (Slack et al. 2008). Amputation of the tadpole 




migrate to the wound site, forming an ependymal epithelium structure called neural 
ampulla which leads to a full tail regeneration in 20 days (Gaete et al. 2012; Slack et 
al. 2008).  In Xenopus larvae, a spinal cord is necessary for the tail regeneration 
(Taniguchi et al. 2008). Ablating spinal cord in tadpoles resulted in decreased 
proliferation and differentiation of the notochord cells, and leads to regeneration of a 
shorter and twisted tail. Tadpoles can repair their cornea within 1 to 2 weeks (Beck et 
al. 2009; Slack et al. 2008). Cells of the inner layer of outer cornea transdifferentiate 
into new lens cells and eventually develop into a new lens. However, the 
regenerative ability in Xenopus larvae is limited to pre-metamorphic stages, little or 
no regenerate is observed after the onset of metamorphosis following an amputation.  
 
Zebrafish have a robust capacity of re-generating a variety of organs and tissues 
including the fin, spinal cord, retina, and heart. Poss et al (2002) suggested that the 
ventricular myocardium of an adult zebrafish heart can recover in 1 week after a 
mechanical injury without scaring. The regenerated heart showed no obvious 
difference from the heart of an un-injured fish. During the zebrafish cardiac 
regeneration, undifferentiated progenitor cells acquires cardiac fate by expressing 
transcriptional activators such as NKX2.5, TBX20 and HAND2, and then 
differentiate into new proliferative cardiomyocytes (Lepilina et al. 2006). In a recent 
study, Mokalled et al (2016) analysed transcription factors that are up-regulated 
during the zebrafish spinal cord regeneration and found an increased level of 
connective tissue growth factor a (ctgfa). They found ctgfa is expressed in the ventral 
ependymal cells at 1 to 2 weeks post injury and promotes early glial bridging across 
the lesion site. ctgfa mutant displayed reduced axon regeneration across the lesion 
site and diminished swimming ability, whereas the overexpression of ctgfa leads to 
increased glial bridging and axon regeneration (Mokalled et al. 2016).  
 
Birds in their embryonic stage display some capacity for retinal regeneration. In 
chick retinas, Müller glial cells serve as the source of neural regeneration (Fischer & 
Reh 2001). It has shown that neurotocxin injection to the retina triggers Müller glia 
at the central retina to re-enter their mitotic cycle, de-differentiate into progenitor fate 




proliferative response of Muller glia was also observed (Wilken & Reh 2016). 
Neonatal mouse heart retains significant cardiac regenerative potential (Porrello et al. 
2013). They are able to produce new cardiomyocytes through proliferation of 
existing cardiomyocytes after inducing ischemic myocardial infarction. However, the 
regenerative ability in birds, mice and rats sharply declines after the embryonic stage 
and becomes extremely low in adulthood. 
 
1.3.4  Regeneration  in  mammals  and  limitations  
In comparison with other well studied regeneration models, adult mammalian species 
have very little ability to replace lost cells after an insult or under pathological 
conditions. Humans show some regenerative response to fingertips amputation but 
only restrictedly limited to the distal end or the terminal phalanx (Muneoka et al. 
2008). In adult human and mouse heart, in vitro studies showed that cardiac 
progenitor cells have the potential to differentiate into fully mature cardiomyocytes 
and cardiomyocytes was likely to be replenished by precursor cells after injury 
(Laugwitz et al. 2005; Hsieh et al. 2007; Wu et al. 2008). However, the limited 
regeneration in human hearts suggested that it is clearly insufficient to restore heart 
function. Although it was believed that mammals do not regenerate new nerve cells 
after an insult or under pathological conditions, studies have shown increased new 
born ependymal cells, astrocytes and oligodendrocyte progenitor cells restricted to 
the lesion site in the injured mice spinal cord (Mothe & Tator 2005; Barnabé-Heider 
et al. 2010). This suggests a degree of plasticity in mammalian CNS progenitor cells. 
However, only very limited neurogenesis occurred in the injured mammalian CNS. 
The regeneration efficiency is also extremely low and incomplete. For instance, in 
brain regions that are regarded as neurogenic such as the subgranular zone (SGZ) of 
the hippocampus and subventricular zone (SVZ), in which neurogenesis is active 
throughout life, an injury leads to increased proliferation of progenitor cells and 
generation of new neurons (Arvidsson et al. 2002). The study investigated newly 
formed neurons after a stroke and found that some were able to differentiate into 
mature neurons and migrate from SVZ to damaged area. However, over 80% of the 
newborn neurons died between 2 to 6 weeks post-ischemia, and eventually lead to 




injured adult mice spinal cord, although endogenous neural progenitors response to 
the injury with increased proliferation, no newly generated neurons were detected 
(Yamamoto et al. 2001). Similarly, a study in adult rats following minimal spinal 
cord injury showed increased ependymal stem cells that primarily differentiate into 
astrocytes but not neurons (Mothe & Tator 2005). Mammals display spontaneous 
sprouting of spared axons after the CNS injury, however, regenerated axons that 
bridge the lesion site are extremely rare. This is primarily due to the formation of the 
glia scar at the injury site and the secreted axon growth inhibitors, such as Nogo-A, 
myelin-associated glycoprotein (Mag) and oligodendrocyte myelin glycoprotein 
(Omgp) were identified to provide a non-permissive environment in axon regrowth 
(Filbin 2003). For example, Nogo-A expressed by oligodendrocytes leads to growth 
cone collapses and prevents axon outgrowth from the glia scar (GrandPré et al. 2000). 
The lack of neurogenesis and axonal regeneration may collectively limit the potential 
of functional recovery of injured CNS in mammals. 
 
1.4  Zebrafish:  connecting  development  and  disease  
1.4.1  Zebrafish  as  a  forward  genetic  model  
A forward genetic study is a laboratory method to identify the function of a gene 
through phenotypes of interest in an experimentally manipulated animal organism. 
(Moresco et al. 2013). Two complementary genetic approaches are often used: 
Forward genetics and reverse genetics (Acevedo-Arozena et al. 2008). 
 
Forward genetics is a phenotypic-driven approach. It is an unbiased method through 
the identification of mutant phenotypes of interest from a large number of individuals 
by inducing random mutations to a large population of genomes, in searching for a 
gene or genes that are responsible for the phenotypes of interest (Griffiths et al. 
2005). Forward genetics do not require prior knowledge of the causative gene. The 
phenotype-to-genotype approach often leads to the discovery of novel genes or 
uncover the novel function of a known gene, and provide opportunities to dissect the 
pathway involved and reveal the underlying mechanisms (Moresco et al. 2013; 





Reverse genetics, on the other hand, is a gene-driven approach. The study involves a 
known gene. Through altering its sequence or its expression, the range of associated 
phenotypic effects such a manipulation causes can be studied, in order to investigate 
the function of a gene of interest (Nagy et al. 2003). Reverse genetic methods such as 
transgenic techniques, genome editing techniques like TALENs (Clark et al. 2011) 
and more recently CRISPR-Cas9 system to specifically knockout a gene of interest 
(Sander & Joung 2014), and knock-down have been widely used in experimental 
organism models to mimic human diseases (Argmann et al. 2006; Griffiths et al. 
2005; Tierney & Lamour 2005). Reverse genetics can provide a deep insight of the 
roles and mechanisms of genes assessed. However, such a gene-to-phenotype 
approach often requires previous knowledge of the genes, such as protein or DNA 
sequences, and limited by the assumption of the functions they may have (Nguyen et 
al. 2011; Moresco et al. 2013).  
 
In a forward genetic screen, animal models such as yeast (S. cerevisiae), fly 
(Drosophila melanogaster) and worm (C. elegans) have been widely used in 
isolating genes that are important for embryonic development. Mammalian models 
such as mice, which share a high degree of gene conservation and physiological 
similarities with human, have also been used in forward genetic screens and provided 
great insights into biological processes that relate to human diseases (Nguyen et al. 
2011). However, a forward genetic screen is laborious, timely and costly. It involves 
several generations of breeding procedure and screening large numbers of individual 
animals (Argmann et al. 2006). For example, in a large-scale genetic screen using 
zebrafish, Driever et al. 1996) screened nearly 500,000 embryos from more than 
30,000 crosses. Many factors have to be taken into account when selecting an 
experimental animal organism for genetic screen in order to balance the cost, time as 
well as the genetic similarities between human and animal models. Lower organisms 
like yeast, fly and worm are suitable for high-throughput in vivo screens because of 
their small size and simple structure. However, their lack of vertebrate-specific 
organs limits their suitability in modelling human disease (Dooley & Zon 2000). 
Although the mouse genome is 99% similar to that of humans, it has not been proven 




such as the cost for maintenance and the high demand for space limits its power to 
carry out large scale screen. It is also difficult to perform in vivo assessment for 
phenotypes and requires antibody staining, surgical intervention and post-mortem 
examination (Lieschke & Currie 2007).  
 
The need of a model organism with a high degree of similarity with humans that is 
also cost efficient has brought zebrafish into focus for a large forward genetic screen. 
Zebrafish has functional homologs of about 70% of human disease associated genes 
(Santoriello & Zon 2012). It is small in size, with a length of 3 ~ 4 cm of an adult 
fish and 3.5 mm of a 3 dpf (days post fertilization) larvae, which makes it possible to 
keep high density laboratory stocks (Kimmel et al. 1995). Zebrafish embryos develop 
externally and embryos are transparent, which provided ease for direct visual 
inspection of phenotypes in vivo and for live imaging analysis (Dodd et al. 2000). 
For instance, the heart beat and blood circulation can be easily observed under a 
dissecting microscope. Simple means like touch and light can be used to assess the 
loco-motor behaviour and visual response. The availability of transgenic lines, in 
which fluorescent proteins are expressed in specific tissues or organs, also enables to 
screen specific phenotypes of interest in a large number of animals (Stewart et al. 
2014).  
 
The zebrafish was first proven to be suitable for producing homozygous diploid 
mutants in genetic analysis in 1981 by George Streisinger (Streisinger et al. 1981). 
Mullins et al (1994) further developed methods for ENU (N-ethyl-N-nitrosourea) 
induced genetic screen and performed a small pilot screen that successfully isolated 
mutants affecting embryogenesis. In 1992, the first two remarkable large scale 
forward genetic screens were initiated by two groups in Boston, USA and Tübingen, 
Germany. A total of 2383 mutants were discovered in the Boston screen (Driever et 
al. 1996) and 4264 mutants in Tübingen screen (Haffter et al. 1996). Genes isolated 
from the screens are involved in many aspects of embryonic development such as 
central nervous system, pigment formation, as well as in behaviour response 





For the past decades, forward genetic screens in zebrafish have discovered many 
genes that are associated with human diseases. In human, muscle degeneration 
disease such as Duchenne muscular dystrophy was caused by the mutation of 
dystrophy gene (dmd) (Kawahara et al. 2011). A mutant sapje (sap) with dmd 
mutation presented similar muscle degeneration phenotype to that of the human was 
identified from a large genetic screen (Bassett & Currie 2003). It has been used as a 
model for human muscular dystrophy to understand the pathological mechanisms 
underlying this incurable disease (Bassett & Currie 2003). Once the disease model is 
established, the transparent embryos allow in vivo analysis and experimental 
manipulation in whole zebrafish embryos. The efficacy and efficiency of 
pharmaceutical agents and compounds can be tested in zebrafish disease models as 
the chorion of embryo is permeable to small molecules. Kawahara et al (2011) 
carried out a chemical screen in the sap mutant that models human muscle dystrophy 
and identified a compound called phosphodiesterase (PDE) inhibitor that was able to 
restore normal muscle structure and improve life spans of these dystrophin-null 
zebrafish. It has been shown that the phosphodiesterase 5 inhibitor (PDE5) reduced 
the muscle weakness in dmd mouse model (Percival et al. 2012), demonstrating the 
suitability of zebrafish in the study of human disease and the potential of zebrafish in 
forward genetic screen. Furthermore, non-directly human disease linked mutations 
could also be useful to reveal the new alleles, unknown functions of genes and 
uncover potential pathways. Van Eeden et al (1996) discovered mutants display both 
motor neuron defect and abnormal somite formation. The study found that a new 
allele named deadly seven (des) is important for encoding delta and notch proteins in 
zebrafish (van Eeden et al. 1996). Notch signalling pathway was proven to play a key 
role in the development of spinal cord (Appel et al. 2001) and motor neuron 
regeneration after injury (Dias et al. 2012). These evidences demonstrate the value of 
zebrafish in linking the developmental genetic studies to disease research.  
 
Like any other animal models, there will be cases that the species and genome 
differences make the research complicate (Stewart et al. 2014). Zebrafish has 23 




genes in zebrafish are duplicated, which could result in a divergence in genes’ 
expression and function.  
 
In summary, the zebrafish is a valuable animal model as it enables the application of 
invertebrate-style forward genetic technology to vertebrate, and genes discovered 
will shed light to the studies of the development and diseases. 
 
1.4.2  Zebrafish  as  a  model  for  motor  neuron  regeneration  
In contrast to mammals, fish and amphibians like salamanders have a great capacity 
to repair CNS injury. Salamanders (Urodeles) are able to regenerate spinal cord after 
an injury throughout their life and are the only tetrapod to regenerate a fully 
differentiated functional spinal cord as adults (Chernoff et al. 2003). In the lesioned 
spinal cord of salamander, ependymal cells rearrange, migrate to the lesion site and 
act as stem cells to produce neuronal cells. Regenerated and myelinated axons as 
well as functional synapses also contributed to successful spinal cord repair in 
salamander (Chernoff 1996). Anuran amphibians such as frogs and toads are also 
capable of regenerate injured spinal cord, however, this regenerative capacity fails 
after the metamorphosis stage (Beattie et al. 1986). Spinal cord regeneration occurs 
during embryonic development in birds. Shimizu et al (1990) transected the spinal 
cord of chick embryos at various ages from embryonic day 2 (E2) to E15 and found 
that chick embryos from E2 to E10 showed both anatomical and locomotor 
restoration. However the regenerative ability declined at later stages, for E15 
transected chick embryos showed reduced number of motor neurons and insufficient 
recovery anatomically and functionally (Shimizu et al. 1990). 
 
The zebrafish has a robust CNS regenerative ability after different types of insults. It 
has shown that following an injury in the telencephalon of adult zebrafish brain, the 
neuronal precursor cells in the injured telencephalon hemisphere reacted with 
increased proliferation, and differentiated into mature neurons around the injury site 
within a week post-injury (Kishimoto et al, 2012). In a recent study of my research 
group, adult zebrafish were found to be able to regenerate dopaminergic cells in the 




in contrast to human, in which the loss of dopaminergic cells is permanent and 
causes Parkinson’s disease.  
 
After a spinal cord transection, neurons in the brain are able to extend axons beyond 
the transection site (Becker et al. 1997), and injured fish recover motor function 
within 6 weeks after the spinal lesion (Becker et al. 2004), indicating the regenerative 
capacity of the zebrafish spinal cord. Reimer et al (2008) revealed for the first time 
that the regeneration of motor neurons can be triggered by a mechanical lesion to the 
spinal cord. Like mammals, progenitor cells in the intact spinal cord of adult 
zebrafish are relatively quiescent. However, the pMN domain of adult zebrafish is 
highly plastic after an injury. In the injured spinal cord, proliferation of Olig2+ 
ependymo-radial glial progenitor cells is increased. These cells later gave rise to 
Hb9+ and Islet-1/2+ motor neurons. Unlike mammals, zebrafish with an injured 
spinal cord exhibited axon growth across the injury site (Reimer et al. 2008). Studies 
have shown that newly formed neurons and axons in adults recapitulate 
developmental mechanisms during recovery from spinal cord injury, indicating that 
many embryonic cues are essential for adult regeneration (Barreiro-Iglesias et al. 
2015; Reimer et al. 2013). For instance, a recent study demonstrated that serotonin 
(5-HT) is able to facilitate spinal motor neuron generation in embryos and is 
reactivated during the process of motor neuron regeneration in adult zebrafish 
(Barreiro-Iglesias et al. 2015). Endogenous dopamine was found to promote 
embryonic motor neuron development (Reimer et al. 2013). Reduced dopamine 
signalling leads to decreased numbers of motor neurons and impaired motor 
behaviour in larvae. In the lesioned spinal cord of adult zebrafish, dopamine 
signalling promotes regeneration of new motor neurons. The same study, using 
human embryonic stem-cell-derived neural stem cells driven toward motor neuron 
differentiation, also showed that the application of a dopamine agonist stimulated the 
generation of Olig2+ progenitor cells as well as of motor neurons, hinting that 
molecules that affect the neurogenesis in zebrafish has similar effects in human stem 
cells (Reimer et al. 2013). Therefore, if we could understand the signals involved and 
the mechanisms behind larvae regeneration, we may be able to apply these findings 




motor neurons in the spinal cord of larval zebrafish had not been systematically 
studied.  
 
Taken together, the accessibility of zebrafish embryos to developmental genetic 
studies, and the excellent regenerative ability of zebrafish, as well as the potential of 
applying findings from zebrafish to clinical research of human disease, make it a 
suitable model for forward genetic screening to look for essential developmental 
motor neuron genes, and the study of motor neuron regeneration after an injury. 
  
1.5  Statement  of  aims  
In this thesis, I aim to study genes that are essential for motor neuron development 
and axon differentiation. In parallel, I aim to investigate the utility of zebrafish larvae 
as a model to study motor neuron regeneration. To achieve these goals, I address the 
following aims: 
 
(1) Forward genetic screen for gene identification. 
– To establish and carry out a small-scale forward genetic screen. To identify 
mutants displaying altered motor neuron and/or motor axon development in order to 
find genes that influence motor neuron generation and axon differentiation.  
– To initiate identification of the mutated genes. 
 
To achieve the first aim, I conducted a forward genetic screen in 111 families and 
characterised 6 identified mutants that display motor neuron and/or motor axon 
phenotypes. 2 mutants with fewer numbers of motor neurons and absence of motor 
axons were selected for further analysis and DNA sequencing for causative mutation 
identification. I have started the analysis to identify candidate genes that may 
contribute to the observed phenotypes.  
 
(2) Motor neuron regeneration in lesioned larval spinal cord. 
– To investigate the plasticity of pMN in developing spinal cord after a lesion. 
– To study whether the other progenitor domains and cell types, such as interneurons, 




In this part, I validated that zebrafish larvae can be used as a model to study motor 
neuron regeneration in developing spinal cord. I demonstrated that pMN domain is 
able to switch from making oligodendrocytes to produce motor neurons. I also 






Chapter  2      Methods  and  Materials  
 
Methods  
2.1  Fish  husbandry 
All zebrafish lines were kept and raised in our animal facility with a 14 hour-light 
and 10 hour-dark cycle following the standard protocol of Westerfield (1995). 
Embryos were collected in conditioned aquarium water containing 0.00001% 
methylene blue and kept at 28.5 ºC; embryos used for mutagenesis genetic screen 
were raised in 25.5 ºC water bath at the first 48 hours. All embryos were staged by 
hour post fertilization (hpf) and day post fertilization (dpf) using standard procedures 
(Kimmel et al. 1995). 
 
2.2  ENU-­induced  forward  genetic  screen  
2.2.1.  N-­ethyl-­N-­nitrosourea  (ENU)  treatment  
The design of this screen is based on the work of Mullins et al (1994), Driever et al 
(1996) and Haffter & Nusslein-Volhard (1996). A three-generation breeding scheme 
was adapted (Figure 2.1). ENU treatment was performed by Maria Rubio and 
Professor David Lyons. Wild-type (wik) males were incubated in ENU bath once a 
week for 3 weeks at a concentration of 3 mM. 3 males confirmed with successful 
mutagenesis were kept and mated with golden strain females to generate F1 
generation. F1 families are heterozygous for induced genome modifications. The 
generation of F1 families were performed by Maria Rubio, and I carried out the 







Fig   2.1   ENU-­induced   mutagenesis   breeding   procedure.   (A)   Mutations   were  
induced   by   ENU-­treatment   in   wik   males.   Mutagenised   males   were   mated   with  
golden  strain  females  to  generate  F1  families.  F1  families  were  then  outcrossed  with  
the   islet-­1:GPF   transgenic   line   in   order   to   obtain   a   F2   generation   with   GFP  
expressed   secondary  motor   neurons   and  motor   axons.  Phenotypic   analyses  were  
performed   in  F3  embryos.  25%  embryos   in  a  F3  clutch  would  be  homozygous   for  
the  induced  mutation  if  both  F2  parents  were  heterozygous  for  a  mutated  gene.  (B)  
Mutant  lines  were  outcrossed  with  another  wild  type  line  TL  that  is  polymorphism  to  




2.2.2  Generation  of  F2-­F4  off-­springs  
Individual F1 fish carrying random mutations was mated with an islet-1:GFP fish 
and kept separately from the original tank. Each successful F1 × islet-1:GFP pair 




Fifty percent of the fish in a F2 family are heterozygotes containing inherited 
mutagenized genomes. 4 to 6 pairs of F2 fish are mated randomly with their siblings 
and their F3 offspring were used for analysis. Mutants of interest were outcrossed 
with another wild-type line TL. Wik and TL are two different strains with different 
polymorphisms (Figure 2.1B). F4 embryos were raised and in-crossed to determine 
whether the subsequent generation replicates the phenotypes of interest.  
 
2.2.3  Phenotypic  screen  in  F3  generation  
An average of 60 to 80 F2 pair mating tanks (around 10 to 12 families) were set up 
each week (Fig 2.2). Eggs were collected with embryo medium and kept at 25.5 ºC. 
We analysed 4 to 6 crosses from each F2 family, as it gives a 68% to 82% 
probability of finding a mutant in an F2 family (Driever et al. 1996). 12 to 20 F3 
embryos from each F2 cross were screened, which gives a 96% to 99.6% chance of 
finding at least one mutant if both parents are heterozygous (Driever et al. 1996). 
 
 
Fig  2.2  Weekly  workflow  for  phenotypic  screen  of  interest.  Pictures  in  this  figure  




islet-1:GFP fish displays a full distribution of GFP positive motor neurons 
throughout the length of the spinal cord at 3 dpf (Fig 2.3 B). Based on my previous 
observation, the first appearance of the full islet-1:GFP+ motor neuron distribution (a 
full band) is at 48 ~ 49 hpf (hours post fertilization) at 28.5 ºC, by 72 hpf all wild-
type embryos appear full positive GFP neuron distribution.  
 
To screen islet-1:GFP+ motor neuron phenotype, 40 embryos were randomly 
selected from each clutch. Chorions were removed with 1mg/ml pronase (Sigma; 
P5147) and embryos were rinsed thoroughly in fresh E3 medium. Dechorionated 
embryos were anaesthetized and screened at two time points for motor neuron 
phenotype: (1) At 42 hpf to 45 hpf, when no control embryos display full distribution 
of GFP positive neurons in the spinal cord (0% full “band” in control siblings) (Fig 
2.3 A). This allows the assessment of premature development of motor neurons. (2) 
At 72 hpf, when all control embryos display fluorescent motor neurons in the mid-
trunk position (100% full “band” in control siblings). This enables to find genes that 




Fig  2.3  Illustrations  of  islet-­1:GFP+  motor  neuron  distribution  in  the  embryonic  
spinal   cord.   (A)  An  embryo  displays  a  non-­completed  distribution  of  GFP+  motor  
neurons  in  the  mid-­trunk  position.  (B)  An  embryo  displays  a  full  distribution  of  GFP+  




To screen secondary motor axon phenotypes, 12 to 20 of 3 dpf embryos from each 
F2 cross were anaesthetized and mounted alive in a lateral position in 1.2% agarose 
gel under a dissection microscope (Nusslein-Volhard & Dahm 2002). islet-1:GFP+ 
motor axons (Fig 2.4) were assessed with a microscope at 10x and 20x objective. 
The parameters for islet-1:GFP+ motor axon phenotype assessment were: absent of 
dorsal axon projection, aberrant axon exits, abnormal branching, ectopic axon growth, 
and so forth. Heterozygous F2 parents that produced a specific mutant phenotype 
were re-crossed to determine the reproducibility of the observed phenotype. All 
screening results were recorded and mutant phenotypes found were described 
individually for their exhibited morphological phenotype, islet-1:GFP+ motor neuron 
phenotype and islet-1:GFP+ motor axon phenotype. 
 
 
Fig  2.4  islet-­1:GFP+  motor  axons  of  a  3  dpf  embryo.  Scale  bar  =  100  μm.  
 
 
2.3  Whole  genome  sequencing  (WGS)  and  bioinformatics  analysis  
WGS sequencing was outsourced to Edinburgh Genomics (University of Edinburgh). 
Bioinformatics analysis for candidate genes was kindly performed by Dr. Richard 
Poole (University College London) using CloudMap (Minevich et al. 2012) from the 
Galaxy web platform.  
  
2.4  Molecular  biology  
2.4.1  RNA  extraction 
RNeasy Mini Kit (QIAGEN; Cat. 74104) was used for RNA extraction. 30 embryos 




MS 222. Lysis buffer (100 µl beta-mercaptoethanol (βME) in 1 ml RLT buffer) was 
added to each sample and then vortexed for 5 min, centrifuged briefly and vortexed 
again for 5 min; samples were centrifuged for 5 min at 13,000 rpm; supernatant of 
each sample was transferred to a clean tube, added in 600 µl 70% ethanol, and then 
transferred to a provided column from the kit to centrifuge for 15 s at 10,000 rpm; 
500 µl RPE buffer was added and centrifuged for 15 s at 10,000 rpm; solution was 
centrifuged again for 3 min at 13,000 rpm to remove the residual RPE buffer. Finally, 
RNA was eluted by adding 30 µl water and centrifuge for 1 min at 10,000 rpm.  
 
2.4.2  cDNA  synthesis  
The synthesis of first strand cDNA was based on the manufacturer’s protocol 
(SuperScript III CellsDirect cDNA Synthesis System; Life Technologies; Cat. 
18080-200). I used 3 ~ 4 ng RNA for reaction setup. cDNA was stored at -20 °C. 
 
2.4.3  Primer  design  
Primers were designed by using a free online software Primer3 
(http://bioinfo.ut.ee/primer3-0.4.0/) and outsourced to Source BioScience 






Sequence   Purpose  
Rbbp4-­F  
(#0187)  




























































2.4.4  Polymerase  chain  reaction  (PCR)  
Expand High Fidelity PCR System (Roche; Cat. 11732641001) or Q5 High-fidelity 
DNA polymerase (NEB, M0491) were used for PCR. Where appropriate, gradients 
of annealing temperature were used.  
 
Depending on the length of the product and the Tm of the primer, the cycler was set 








For Expand High Fidelity PCR System: 
Initial  denaturation:  94  °C  2  min  
Denaturation:  94  °C    15  s  
35x  Annealing:  55-­60  °C  30  s    
Extension:  72  °C  25  s  ~  1  min  
Final  extension:  72  °C  7  min  
Hold:  4  °C  
 
 
For Q5 High-fidelity DNA polymerase: 
Initial  denaturation:  98  °C  30  s  
Denaturation:  98  °C    10  s  
7x  Annealing:  59-­61  °C  30  s    
Extension:  72  °C  40  s  ~  1  min  
Denaturation:  98  °C    10  s  
35x  Annealing:  69-­71  °C  30  s    
Extension:  72  °C  40  s  ~  1  min  
Final  extension:  72  °C  2  min  
Hold:  4  °C  
 
 
2.4.5  Gel  electrophoresis  and  extraction  
DNA and RNA fragments were analysed in a buffer filled electrical field in 1% 
Agarose gel (1.0 g agarose in 100 ml 1x TAE buffer). 5 µl ethidium bromide (EtBr; 
final concentration of 0.2 µl/ml) which binds to the DNA was added into the gel to 
allow the visualisation of the DNA under ultraviolet (UV) light. Gel extraction was 
performed by using QIAquick Gel Extraction Kit (QIAGEN; Cat. 28704) according 
to the manufacturer’s instructions.  
 
2.4.6  Ligations  and  cloning  of  PCR  fragments  
Where appropriate, PCR products were ligated and cloned into a vector by using 




(NEB, M0202) and cloned into a PCSP2+ vector (courtesy of Daniel Wehner for the 
vector).  
  
2.4.7  Transforming  the  competent  cells  
To introduce a plasmid vector with foreign DNA insert, I used either 
StrataClone SoloPack Competent Cells (200185) or NEB 5-alpha Competent E. coli 
(C2987H), according to according to the protocols of the manufacturers. 
  
2.4.8  Blue/White  selection  of  ligated  vectors  
White colonies were picked for plasmid DNA analysis. The principle of the blue-
white screening is to identify recombinant bacterial colonies based on the activity of 
β –galactosidase. β –galactosidase is an enzyme produced by lacZ gene in E.coli and 
is able to cleave lactose to glucose and galactose. A chemical X-gal that can also be 
cleaved by functional β-galactosidase is used to visualize the insert of the plasmid. A 
host E. coli strain containing a plasmid carrying an insert of PCR product is expected 
to form white colonies, while E. coli harbouring a plasmid without an insert will be 
blue.       
 
2.4.9  Growth  of  bacterial  culture    
Single colony was picked and incubated in 6 ml LB medium with 12 µl ampicillin 
(50mg/ml, final working concentration 1:500) at 37 °C with agitation overnight. 
 
2.4.10  Plasmid  DNA  isolation  
FastPlasmid Mini Kit (5 Prime; 2300000) was used to isolate plasmid DNA 
according to the manufacturer’s instructions.   
 
2.4.11  Concentration  measurement  
Concentration (ng/µl) and purity of nucleic acid samples were measured with 







2.4.12  Sanger  sequencing        
Sanger sequencing was performed by Source Bioscience          
(http://www.sourcebioscience.com/). T3, T7 or sp6 promoters were selected based on 
appropriate plasmid map. 
 
2.4.13  Restriction  digestions  
Appropriate NEB enzymes and buffers were selected for restriction digestions based 
on the instructions of the manufacturer. The success of the digestion was analysed by 
running agarose gel electrophoresis.  
 
2.4.14  DNA  purification  
DNA purification was carried out using QIAquick PCR Purification Kit (QIAGEN, 
Cat. 28104) according to the manufacturer’s instructions.   
 
2.4.15  in  vitro  transcription  of  the  RNA  
The linearized DNA was precipitated overnight at -20 °C with 0.3 M Sodium Acetate, 
and two volumes of 100% ethanol. Antisense RNA was transcribed by using 
MAXIScript® Kit (Ambion), and sense RNA was transcribed by using mMESSAGE 
mMACHINE® Kit according to the manufacturers’ instructions.  
 
2.4.16  RNA  clean-­up  
RNA clean-up was performed by using RNeasy Mini Kit (Invitrogen; AM1320) 
based on the protocol of the manufacturer.  
 
2.4.17  Genomic  DNA  isolation    
Genomic DNA was isolated using Gentra Puregene Tissue Kit (Qiagen; Protocol of 
Dr. Linde Kegel). 80 to 120 homozygous mutant embryos and their siblings were 
collected and frozen in liquid nitrogen. Before DNA isolation, sample tubes were 
thawed on ice and combined. 3 ml of Cell Lysis Solution and 15 µl Proteinase K (20 
mg/ml) were added into each sample and inverted 25 times; sample were incubated 
at 55 °C overnight (O/N). On the next day, the lysates were cooled at room 




25times. Samples were incubated at 37 °C on a mixing table for 2~3 h, cooled on ice 
for 3 min and 1 ml Protein Precipitation Solution was added; the samples were then 
cooled on ice for another 5 min, vigorously vortexed for 20 s at high speed and 
cooled on ice for 5 min again. Tubes were centrifuged at 2,000 x g for 10 min at 4 °C 
and supernatant of each sample was transferred to a clean tube containing 3 ml 2-
propanol, mixed by inverting 50x and then incubated at -20 °C O/N. Solution was 
centrifuged at 2000 x g for 30 min at 4°C, supernatant was removed and tubes were 
drained. 3 ml ice-cold 70% ethanol was added and tubes were inverted for several 
times to wash DNA pellet. Centrifuge again at 2,000 x g for 3 min at 4 °C, remove 
supernatant and air dry pellet. 150 µl of DNA Hydration Solution was added and 
incubated at 65 °C for a minimum of 30 min to 1h until DNA is dissolved. DNA 
solution was incubated O/N at RT while gently agitating at ~30 rpm. Isolated 
genomic DNA samples were stored at -80 °C. 
 
2.4.18  Genotyping  
Genotyping protocol was adapted from Dr. Marcos Cardozo. Whole embryos  were 
incubated in 50 µl of 5 mM NaOH at 95 °C for 20 min, and then vortexed at the 
highest speed until dissolved completely. Tubes were put on ice, added with 1/10 of 
1 M Tris PH 8.0, and then centrifuged for 2 min at maximum speed. 1 µl supernatant 
was used for PCR reaction setup. 
 
2.5  Histology  
2.5.1  Immunohistochemistry  (IHC)  on  whole-­mount  embryos  
Embryos and larvae were fixed in 4% PFA/1% DMSO and washed in 1x PBS. 33 ~ 
72 hpf embryos were incubated with 2 mg/ml collagenase diluted in PBS; 3 to 5 dpf 
larvae were incubated in 10 mM citric acid (pH 6) at 110 °C for 10 min. Embryos 
and larvae were washed in 1x PBS and non-specific binding sites were blocked with 
whole mount IHC blocking buffer. Appropriate primary antibodies were diluted in 
IHC blocking buffer and incubated at 4 °C O/N. Embryos and larvae were washes in 
1x PBStx (0.1% Triton X-100) and incubated in secondary antibodies diluted in 1x 




washing in 1x PBStx and 1x PBS, embryos were cleared in 70% Glycerol/1x PBS 
and mounted on slides. 
 
2.5.2  IHC  on  cryostat  sections  
Larvae at desired developmental stage were terminally anesthetized with MS 222, 
fixed in 4% PFA/1% DMSO for 3 h at RT, and washed in 1x PBS. Fixed larvae were 
immersed in 30% sucrose/1x PBS and incubated overnight at 4 °C. Larvae were 
embedded in OCT embedding medium in a mould and flash frozen in liquid 
nitrogen- cooled methyl-2-butane for ~15 s. 14 µm non-consecutive sections were 
cut from the regions of interest on a cryostat (CM3050 S, Leica, Wetzlar, Germany), 
collected with Superfrost coated glass slides. Sections were dehydrated, delipidized 
and permeabilized in a pre-cooled methanol bath at -20 °C for 10 min. Section slides 
were washed in 1x PBS for 10 min and blocked in 200 µl IHC blocking solution for 
1.5 h. Appropriate primary antibodies were added and incubated over night at 4 °C. 
After extensive washes in 1x PBStx (0.2% Triton X-100), sections were incubated in 
200 µl secondary antibodies in IHC blocking buffer for 1 ~ 1.5 h at RT protected 
from the light. Sections were washed in 1x PBStx (0.2% Triton X 100) and 1x PBS, 
and then mounted in Fluoromount. 
 
2.5.3  In  situ  hybridization  on  whole-­mount  embryos  
This in situ hybridization protocol was based on Thisse & Thisse (2008). Embryos of 
desired developmental stages were dechorionated, terminally anaesthetized and fixed 
in 4% PFA/1x PBS RT at 4 °C. Embryos were dehydrated in 1 ml 100% methanol 
and left at -20 °C O/N. Through a 75%, 50%, 25% methanol/PBS rehydration series 
and extensive washes in 100% PBT, embryos were permeabilized in Proteinase K 
(10 µg Proteinase K / 1ml PBT) at RT. The digestion was terminated by incubating 
the embryos in 4% PFA for 20 min. Residual PFA was removed by washing in 1x 
PBT. Embryos were pre-hybridized with HM for 5 h in a 65 °C water bath to reduce 
the background staining. Embryos were incubated in 300 µl preheated HM 
containing RNA probe and left to hybridize O/N at 65 °C. To prevent nonspecific 
hybridization, embryos were washed with a series of pre-warmed HMW at 65 °C: 




PBT. Embryos were washed again at room temperature through a series of 10 min 
washes: 75%, 50%, 25% 0.2x SSC in PBT; 1x PBT. Embryos were incubated for 4 h 
in blocking buffer at RT on a shaker, and then incubated in anti-DIG antibody 
solution (1/10,000 dilution in blocking buffer) O/N at 4 °C with gentle agitation. 
Embryos were washed in 1x PBT at room temperature for 6 x 15 min. To equilibrate 
the embryos for the staining, embryos were washed in Alkaline Tris buffer (pH 9.5). 
They were then incubated in NBT/BCIP staining solution at RT until the desired 
staining intensity was reached. The reaction was stopped by washing with stop 
solution at RT with gentle agitation. Wash in 1x PBS to remove and transfer embryos 
to 70% glycerol in PBS for mounting.  
  
2.5.4  EdU  detection  
EdU labelling was detected by Click-iT EdU Alexa Fluor 647 Imaging Kit (Life 
Technologies; C10340). Larvae were terminally anesthetised and fixed in 4% PFA/1% 
DMSO for 3 h at RT, washed in 1x PBS and 1x PBStx (0.2% Triton X-100); 
emrbyos were digested for 40 min in collagenase (2 mg/ml in PBS), and washed 
again in 1x PBS and 1x PBStx (0.2% Triton X-100). Click-iT™ reaction cocktail 
was prepared by combining the following components in order: 4.3 µl 10x Click-it™ 
reaction buffer, 88.7 µl H2O, 2 µl CuSO4, 0.1 µl Alexa Fluor azide 647, 5 µl 
Reaction buffer additive. Samples were incubated in 500 µl reaction cocktail at 4 °C 
for 2.5 h protected from the light; and then washed in 1x PBS to remove the reaction 
cocktail. Finally, larvae were transferred to 70% Glycerol in PBS and mounted on 
slides. 
  
2.5.5  Whole-­mounted  larvae  TUNEL  Assay  
Zebrafish larvae at 5 dpf were anesthetized, fixed in 4% PFA/1% DMSO in PBS at 
RT for 3 h, washed in PBS and PBST (0.2% Tween® 20). Larvae were digested with 
collagenase (Sigma-Aldrich, Cat. No. C9891; 0.2 mg/ml in PBST) for 50 min. The 
TDT reaction cocktail was prepared according to the manufacture’s description 
(Click-iT® TUNEL imaging assay, C10247). Larvae were washed in PBS and 




extensive washes in PBS, larvae were either processed for immunohistochemistry or 
transferred to 70% glycerol in PBS.  
  
2.5.6  Acridine  orange  detection  
Dechorionated embryos were incubated in 10ng/µl Acridine orange solution in the 
dark for 20 min. Embryos were washed in embryo medium 3 x 10min and analysed 
under a fluorescence microscope. 
2.6  Spinal  cord  injury  in  zebrafish  larvae  
Spinal cord injury was performed on larvae from 3 dpf onwards (Protocol of Gianna 
Maurer). 1.2% low melting point agarose (0.12 g in 10ml PBS) was heated up in 
microwave and kept warm. Anesthetised larvae were mounted in agarose in a lateral 
position. Agarose was removed from desired areas to expose yolk and lesion site. 






2.7  Microinjection    
Injection needles were pulled from glass capillary by using a P-97 Flaming/Brown 
micropipette Puller. Messenger RNAs (mRNAs) were injected into one-cell stage 
embryos. mRNA was supplemented with 0.2% w/v phenol red (Sigma) to facilitate 
visualisation of the volume injected. For EdU injection, 5 nl of 5 mM EdU solution 
(2 µl EdU 10 mM, 1 µl 0.1 M KCl buffer, 1 µl PhenolRed Solution) was injected 





2.8  Quantification  and  statistical  analysis  
Zeiss stereomicroscope Lumar V.12 was used for the screen of motor neuron 
phenotypes, and Zeiss Imager.Z Apotome was used for the screen of motor axonal 
phenotypes. LSM 710 confocal microscope with a Zeiss Zen 2011 software was used 
for the acquisition of all fluorescent images. Acquired images were retrieved by 
image J/Fiji program (National institute of health, Bethesda, MD, USA).  
 
For cell counts in whole embryos, confocal images were opened in Image J/Fiji 
(National Institute of Health, Bethesda, MD, USA). Numbers of cells in a defined 
area of interest were counted manually in a stereological fashion throughout the z-
Confocal stack. For cell profile counts in sections, at least 4 sections were analysed 
per animal and values were expressed as profiles per 14 µm section. Stereological 
counts were manually performed in confocal image stacks of 4 randomly selected 
cryostat sections using Image J/Fiji software. 
 
A Zeiss Scope.A1 microscope equipped with Axio Vision software was used for the 
acquisition of images stained with ISH. Figures were prepared using Adobe 
Photoshop CC 2014. The graphs and statistical analysis were obtained through 
GraphPad Prism 5. 
 
Materials 
2.9  Transgenic  fish  lines  and  mutants 
Wild-­type  
Tg(islet-­1:GFP),  abbreviated  as  islet-­1:GFP  (Higashijima  et  al.  2000);;  
Tg(mnx1:GFPml2),  abbreviated  as  Hb9:GFP  (Flanagan-­Steet  et  al.  2005);;  
Tg(olig2:DsRed2),  abbreviated  as  olig2:DsRed  (Kucenas  et  al.,  2008);;  
Tg(pax2a:GFP),  abbreviated  as  pax2a:GFP  (Picker  et  al.,  2002);;  
Tg(sox10(7.2):mRFP),  abbreviated  as  sox10:mRFP  (Kirby  et  al.,  2006);;  
Tg(mbp:EGFP),  abbreviated  as  mbp:GFP  (Almeida  et  al.,  2011);;  
Mutant  family  55,  abbreviated  as  #55;;  
Mutant  family  151,  abbreviated  as  #151;;  
Mutant  family  160,  abbreviated  as  #160;;  




Mutant  family  249,  abbreviated  as  #249;;  





Primary  Antibodies   Host  
Species  
Dilution   Supplier  /  Cat.  No  
Acetylated  a-­tubulin   Mouse   1:1000   Sigma-­Aldrich  /  F7799  
α-­ChAT   Goat   1:500   Abcam  /  AB1449  
α-­Claudin  K   Rabbit   1:1000   Eurogentec  
α-­GABA   Rabbit   1:1000   Sigma-­Aldrich  /  A2052  
α-­GFP   Chicken   1:500   Abcam  /  AB13970  
α-­HB9   Mouse   1:400   DSHB  
α-­Islet1   Mouse   1:2000   DSHB  
Alexa  Fluor  546  phalloidin   Mouse   1:100   invitrogen  
F59   Mouse   1:50   DSHB  
Pax2   Mouse   1:500   Covance  /  PRB-­276P  
zn-­8   Mouse   1:500   DSHB  
zn-­12   Mouse   1:1000   DSHB  
3A10   Mouse   1:500   DSHB  
4D9  engrailed   Mouse   1:50   DSHB  
α-­phospho-­Histone  H3(pH3)   Rabbit   1:1000   Millipore  (06-­570)    
  
Secondary  antibodies  
Secondary  Antibodies   Dilution   Supplier  /  Cat.  No  
Cy3  Donkey  Anti-­Chicken  IgY  (IgG)     1:200   Jackson  ImmunoResearch  
Laboratories,  Inc.    
703-­165-­003  
Cy3  Donkey  Anti-­Goat  IgG     1:200   Jackson  ImmunoResearch  
Laboratories,  Inc.    
705-­165-­147  
Cy3  Donkey  Anti-­Mouse  IgG     1:200   Jackson  ImmunoResearch  





Cy3  Donkey  Anti-­Rabbit  IgG     1:200   Jackson  ImmunoResearch  
Laboratories,  Inc.    
711-­165-­152  
Cy5  Donkey  Anti-­Rabbit  IgG     1:200   Jackson  ImmunoResearch  
Laboratories,  Inc.    
711-­154-­152  
DyLight  649  Donkey  anti  Rabbit  IgG     1:200   Jackson  ImmunoResearch  




2.11  Enzymes    
Collagenase   Sigma-­Aldrich  (C9891)  
Bam  HI-­HF   New  England  Biolabs  Ltd  (R3136T)  
Hind  III   New  England  Biolabs  Ltd  (R0104S)  
Pronase   E   (Protease   type   XIV   from  
Streptomyces  griseus)  
Sigma-­Aldrich  (P5147)  
Proteinase  K  Solution   invitrogen  AM2548  
Proteinase  K,  recombinant,  PCR  grade     Roche  (03115887001)  
 
  
2.12  Buffers  and  solutions    
Alkaline  tris  buffer  
  
100  mM  Tris  HCl  1M  pH  9.5     
50  mM  MgCl2          
100  mM  NaCl            
0.1%  Tween  20  
IHC  blocking  buffer    
(whole-­mount  embryos)  
1%  Dimethyl  sulfoxide  (DMSO)  
1%  Normal  donkey  serum  (NDS)  
1%  Albumin  (BSA)  
0.7%  Triton  X  100  
IHC  blocking  buffer  (sections)   2%  Normal  donkey  serum  or  
normal  goat  serum  (NGS  or  NDS)  




In  situ  blocking  buffer   1x  PBT  
2%  Normal  sheep  serum    
2  mg/ml  BSA  
Citric  acid  10  mM  pH  6   1.92  g  Ctric  acid  
In  1  L  dH2O  
Adjust  to  pH  6    
EDTA  0.2  M  pH  8   18.6  g  EDTA  
3  g  NaOH  pellets  
In  250  ml  dH2O  
Adjust  to  pH  8  
Glycine  50  mM   0.0375  g  Glycine  
In  10ml  0.2%Triton  X  100/1x  PBS  
Hybridization  mix  (HM)   50%  Formamide  
5x  SSC  
0.1%  Tween  20    
50  µg/ml  Heparin  (50  mg/ml)  
5  mg/ml  tRNA  from  brewer’s  yeast  
In  Nuclease-­free  dH2O  
Adjust  to  pH  6.0    
Hybridization  mix  for  washes  (HMW)   50  %  Formamide  
5x  SSC  
0.1%  Tween  20  
In  Nuclease-­free  dH2O  
Paraformaldehyde  (PFA)  4%   16  g  Paraformaldehyde  
40  ml  10x  PBS  
In  400  ml  dH2O  
PBT   1x  PBS  pH  7.4  
0.1%  Tween  20    
Phosphate   buffered   saline   (PBS)   10x   PH  
5.5  
10.8  g  Na2HPO4  
65  g  NaH2PO4  
80  g  NaCl  
2  g  KCl    
In  1  L  dH2O  




Phosphate   buffered   saline   (PBS)   10x   PH  
7.4  
4  g  KCl  
28.3  g  NaH2PO4  
4.8  g  KH4PO4  
160  g  NaCl  
In  2  L  dH2O  
Adjust  to  pH  7.4  
Phosphate   buffered   saline   (PBS)   20x   pH  
7.4  
4  g  KCl  
4  g  KH2PO4  
23  g  Na2HPO4  
160  g  NaCl  
In  1  L  dH2O  
Adjust  to  pH  7.4  
SSC  20x  pH  7   175.3  g  NaCl      
88.2  g  Citric  acid  trisodium  salt    
In  1L  dH2O  
Adjust  to  pH  7  
In  situ  stop  solution     1x  PBS  pH  5.5     
     
1  mM  EDTA        
0.1%  Tween  20  
Tris  HCl  1  M  pH  9.5   121.1  g  Trizma  base  
In  1  L  dH2O  
Adjust  to  pH  9.5  
  
  
2.13  Reagents  and  solvents  
  
Name   Supplier  (Cat.  No./Code)  
Agarose   Thermo   Fisher   Scientific   (BP1356-­
100)  
Anti-­Digoxigenin-­AP  Fab  fragments   Roche  (11093274910)      
Ampicillin  sodium  salt   Sigma-­Aldrich  (A9518)  
2-­mercaptoethanol  (βME)       Fluka  




Dimethyl  Sulfoxide  (DMSO)   Sigma-­Aldrich  (D8418)  




Formamide   Sigma-­Aldrich  (47670)  
Fluoromount-­G   SouthernBiotech  (0100-­01)  
Glycerol   Sigma-­Aldrich  (G5516)  
Glycine  for  electrophoresis   Sigma-­Aldrich  (G8898)  
Heparin  sodium  salt  from  porcine  
intestinal  mucosa  
Sigma-­Aldrich  (H3393)  
LB-­Medium   MP  Biomedicals  (3002-­011)  
Methanol   Thermo  Fisher  Scientific  (M/4000/17)  
2-­Methylbutane   Sigma-­Aldrich  (320404)  
Magnesium  chloride  (MgCl2)   Sigma-­Aldrich  (M8266)  
Magnesium  chloride  solution   Sigma-­Aldrich  (63069)  
BCIP/NBT  (5-­bromo-­4-­chloro-­3-­indolyl  
phosphate/nitro   blue   tetrazolium)  
tablet  
Sigma-­Aldrich  (B5655)  
Normal  donkey  serum   EMD  Millipore  (S30)  
Sheep  serum   EMD  Millipore  (S22)  
OCT  Embedding  Matrix   CellPath  (KMA-­0100-­00A)  
Potassium  chloride  (KCl)   Sigma-­Aldrich  (P5405)  
Paraformaldehyde   Sigma-­Aldrich  (P6148)  
2-­propanol   Sigma-­Aldrich  (I9516)  
RNaseOUT   Recombinant  
Ribonuclease  Inhibitor  
invitrogen  (10777-­019)  
Sodium   phosphate   dibasic   dehydrate  
(Na2HPO4)  
Sigma-­Aldrich  (71643)  
tRNA   (Ribonucleic   acid   from   torula  
yeast,  Type  VI)  
Sigma-­Aldrich  (R6625)  
Triton  X  100   Sigma-­Aldrich  (93426)  
Tween  20   Sigma-­Aldrich  (P4348)  






Name   Supplier    
(Cat.  No.  /Product  code)  
Click-­iT  EdU  Alexa  Fluor  647  Imaging  Kit   Life  Technologies  (C10340)  
Expand  High  Fidelity  PCR  System   Roche  (11732641001)  
FastPlasmid  Mini  Kit   5  Prime  (2300000)  
Gentra  Puregene  Tissue  Kit   QIAGEN  (158667)  
MAXIscript  kit   Invitrogen  (AM1320)  
RNeasy  Mini  Kit   Invitrogen  (AM1320)  
QIAquick  PCR  Purification  Kit   QIAGEN  (28104)  
QIAquick  Gel  Extraction  Kit   QIAGEN  (28704)  
StrataClone  SoloPack  Competent  Cells   Agilent  Technologies  (200185)  
StratacClone  PCR  Cloning  Kit   Agilent  Technologies  (240205)  
SuperScript   III   CellsDirect   cDNA   Synthesis  
System  











Chapter   3         In   vivo   screen   for   motor   neuron  
development  and  differentiation  genes  
 
3.1  Introduction  
3.1.1  Development  of  motor  neurons  and  axons  in  zebrafish  spinal  cord  
In the developing zebrafish spinal cord, motor neurons group together in each spinal 
segment and extend axons in a stereotypical manner to innervate different muscle 
groups and facilitate locomotor movements (Myers et al. 1986; Eisen et al. 1986). 
Spinal motor neurons are classified into two types – primary and secondary motor 
neurons (Eisen et al. 1986; Eisen 1994; Pfaff & Kintner 1998). Primary motor 
neurons are born from 9 hpf onwards and can be subdivided into 3 groups: rostral 
primary (RoP), middle primary (MiP) and caudal primary (CaP) motor neurons 
(Myers et al. 1986) (Fig 3.1 A). Primary motor neurons initiate axon projections in a 
cell-type specific manner (Myers et al. 1986; Eisen et al. 1986; Zeller & Granato 
1999). All three types of motor axons first extend their growth cones following a 
common path to reach the intermediate target – the horizontal myoseptum (HM) and 
pause for about two hours (Myers et al. 1986). After that, each type of motor axon 
diverges into their specific pathway to innervate ventral, dorsal and mediolateral 
muscles (McWhorter et al. 2003). The horizontal myoseptum is an important 
landmark and choice point for axon outgrowth. The CaP motor axon is the first to 
grow out of the spinal cord at around 18 hpf (Rodino-Klapac & Beattie 2004). At 
around 29 hpf, RoP, MiP and CaP axons have extended ventral-laterally, dorsally 
and ventrally into their target muscle groups (Rodino-Klapac & Beattie 2004). 
Secondary motor neurons are born from 16 hpf onwards (Eisen 1994). The first 
ventral secondary motor axon exits the spinal cord at around 28 hpf, while RoP-like 
and MiP-like axons extend from 48 hpf to 72 hpf (Myers et al. 1986; Ott et al., 2001). 
In human, a-motor neurons are the most abundant class of human motor neurons and 
control extrafusal muscle fibres, whereas g-motor neurons innervate intrafusal 
muscle fibres (Patrick J Babin et al. 2014). Primary motor neurons have not been 
described in amniotes, and g-motor neurons have not described in zebrafish, 




neurons (Babin et al. 2014). A subtype of a-motor neurons – FF-subtype (fast-switch, 
fatigable) is found to be particularly vulnerable to degenerative disease such as spinal 
muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), whereas g-motor 
neurons  are more resistant (Patrick J Babin et al. 2014; Conradi & Ronnevi 1993). 
     
 
 
Fig  3.1  Projections  of  primary  and  secondary  motor  axons  in  embryonic  spinal  
cord   of   zebrafish.   This   figure   is   adapted   from   McWhorter   et   al.   (2003).      (A)  
Schematic   of   three   types  of   primary  motor   neurons:  RoP,  MiP  and  CaP.  All   three  
types  of  motor  axons  follow  a  common  path  to  reach  the  first  immediate  target  HM,  
and  then  diverge  after  reach  the  second  intermediate  target  –  the  ventral  edge  of  the  
notochord,   to   grow   ventral-­laterally,   dorsally   and   ventrally.   (B)   Schematic   of  
secondary  motor  neurons  extending  axons  for  ventral  and  dorsal  muscle  innervation.    
	  
	  
Primary motor axons pioneer the paths of secondary motor axon (Pike et al. 1992). 
However, primary motor axons may not be required for the path-finding of 
secondary motor axons. Pike et al (1992) ablated primary motor neurons and showed 
secondary motor neurons are able to form normal ventral nerves without the 
guidance of primary motor axons. Panzer et al (2005) described a “where’s waldo” 
(wdo) mutant, in which secondary motor axons grow aberrantly and ectopically, 
whereas primary motor axons remain unaffected, indicating additional cues are 




So far, many genes have been identified to play a role in primary motor axon exits in 
zebrafish. For example, the diwanka gene is important for motor axon migration 
(Zeller & Granato 1999). In the diwanka mutant, motor neuron differentiation and 
survival are unaffected, however, primary motor axons failed to grow beyond the 
horizontal myoseptum to the somites. The topped gene specifically impact the 
extension of CaP axons (Rodino-Klapac & Beattie 2004).  In topped mutants, ventral 
primary CaP axon stalled in the horizontal myoseptum, whereas the dorsal MiP 
axons project normally. PlexinA3 is an essential guidance receptor for primary motor 
axon path-finding (Feldner et al. 2007; Palaisa & Granato 2007; Plazas et al. 2013). 
Knock down or knock out of plexinA3 results in aberrant primary motor axon 
branching and ectopic exiting from the spinal cord. Work of Zhong et al (2012) 
elucidated the role of chondrolectin (chodl) gene in motor axon development by 
knock-down of chodl in zebrafish embryos, which caused a stalling of primary motor 
axon development in the horizontal myoseptum. However, there is little know about 
the essential genes that take part in secondary motor neurogenesis and their axon 
differentiation and growth. As mentioned above, secondary motor neurons are maybe 
more similar to human motor neurons (Babin et al. 2014). Therefore, if we 
understand how these motor neurons are generated and how their axons find their 
targets, we might be able to promote the regeneration of motor neurons that are not 
replaced in human motor neuron diseases and spinal cord injury in the future. 
Therefore, I was interested in searching for genes that influence the development of 
secondary motor neurons and their axon path-finding.  
 
Owing to the generation of a transgenic reporter line, Tg(islet-1:GFP) (GFP; green 
fluorescent protein), in which the expression of GFP is driven by islet-1 promoter 
(Uemura et al. 2005), I was able to examine the secondary motor neurons and axon 
morphologies in living animals. In Tg(islet-1:GFP) transgenic line (referred to as 
islet-1:GFP form here onward), GFP is expressed in trigeminal ganglion neurons, 
Rohon-Beard sensory neurons and some commissural interneurons (Uemura et al. 
2005). In the spinal cord, at 72 hpf, islet-1:GFP+ neurons are the dorsal subset of the 
secondary motor neurons, although some ventral projection can be observed, they 




2005; Menelaou & Svoboda 2009) (Fig 3.2). For studies of ventrally projecting 
secondary motor neurons, another transgenic line Tg(gata2:GFP), in which GFP is 
expressed in ventral sub-population of secondary motor neurons that innervate 
ventral group of muscles, is commonly used (Menelaou & Svoboda 2009). In my 
study, I used islet-1:GFP line that is available in my research group as a readout in 
our genetic screen.  
 
	  
Fig  3.2   In   the  spinal  cord  of   islet-­1:GFP  transgenic   line,  GFP  positive  neurons  are  
the   dorsal   subset   of   the   secondary   motor   neurons   (arrowhead)   that   project   to  
innervate   dorsal  muscle   group   at   72   hpf.   Arrow   indicates   islet-­1:GPF  motor   axon.  
Scale  bar  =  50  μm.  
	  
	  
3.1.2  ENU-­induced  forward  genetic  screen    
In order to identify genes important for secondary motor neuron development and 
axon differentiation in an unbiased manner, I conducted a N-ethyl-N-nitrosourea 
(ENU) induced mutagenesis screen. It is a chemical mutagenesis method by 
incubating adult male fish with a potent mutagen ENU in order to generate progenies 
carrying heritable genetic lesions (Mullins et al. 1994).  
 
ENU is a chemical mutagen used to create point mutations that affects single genes 
in large scale mutagenesis screen. It is an alkylating agent that acts by transferring its 
ethyl group to oxygen or nitrogen site of DNA bases and causes mis-pairing and 




efficient chemical mutagen with a rate of ∼10−5 (about 1/1000 of the offspring) to 
generate point mutation in a given gene (Argmann et al., 2006). ENU has a lot of 
advantages compared with other mutagenesis methods. For instance, 
ethylmethanesulfonate (EMS) is commonly used in Drosophila and C.elegans, 
however, it gives a lower rate of recoverable mutations in zebrafish. Radiation 
mutagenesis such as X-rays and gamma rays show 10 folds lower rates of 
recoverable point mutation than ENU (Mullins et al. 1994; Solnica-Krezel et al. 
1994). Point mutations allow the study of gene mutation in either complete or partial 
loss-of-function, as well as gain of function (Detrich et al. 1999). 
 
In order to obtain progeny with non-mosaic DNA modifications (Solnica-Krezel et al. 
1994), a pre-meiotic mutagenesis was performed (Professor David Lyons, Maria 
Rubio). ENU targets all cell stages in the male germ line, however, only mutations in 
pre-meiotic spermatogonial stem cells create non-mosaic mutation (Knapik 2000). 
This is because lesions are induced in a single strand of DNA and are fixed in both 
strands during DNA replication and cell proliferation before differentiation to mature 
sperm cells (Nair & Pelegri 2011; Mullins et al. 1994). The genome modifications 
created by ENU are heritable and mutations can be recovered in their F2 offspring 
(Solnica-Krezel et al. 1994). In this case, 50% of a F2 family are heterozygous and 
25% F3 progeny are homozygosis for recessive mutations following the Mendelian 
ratios (Nusslein-Volhard 2012). This is in contrast to the mutagenesis in mature 
spermatozoa and female germ cells, in which the mutagenic effect is mosaic and 
recoverable mutation rate is low, as modifications are not fixed until after 
fertilization (Balling 2001). In post-meiotic germ cell mutagenesis, less than 25% 
progeny in F2 family carries new mutations due to the mosaic character of F1 
generation, and subsequently give rise to less than 10% F3 progeny exhibiting a 
mutant phenotype (Driever et al. 1996).  
 
In our genetic screen, individual F1 fish were mated with individual islet1:GFP 
animal to produce a F2 generation with GFP expressed motor neurons and motor 
axons. Phenotypic analysis is carried out in the F3 generation, and embryos are 




axon projections for identifying genes impacting secondary motor neuron generation 
and/or axon development.  
 
3.1.3  Whole  genomes  sequencing  for  gene  identification  
The ultimate goal of the ENU screen is to search for a causative gene that is 
responsible for a particular mutant phenotype. Briefly, genetic mapping involves the 
localization of a critical interval on a chromosome containing the mutation, followed 
by a targeted examination for candidate genes within this region, and subsequent 
validation by genotyping individual phenotypically wild-type siblings and 
phenotypic mutants.  
 
A traditional method for the identification of a phenotype causing gene is positional 
cloning. Positional cloning is to use genetic markers (DNA segments) to localize 
candidate genes to a specific linkage group, and then increasingly narrow it down to 
a critical interval on chromosome (Detrich et al. 1999). For fine mapping and 
candidate gene search, bulked segregant analysis (BSA) was used to identify closely 
linked markers by comparing the amplification difference of genomic DNA pools 
between mutant and their phenotypically wild-type siblings (Quarrie et al. 1999; 
Puliti et al. 2007). Linked markers are defined when PCR (Polymerase chain reaction) 
amplified fragments only present in wild-type pool but absent in mutant pool. The 
process of positional cloning is cumbersome, tedious and time-consuming. For a low 
coverage, mapping has to be carried out in pools of embryos to test the linkage of 
hundreds of markers, which are to be verified with individual embryos to confirm the 
linkage of the mutation to a specific chromosome, and to further isolate markers 
tightly linked to the mutation. These steps usually involve hundreds even thousands 
of PCR amplifications and gel electrophoresis.   
 
Next Generation Sequencing (NGS) technology, it has become widely used as a 
high-throughput method for linkage analysis and to identify mutated genes that 
correspond to an observed phenotype in both zebrafish (Voz et al. 2012) and other 
species. The principal of NGS is to identify a single nucleotide polymorphism (SNP) 




sequence and their phenotypically wild-type siblings (Henke et al. 2013). It requires 
the generation of homozygous mutants from a mutant founder to a separate 
polymorphic mapping strain, in order to provide a high level of polymorphic 
variation for genetic mapping as well as to distinguish strain specific alleles from the 
phenotype-causing mutation (Henke et al. 2013). For sequencing, embryos are 
collected from heterozygous carriers and sorted into mutant and phenotypically wild 
type embryos. Genomic DNA pooled from the mutants and their siblings are 
fragmented to short fragments using routine preparation of DNA libraries and 
processed with an Illumina sequencing technology equipped with manufactured 
primers. For genetic linkage analysis, the short sequences generated are assembled 
and aligned to the wild type reference genome. Chromosome regions containing the 
mutation are established from comparing the differences between the 
reference sequence and the mutant sequence. Through the public available genomic 
database, SNP within the linked region can be identified as potential candidate gene 
that is causing the phenotype (Voz et al. 2012; Schneeberger 2014). 
 
WGS is a powerful replacement for traditional positional cloning due to its efficiency, 
easy applicable and time-effective features. With the recent advancement of the 
technology the cost is becoming more and more affordable, making it an excellent 
tool for genetic mapping of mutate genes. In my research, I took advantage of the 
WGS technique to identify genes that are responsible for phenotypes observed in 
mutants of interest. 
 
3.2  Results  
3.2.1  A  screen  for  mutants  that  affect  secondary  motor  neuron  and  their  
axon  differentiation  
To discover new genes that are essential for the differentiation of spinal motor 
neurons and axons, I conducted a forward genetic screen for recessive alleles 
affecting secondary motor neuron generation and their axon path-finding in zebrafish 
mutagenized with ENU. I used a transgenic reporter line that selectively labels dorsal 
subtypes of secondary motor neurons as a readout for the assessment of motor 




which the timing of islet-1:GFP motor neuron development or the number of cells 
were altered, in order to find genes that are important for motor neuron development; 
(2) mutants that display errors in islet-1:GFP motor axon projections, such as ectopic 
spinal exits, abnormal branching, mis-projection or stalling, in order to identify genes 
that are essential for motor axon path-finding.  
 
I started ENU screening by generating F2 heterozygotes that are carrying random 
mutations. Nearly one thousand pairs of individual F1 animals and individual islet-
1:GFP fish were mated. 301 F2 families from 666 successful pair mating were raised, 
representing a total of 602 mutagenized genomes. Of these 301 F2 families, 111 with 
reasonable numbers (> 8) of fish and relatively balanced gender were used for the 
screen, representing 222 mutagenized genomes. With the help of my colleagues Dr. 
Karolina Mysiak and Dr. Antón Barreiro-Iglesias, 60-80 pairs from the F2 families 
were set up each week, an average of 1200 embryos were screened for any motor 
neuron phenotype, and islet-1:GFP+ dorsal projections were examined in 700-800 
flat-mounted living embryos at 3 dpf under a microscope. The mating and screening 
process lasted for 44 weeks and a total of 52,800 embryos were screened for 
phenotypes of interest. On average 4-6 crosses per family were evaluated from a total 
of 111 F2 families. This correspond to approximately 1.6 mutagenized genome 
screened per F2 family. I calculate that we effectively screened 178 mutagenized 
genomes of the 222 genomes represented in the 111 F2 families.  
 
We found 6 families in which embryos display gross morphological defects. In all 6 
families, embryos showed different morphological phenotypes including small eyes, 
heart oedema, curved body axis and signs of necrosis which eventually lead to 
complete degeneration (Fig 3.3). To avoid any indirect effects on motor neuron or 
axon development due to the overt physical impairment, these mutants were 
discarded.  





Fig   3.3   Identified   mutant   lines   with   general   morphological   defects.   (A)  
Phenotypically   wild-­type   control   sibling   at   3   dpf.   (B-­G)   6   mutants   with   general  
developmental  defects  showing  small  heads,  small  eyes,  heart  oedema  and  curved  
body  axis  are  shown  (indicated  with  arrows).  Lateral  views  of  embryos  are  shown,  
rostral  is  left,  dorsal  is  up.  Scale  bar:  500  μm  in  A  for  B-­D;;  500  μm  in  E  for  F,G.    
	  
 
From the screen, another 6 mutant lines were discovered with altered motor neuron 
numbers and/or motor axon outgrowth. Among these 6 mutant lines, 4 were 
identified with fewer islet-1:GFP motor neurons at 3 dpf (Fig 3.4 B’-E’). These 4 
mutant lines were designated #151, #160, #171, #217 on the basis of their F2 family 
names. In addition to their motor neuron defects, mutants also displayed 








Fig  3.4  Four  mutant  lines  identified  with  fewer  islet-­1:GFP+  motor  neurons  at  3  
dpf.   (A)  Bright  field   image  of  a  control  sibling  at  3  dpf.  (B-­E)  Bright  field   images  of  
the   morphologies   of   4   mutants   designated   #151,   #160,   #171,   #217   are   shown.  
Mutants  displayed  morphological  phenotypes  such  as  small  eyes  and  rounded  yolk  
sac   (arrows).   (A’-­E’)  Higher  magnification  of   the  areas  boxed   in  A-­E,   respectively,  
are  shown.  The  number  of   islet-­1:GFP+  motor  neurons  (arrowheads)   is  reduced   in  
all  4  mutants  (B’-­E’),  compared  with  the  control  sibling  (A’).  Lateral  views  of  embryos  
are  shown,  rostral  is  left,  dorsal  is  up.  Maximum  intensity  projection.  Scale  bars:  500  
μm  in  A  for  B-­E;;  100  μm  in  A′  for  B′-­E′.  
	  
	  
The remaining 2 mutant lines showed defects in islet-1:GFP+ motor axon outgrowth 
(Fig 3.5). At 3 dpf, mutants from designated #55 were shorter in size and appeared 
curved compared to non-homozygous siblings. Islet-1:GPF+ motor axons were 
disorganized in ventral position while dorsal projections were missing. The mutant 




#249 mutants have smaller eyes and a more rounded yolk sac compared with their 
control siblings. 
     
 
     
Fig   3.5   Two   families   identified   with   islet-­1:GFP+   motor   axon   defects.   (A-­C)  
Bright   field   images  of  a  control   sibling,  a  #249  mutant  and  a  #55  mutant  at  3  dpf.  
#55   showed   short   body   size   and   curved   body   axis   (arrow   in   C).   (a-­c)   Higher  
magnification  of  the  areas  boxed  in  A-­C,  respectively,  are  shown.  In  #249  mutant  (b),  
dorsal  motor  axons  were  absent  (arrowhead)  and  ventral  axons  were  relatively  short  
(arrow),   whereas   in   #55   (c),   dorsal   islet-­1:GFP+   axons   (arrowhead)  were  missing  
and  ventral  projections  (arrow)  were  disorganised,  in  comparison  with  control  sibling  
(a).   Lateral   views   of   embryos   are   shown,   rostral   is   left,   dorsal   is   up.   Maximum  
intensity  projection.  Scale  bars:  500  μm  in  A  for  B,  C;;  100  μm  in  a  for  b,  c.  
 
 
In order to confirm the mutation is inherited from their founder parents (germline 
transmission), mutant lines were outcrossed with another wild type line (eg. TL) that 
is polymorphic to the founder fish (wik). Off-springs raised were used for in-crosses 
and assessed for their phenotypic replications in the subsequent generations. 
Successive outcrosses also reduce the probability that more than one mutation leads 
to the observed phenotypes. Moreover, genetic mapping to identify phenotype-
causative genes relies on detecting the DNA polymorphism difference between two 
strains (Detrich et al. 1999), therefore this is a time-consuming but necessary step in 
obtaining mutants as well as creating a mapping strain for genetic linkage analysis 




phenotypes were confirmed in the F4 generation of 4 mutant lines: #151 and #171 
with fewer numbers of islet-1:GFP+ motor neurons; #55 and #249 with islet-1:GFP+  
motor axon defects.  
 
3.2.2  Mutant  characterization  at  early  developmental  stage  
3.2.2.1  Sonic  hedgehog  signalling  pathway  is  not  affected 
I first analysed the molecular pathways that could possibly be affected in these 
mutants. Sonic hedgehog signalling (Shh) is a pivotal morphogen in spinal cord 
differentiation and regulates the generation of motor neurons from the motor neuron 
progenitor domain (pMN) in the ventral spinal cord (Francius & Clotman 2014). For 
example, in the mutant smoothened (smo), primary motor axons are disorganized and 
secondary motor neurons are missing (Chen et al. 2001).  Reimer et al (2013) shown 
that endogenous dopamine acting on the Shh pathway enhances motor neuron 
generation in the ventral spinal cord. Morpholino oligonucleotides (MOs) knock-
down of dopamine receptor drd4a delayed the production of dorsal subtype of islet-
1:GPF+ motor neurons in zebrafish embryos (Reimer et al., 2013).  
 
In Shh pathway, transmembrane protein Patched 2 (Ptc2) binds to another protein 
Smoothened (Smo), which inhibits glioma-associated oncogene homolog 3 (Gli3) 
and result in repressed gene expression. When Shh binds to Ptc2, Smo is de-
repressed, which in turn activates the downstream pathway. This indicates that Ptc2 
acts as a negative regulator in a Shh feedback loop (Fig 3.6). To test the possible 
involvement of Shh, I used an antisense RNA probe to detect ptc2 and performed in 
situ hybridization at 24 hpf. As mutants cannot be clearly distinguished from their 
phenotypically wild-type siblings at 24 hpf, I used a pool of mixed embryos (+/+, 
+/m, m/m) for each mutant line (n = 20-30, N = 3). If Shh was affected in a mutant 
line, the expression of ptc2 would be altered in 25% of embryos. I observed no 
apparent change in ptc2 expression in embryos examined in 4 mutant lines (15-22 
out of 60-90 embryos for each line were expected to show a change in ptc2 
expression) (Fig 3.7), suggesting that a different pathway may be affected in these 
four mutant lines.  





Fig  3.6  Illustration  of  Shh  pathway.  This  figure  is  adapted  from  Evans  et  al.  (2012).  
The  left  figure  shows  when  Shh  cannot  bind  to  Ptc,  Ptc  protein  binds  to  Smo,  which  
lead   to   inactivated  downstream  pathway.  The   right   figure  shows  when  Shh  binds  
Ptc,   the  Ptc-­Smo  complex   is  disassociated,  which   lead   to   functional  Gli   activator  




Fig  3.7  Illustration  of  ptc2  expression  at  24  hpf.  (A)  Lateral  view  is  shown,  dorsal  
is   up,   anterior   is   to   the   left.   (B)  High-­magnification   image  of   the   area   boxed   in  A.  
Scale  bars:  A  =  50  μm,  B  =  100  μm.  
  
  
3.2.2.2   Immunohistochemistry   (IHC)   to   verify   the   specificity   of  mutant  
phenotypes  
To verify whether the motor neuron and axon phenotypes observed were the 
consequences of early abnormalities, I surveyed the degree of defects in all 4 mutants 
at early developmental stage (Table 3.1). I used several molecular markers to 
examine early born neurons and axons at 33 hpf. Similar to ptc2 in situ hybridisation, 
antibody labelling at this time point was applied to a pool of embryos (+/+, +/m, m/m) 




early developmental abnormalities, I expected to detect ~25% of embryos with 
altered patterns for the markers tested.  
 
I applied acetylated a-tubulin to label brain commissure tracts, cell bodies and early 
projecting motor axons (Fig 3.8 A-B). A zn-12 antibody is also applied to label 
motor axon projections (Feldner et al. 2007). HB9 antibody was used to detect the 
appearance of early born motor neurons (Fig 3.8 F) (Barreiro-Iglesias et al. 2015). To 
analyse the appearance of interneurons, I used anti-3A10, which labels Mauthner 
cells in the hindbrain and commissural ascending primary (CoPA) interneurons in the 
spinal cord (Feldner et al. 2007) (Fig 3.8 D,E). A 4D9-engrailed antibody that marks 
muscle pioneer cells at the horizontal myoseptum (Feldner et al. 2007) was also 
included (Fig 3.8 G). I found that in mutant lines #151, #171 and #249, embryos 
showed no apparent abnormalities for all markers used. This indicates that early 
development of cell types, recognised by the above antibodies was not altered. 
However, mutant line #55 displayed abnormal formations of primary motor axons 
(Fig 3.9 C-C’), Mauthner axons as well as CoPA interneuron axons (Fig 3.9 A-B’), 
suggesting the motor axon phenotype is likely to be the secondary effect of an early 
general developmental defect. This also demonstrates that I was able to detect early 
deficits in a mutant line from a pool of mixed embryos. As I was looking for genes 
more specifically involved in motor neuron development, the analysis was not 















Table  3.1  Mutant  lines  and  structures  analysed  at  33  hpf  by  IHC    
  
Mutant  line    

















0/41   0/55   0/26  












0/37   0/22  
RB  neurons      0/53   0/37   0/22  
Brian   commissural  
tracts  
   0/53   0/37   0/22  
Zn-­12   CaP  axons      0/62   1/46  
(2.1%)  
0/34  
Hb9   Motor  neurons   0/21   0/24   0/33   0/25  
4D9  
engrailed  
Muscle  pioneer  cells   0/19   0/20   0/18   0/15  
 
Note:  (1)  As  mutants  cannot  be  clearly  distinguished  from  their  control  siblings,  the  
works   presented   here   are   qualitative   analysis.   (2)   N   with   a   phenotype/Total   n  
analysed   stands   for   numbers   of   embryos   display   an   abnormal   phenotype   in   the  
marker   tested   among   the   total   number   of   embryos   examined.   (3)   Occasionally,   I  
observed  one  or  two  extra  motor  axon  exits  from  the  spinal  cord  in  #151  and  #171  in  
a   acetylated   tubulin   and   zn-­12   labelled   CaP   axons.   However,   the   number   of  







Fig   3.8   Illustrations   of   antibody   staining   at   33   hpf   non-­mutant   embryos.   (A)  
Acetylated   a-­tubulin   labelled   commissural   tracts   in   the   brain.   DVDT   stands   for  
dorsal-­ventral  diencephalic  tract;;  PC  indicates  posterior  commissure;;  POC  indicates  
post-­optic  commissure;;  AC  indicates  anterior  commissure  (Chitnis  &  Kuwada  1990;;  
Hjorth   &   Key   2002).   (B)   Acetylated  a-­tubulin   labelled   ventral   nerve   tracts   (arrow)  
and  Rohon-­Beard  (RB)  sensory  neurons.  (C)  zn-­12  antibody  labelled  ventral  axons  
(arrow).   (D)   3A10   labelled   Mauthner   cells   (arrow)   and   axons   (arrowhead)   in   the  
brain,   as   well   as   (E)   CoPA   interneurons   (arrow)   and   axons   (arrowhead).   (F)  
Appearance  of  HB9  immuno-­labelled  early  born  motor  neurons  (arrow)  in  embryonic  
spinal   cord.   (G)   4D9  engrailed  antibody   labels  muscle  pioneer   cells   (arrow)   in   the  
spinal  cord.  Lateral  views  of  embryos  are  shown,  rostral  is  left,  dorsal  is  up;;  expect  
for   (D)   Coronal   view   of   the   embryo   is   shown;;   anterior   is   up.   Maximum   intensity  






Fig   3.9   Mutant   line   #55   showed   motor   axon   and   interneuron   axon  
abnormalities  at  33  hpf.  (A-­A’’)  Coronal  view  of  embryos  are  shown;;  anterior  is  up.  
Compared   with   the   control   sibling   (A),   3A10   antibody   labelled  Mauthner   axons   in  
mutants   (A’,A’’)   displayed  abnormal  branches   (indicated  by  arrows).   (B,B’)   Lateral  
views  of  embryos  are  shown,   rostral   is   left,   dorsal   is  up.   In   the  spinal   cord,  CoPA  
interneurons  and  axons  are  disorganized   in   the  mutant   (B’).   (C,C’)  Mutant  embryo  
(C’)  showed  a  deformation  of  acetylated  a-­tubulin  stained  motor  neuron  cell  bodies  
and  axons.  Maximum  intensity  projection.  Scale  bars:  100  μm  in  A  for  A’,  A’’;;  50  μm  








In Summary, we conducted a small scale ENU screen in 111 F2 families in search 
for genes that influence motor neuron and motor axon differentiation – specifically 
for dorsal project motor neurons. In the initial screen, together with my colleagues, 
we identified 6 families with fewer islet-1:GFP+ motor neurons and/or deficient 
dorsal motor axons. From these 6 mutant lines, phenotypes of 4 mutant families (#55, 
#151, #171, #249) were confirmed and analysed at early stage to verify the 
phenotypic specificity. Except for #55, which showed aberrant islet-1:GFP axons, I 
found embryos from the remaining 3 mutant lines showed no early developmental 
abnormalities with the markers tested.  
 
In my research, I focused on two mutant lines for more detailed examinations at later 
stages: #151, in which mutant embryos displayed the most prominent islet-1:GPF 
motor neuron defects; and #249 with missing islet-1:GPF motor axons.  
 
3.2.3  Verification  of  mutant  line  #249  
3.2.3.1  Dorsal   secondary  motor   axons   failed   to   grow   out   and   the   late  
born  motor  neuron  generation  is  compromised  in  #249  mutant  
At 3 dpf, #249 mutants showed a failure in islet-1:GFP+ motor axon outgrowth, 
whereas in their control siblings, axons have extended dorsally (Fig 3.10). As 
mentioned earlier, although GFP is mainly expressed in those dorsally projecting 
secondary motor neurons (Uemura et al. 2005), some ventral projection can also be 
observed in islet-1:GPF transgenic line (Menelaou & Svoboda 2009). Mutants also 




Fig   3.10   islet-­1:GFP+  motor   axons   are   absent   in   #249   at   3   dpf.   (A)  A   control  




projection  (arrowhead).  (B)  Mutant  failed  to  grow  dorsal  axons  (indicated  with  arrow),  
and  showed  altered  ventral  projections  (arrowhead)  compared  with  control.  Lateral  
views  of  embryos  are  shown,  rostral  is  left,  dorsal  is  up.  Scale  bar  =  50  μm.  
 
 
To test if the axon defect is specific to secondary motor axons, I used acetylated a-
tubulin that labels both primary and secondary axons at 3 dpf, and a cell-type-
specific marker zn-8 for secondary motor axons. Antibody zn-8 recognizes the cell 
recognition molecule neurolin/DM-GRASP, which is present only on secondary 
motor neurons and their axons (Ott et al., 2001; Menelaou & Svoboda 2009). Results 
showed in both control siblings and mutants that an antibody to acetylated a-tubulin 
labelled dorsal and ventral motor axons are present (Fig 3.11 A’’,B’’), whereas 
dorsally projecting secondary motor axons are missing in zn-8 staining (Fig 3.11 
A’,B’), indicating that the development of primary motor axons was normal. 
Interestingly, the mutant also showed axons accumulated in the pathway above the 
HM, suggests that the secondary motor axons that project ventro-medially in RoP 
pathway may also be affected (Fig 3.11 B’). These data indicate that the failure of 







Fig  3.11  #249  mutant  embryos  show  a  lack  of  secondary  dorsal  motor  axons.  
(A,B)  At  72  hpf,  islet-­1:GFP  control  sibling  has  grown  dorsal  projection  (arrowhead),  
whereas  dorsal   axons  are  missing   in   the  mutant   (indicated  by  arrowhead).   (A’,B’)  
zn-­8   antibody   staining   revealed   both   dorsal   (arrowhead)   and   ventral   secondary  
axons  (arrow)  in  the  control  sibling  (A’).  However,  zn-­8  labelled  dorsal  projection  is  
absent   in   the  mutant   (indicated  by  arrowhead),  and  showed  accumulated  axons   in  
the  pathway  above  the  HM  (indicated  by  asterisk).  zn-­8  labelled  ventral  projection  is  
present   in   the   mutant   (arrow).   (A’’,B’’)   Acetylated   a-­tubulin   labelling   in   control  
sibling  (A’’)  and  mutant  (B’’)  showed  dorsal  and  ventral  projection.  Lateral  views  of  









In order to investigate whether the generation of motor neurons in the mutants is 
altered, I used two antibodies to examine the numbers of motor neurons. I used anti-
Islet-1 to label late-born motor neuron somata (Feldner et al. 2007). Islet-1 is a 
transcription factor that belongs to LIM family. islet-1 mRNA can be detected in 
Rohon-Beard sensory neurons and interneurons such as DoLA (dorsal longitudinal 
ascending neuron) (Inoue et al. 1994). In motor neurons, endogenous islet-1 mRNA 
is also expressed by secondary motor neurons after 20 hpf (Inoue et al. 1994). This is 
unlike the islet-1:GPF transgenic line, in which GFP is expressed mainly in the 
dorsal subtype of secondary motor neurons. Reimer et al (2008) showed that 89% of 
the GFP-expressing neurons in the islet-1:GFP animals are double-labelled by the 
Islet-1 antibody, indicating the transgene expression is specific (Reimer et al. 2008). 
I also used choline acetyltransferase (ChAT) to label mature motor neurons in the 
spinal cord.  
 
I first compared the number of GFP+ cells in spinal cord sections of the mutants and 
control siblings. At 3 dpf, the number of GFP+ cells in mutant group was 6.75 ± 0.91, 
34% less than the control group 10.22 ± 0.56 (**p=0.0050; 14 µm spinal cord section, 
4 sections per embryo; n = 9-9; Mean ± SEM; Unpaired t test, two-tailed) (Fig 3.12 
C). Using anti-ChAT to label fully differentiated motor neurons, mutant embryos 
showed 30% fewer numbers ChAT immune-labelled cells in comparison with 
control siblings (Control group: 14.81 ± 0.65, mutant group 10.39 ± 0.61; Mean ± 
SEM; ***p=0.0001; 14 µm spinal cord section, 4 sections per embryo; n = 9-9; 
Unpaired t test, two-tailed) (Fig 3.12 D). I observed 14% lower numbers of Islet-1 
immunoreactive motor neurons in the mutant group, compared with control group 
(Control: 116.2 ± 3.23, Mutant: 100.2 ± 3.97; 60 µm spinal cord; Mean ± SEM; 
**p=0.0044; n = 13-12; Unpaired t test, two-tailed) (Fig 3.12 G). These results 
indicate that the generation of the late-born motor neurons is decreased in the 
mutants 
 
Taken together, these data suggest that the mutation affects not only the dorsal and 
rostral secondary motor axon outgrowth, but also the number of a small population 







Fig  3.12  #249  mutants  have  fewer  motor  neurons  at  3  dpf.  (A-­B’)  Cross  sections  
of   the   spinal   cord;;   dorsal   is   up.   (C)   Quantification   shows   few   numbers   of   GPF+  
motor   neurons   are   generated   in   the   mutants   (**p=0.0050;;   Unpaired   t   test).   (D)  
Control  siblings  show  higher  numbers  of  fully  differentiated  spinal  motor  neurons  at  
3  dpf,  compared  with  the  mutants  (***p=0.0001;;  Unpaired  t  test).  (E,F)  Lateral  views  
of  embryos  are  shown;;  rostral  is  left;;  dorsal  is  up.  Rohon-­Beard  sensory  neurons  are  
indicated  with  RB,   Islet-­1   immuno-­labelled  motor  neuron  are   indicated  with  arrows.  
(G)  Fewer  numbers  of  anti-­Islet-­1  labelled  motor  neurons  in  the  mutants,  compared  
with  control  siblings  (**p=0.0044;;  Unpaired  t  test).  Scale  bars:  A’’  =  25  µm  for  A-­B’’;;  









To test whether fewer motor neurons are due to decreased motor neuron progenitor 
cell proliferation, I crossed #249 heterozygotes with a olig2:DsRed transgenic line. 
In the olig2:DsRed line, DsRed protein is expressed in motor neurons and 
oligodendrocytes lineage cells (OPCs) under the regulatory sequences of the olig2 
gene. #249/olig2:DesRed heterozygous parents were identified from further in-
crosses and mutant embryos express DsRed protein were used for progenitor cell 
proliferation detection. I investigated the proliferation of olig2:DsRed+ cells in the 
mutant pMN zone at 51 hpf, when mutants can be distinguished from their 
phenotypically wild-type siblings, and at 72 hpf. To do so, I used the proliferation 
marker anti-phospho-Histone H3 (PH3) to label cells in M phase of the cell cycle. In 
this case, proliferating progenitor cells in the pMN were PH3 positive and DsRed 
positive cells. Quantification analysis of the number of olig2:DsRed+/PH3+ double 
labelled cells showed no significant difference between control and mutant group at 
51 hpf (Control: 6.14 ± 0.70, Mutant: 9.42 ± 1.36; Mean ± SEM; P=0.0950; 300 µm 
spinal cord; n = 7-7; Mann Whitney test, two-tailed) (Fig 3.13 A-C). At 72 hpf, I 
observed 0.50 ± 0.22 olig2:DsRed+/PH3+ cells in control siblings, whereas no 
double labelled cells were detected in the mutants (Fig 3.13 D-F) (P=0.1818; 300 µm 
spinal cord; n = 6-5; Mean ± SEM; Mann Whitney test, two-tailed). I observed some 
PH3 positive cells outside of the pMN domain, demonstrating that I am able to detect 
such cells. However, to confirm that the proliferation of motor neuron progenitor 
cells in the mutants is indeed not reduced, bigger sample size is required to increase 
the statistical power of the findings. For example, at 51hpf PH3 labelling, 13 samples 
in each group is needed in order to achieve statistical power of over 80%.  
 
Furthermore, as the earliest time point that the mutants can be phenotypically 
distinguished from their control siblings was at 51 hpf, it is necessary to examine the 
proliferation at earlier time points once the phenotype causative gene is confirmed. 
Future experiments also need to address that reduced number of motor neurons is not 






Fig  3.13  Proliferation  of  motor  neuron  progenitor  cells  is  not  reduced  in  #249  
mutants.   (A,B)  Lateral  views  of  51  hpf  embryos  are  shown;;  rostral  is  left,  dorsal  is  
up.  PH3  positive  and  DsRed  positive  cells  are   indicated  by  arrows.  (A’-­B’’’)  Single  
optical   sections  at  higher  magnification  show  a  DsRed+/PH3+  double   labelled  cell  
(indicated  by  asterisks  in  A,  B).  (C)  Quantification  showed  no  significant  difference  in  
numbers  of  olig2:DsRed+/PH3+  cells   in   the  pMN  zone  between  control  group  and  
mutant  group  at  51  hpf  (P=0.0950,  Mann  Whitney  test).  (D,E)  Lateral  views  of  72  hpf  
embryos  are   shown;;   rostral   is   left,   dorsal   is  up.   (D’-­D’’’)  Single  optical   sections  at  
higher  magnification  show  a  DsRed+/PH3+  double  labelled  cell  (indicated  by  arrow  




cell   outside   of   the   areas   of   interest   (indicated   by   arrow   in   E).   (F)   No   significant  
difference  in  numbers  of  olig2:DsRed+/PH3+  cells  in  the  pMN  zone  between  control  
group  and  mutant  group  at  72  hpf  (P=0.1818,  Mann  Whitney  test).  Scale  bars:  B  =  
100  µm  for  A;;  B’’’  =  15  µm  for  A’-­B’’;;  E  =  100  µm  for  D;;  E’’’  =  15  µm  for  D’-­E’’.  
  
  
3.2.3.2  Mutant  embryos  failed  to  form  myelin  
In embryonic spinal cord, olig2-expressing pMN domain specifies motor neurons as 
well as oligodendrocytes (Kazakova et al. 2006). Oligodendrocyte progenitors (OLPs) 
produced from pMN first proliferate, then migrate laterally and dorsally before 
differentiating into mature oligodendrocytes. In the central nervous system, single or 
multiple axons are enwrapped by multiple layers of myelin sheaths formed by 
oligodendrocytes (Kazakova et al. 2006). Myelination of motor axons reduces energy 
consumption for neuronal communication and facilitates rapid saltatory conduction 
of action potentials along axons. In the CNS system, neurons and oligodendrocytes 
interact reciprocally to coordinate myelination. Neurons are capable of regulating the 
development of myelin-forming oligodendrocytes (Simons & Trajkovic 2006). 
Neuronal signals such as plate-derived growth factors (PDGF) were found to mediate 
myelination by controlling OPC proliferation and survival (Simons & Trajkovic 
2006). Vartanian et al (1999) suggested that neuregulins derived from motor neurons 
in the ventral ventricular zone of the spinal cord are likely to be required for 
oligodendrocytes lineage development. Spinal cord cultures from neuregulin knock-
out mice showed specific loss of myelin-forming oligodendrocytes, whereas the 
addition of recombinant neuregulin rescued oligodendrocytes development 
(Vartanian et al. 1999). Axonal factors are also found to be able to stimulate the 
development of oligodendrocytes and myelination (Barres & Raff 1999; Gabrièle 
Piaton et al. 2010). It has shown that oligodendrocytes and myelin specific proteins 
also play a role in motor axon development. For example, a myelin protein called 
proteolipid protein (PLP) was identified as an essential mediator for myelinated axon 
stability and integrity (Gabrièle Piaton et al. 2010). PLP-deficient mice showed 
axonal swelling and degeneration in the optic nerve and spinal cord (Griffiths et al. 




survival. Defects in oligodendrocytes could cause demyelination which leads to 
subsequent axon degeneration (Nave 2010).  
 
To investigate if the myelin formation was compromised in the mutants, I examined 
myelination in mutant embryos with an antibody against the myelin protein Claudin 
k (Münzel et al. 2014). I did not detect myelin sheath in the mutants at both 72 hpf 
and 80 hpf (Fig 3.14), suggesting the gene may also influence oligodendrocyte 




Fig  3.14  Mutants  failed  to  form  myelin  at  3  dpf.  (A,A’)  Mutants  show  an  absence  
of   myelin   (indicated   by   asterisk)   at   72   hpf,   compared   with   control   siblings.   (B,B’)  
Anti-­Claudin  K  labelling  confirms  the  failure  of  myelination  in  the  mutants  (asterisk)  
at   80   hpf.   Dorsal   is   up,   ventral   is   down.   (Cross   sections,   14   μm   spinal   cord   per  









3.2.3.3  Muscle  development  is  impaired  in  the  mutants  
Muscle precursor cells located adjacent to the notochord in the horizontal 
myoseptum (HM) region and can differentiate into specific types of muscle fibres 
(Devoto et al. 1996). In zebrafish, spinal motor neurons in each somatic 
hemisegment first project their axons in a common path to reach the HM, then 
choose their individual pathway to reach their target muscle groups. Primary motor 
axons mainly innervate fast muscle fibres whereas secondary motor axons are 
responsible for both types of fast and slow muscles (Patrick J Babin et al. 2014). A 
zebrafish mutant spadetail provided evidence that muscle fibres play a role in axonal 
pathway selection (Eisen & Pike 1991). In the spadetail mutant, fewer primary motor 
neurons were produced and primary motor axons display severe pathfinding defects 
in muscle deficient myotomes. A reduction in the number of muscle cells in wild-
type embryos leads to a similar motor neuron and axon phenotype to that of the 
spadetail mutant embryos, suggesting that deficiency in muscle development may 
create an unsupportive environment for the navigation of axon growth. Other studies 
have also shown that genes functioning in muscle cells can be crucial for motor axon 
outgrowth. For instance, a zebrafish mutant topped discovered from a genetic screen 
manifests a defect in CaP axon pathfinding (Rodino-Klapac & Beattie 2004). Cell 
transplantation of wild-type cells into the mutant embryos revealed the non cell-
autonomous function of topped for motor neurons. By examining the cell types that 
provide topped activity, studies in chimeric embryos showed that the correct CaP 
axon pathfinding can only be restored by ventromedial fast muscle cells. This 
indicates a role of topped gene in promoting motor axon outgrowth by acting in fast 
muscle cells. Another two motor axon mutant genes, diwanka, which plays a role in 
establishing the common projection for primary motor axons, and unplugged, which 
is important for the correct pathfinding for CaP and RoP axons, have also been 
identified to act through a non cell-autonomous mechanism and functioning in slow 
muscles (Zeller & Granato 1999; Zhang et al. 2004). In the unplugged mutant, 
transplant experiments showed that the unplugged gene, which encodes a homolog of 
muscle specific kinase (MuSK), is not required in CaP and RoP motor neurons, but 
activates in the surrounding environment to guide axon pathway choices (Zhang & 




unplugged gene activity and were capable of rescue the motor axon defects. Adaxial 
cells are a type of muscle pioneer cells that develop into slow muscle fibres of the 
adult fish (Devoto et al. 1996). In chick, motor nerve formation was affected by the 
removal of somatic muscle precursors (Eisen 1994). Taken above, muscle 
development can be crucial for the proper axon outgrowth of motor neurons. 
 
To test if muscle morphology is impaired in the mutants, I used phalloidin to label 
fast muscle fibres, and F59, which recognises slow muscle fibres. In general, mutants 
display reduced labelling intensity in both antibodies labelled muscle types in the 
trunk, and showed disrupted muscle fibres in the tail at 3 dpf (Fig 3.15), indicates 




Fig  3.15  Muscle  development  is  impaired  in  the  mutants.  (A-­C’)  Mutants  showed  
less   density   in   Phalloidin   labelled   fast   muscles   and   disconnected   muscle   fibres  
(arrows)  in  trunk  region  and  tail  at  3  dpf,  compared  with  control  siblings.  (D-­F’)  F59  
labelled   slow  muscles   revealed   less   density   in  mutants   and   disconnected  muscle  
fibres   (arrows).   Lateral   views   of   embryos   are   shown;;   rostral   is   left;;   dorsal   is   up.  









3.2.3.4  Generation  of  Pax2  interneurons  is  not  changed  
To detect the impact of the gene on the other neuron populations such as 
interneurons, I quantified and compared the numbers of Pax2 immuno-labelled 
interneurons by immunohistochemistry antibody labelling. In control siblings, 
numbers of Pax2+ cells reached 56.77 ± 2.58, comparable to the numbers in mutant 
embryos 57.67 ± 3.50 (P=0.8367; 60 µm spinal cord; n = 13-12; unpaired t test, two-
tailed) (Fig 3.16). This result indicates the generation of Pax2 interneurons in #249 
mutants is not affected.  
 
 
Fig   3.16   Numbers   of   Pax2   positive   immunoreactive   interneurons   in  mutants  
are  comparable   to  control   embryos.   (A,B)  Lateral  views  of  embryos  are  shown,  
rostral   is   left,   dorsal   is   up.   (C)   Quantification   shows   no   statistical   difference   in  
numbers   of   Pax2+   interneurons   between   control   siblings   and   mutant   embryos  
(Unpaired  t  test,  P=0.8367).  Scale  bar  =  25  µm.  
 
 
3.2.4  #249  candidate  gene  identification  
To identify mutated gene that is responsible for the motor axon phenotype observed 
in #249, I isolated genomic DNA pools from 141 control siblings and 90 mutants at 
3dpf. NGS was outsourced to Edinburg Genomics. Bioinformatics analysis of raw 
reads generated from NGS and gene annotation was kindly performed by Dr Richard 
Poole (University College London), using a CloudMap (Minevich et al. 2012) tool 
that is available on Galaxy web platform. Assembled sequence was aligned to 
zebrafish reference genome Zv9/danRer7 and was viewed via UCSC genome 
browser. The mutation was mapped between 10-15 Mb on chromosome 4 containing 




causative mutation in #249 is to priorities a suitable candidate gene that may possibly 
play a role in the process of motor axon growth. From these candidates, only one was 
a nonsense mutation at Chr4:1399241952.8 in the transcript 
ENSDART00000019647, coding for a Psmc2 (proteasome 26S subunit, ATPase 2) 
protein. The remaining candidate genes cause missense mutations (Appendix 1). A 
nonsense mutation is a point mutation in DNA sequence that give rise to a pre-
mature stop codon. A missense mutation causes a change in amino acid and lead to 
the change in protein sequence. In the nonsense mutation, a premature stop codon 
occurred in the coding sequence often give rise to unfinished or inactivate protein 
product, thus it is likely to have considerable impact on protein function and lead to a 
phenotypic effect that is severer than the missense mutation. Furthermore, psmc2 
encodes a sub-unit of 26S proteasome, which is a major component of the ubiquitin 
proteasome system (UPS) (Yi & Ehlers 2007). Studies have shown that ubiquitin 
proteasome system (UPS) plays a role in axon guidance (Imai et al. 2010; Lewcock 
et al. 2007; Mehta et al. 2004). Taken above, psmc2 is a reasonable choice and was 
selected as a candidate gene potentially responsible for the #249 mutant phenotype 
for further validation. 
 
3.2.4.1  PCR  based  candidate  gene  genotyping  
In the #249 mutant genome, a C-to-T substitution occurred at the first exon of 
candidate gene psmc2 give rise to a nonsense mutation. This C-to-T conversion 
caused a pre-mature stop codon in the coding region, resulting a truncated protein 
translation of psmc2 (Fig 3.17). To confirm the presence of the C/T transition in 
genomic DNA (gDNA) in #249 mutants, I amplified and sequenced a fraction of 
gDNA (~340 bp) flanking the mutation site for both mutants and their siblings. 
Results from sequencing individual control embryo (n = 10) and mutant embryo (n = 
9) confirmed that this G-to-T replacement exits in the DNA sequence of psmc2 
candidate gene. This piece of information is important as it confirmed the change of 
amino acid in the resulting protein sequence, and hinted a possible functional impact 







Fig  3.17  #249  mutant  has  a  pre-­mature  stop  codon  in  candidate  gene  psmc2.  
(A)   Illustration   of   psmc2   genome.   Sequence   electropherograms   of   a   wild-­type  
embryo   and   a   #249   mutant   from   individually   genotyped   control   siblings   (n   =   10)  
and  #249  mutants   (n   =   9)   indicating   the   nucleotide   substitution   from  C   to   T   in   the  
exon   1   (boxed   area).   (B,C)   Schematics   show   the  C   to   T  mutation   caused   a   one-­




3.2.4.2  psmc2  gene  is  widely  expressed  during  embryonic  development  
Full length cDNA of zebrafish psmc2 encodes a protein of 433 amino acids. 
Comparison of the amino acid sequence of zebrafish across species revealed a high 
degree of overall conservation: 98.8% identity with human, 99% identity with mouse 





To study whether the psmc2 gene is expressed during embryonic development, I 
generated an anti-sense RNA probe for psmc2 and examined the expression pattern. I 
first performed psmc2 in situ hybridization at 24 hpf in whole-mounted wild-type 
wik embryos. I observed a widely expressed psmc2 in the whole embryo and 
prominent expression in somites (Fig 3.18 B-C’’). This broad expression pattern is 
expected, as psmc2 encoded 26S proteasome sub-unit belongs to the ubiquitin 
proteasome system, in which ubiquitin is named after its universal presence (Yi & 
Ehlers 2007). This data suggests psmc2 is expressed at early stage of embryonic 
development. To further investigate the psmc2 gene regulation (the amount and the 
timing of the appearance), in situ can be performed at earlier as well as later stages of 
development.   
 
To test whether the mRNA expression of psmc2 is affected in #249 mutants. I 
applied RNA in situ hybridization using a psmc2 anti-sense probe in a pool of 
embryos (+/+; +/m; m/m) collected from #249 heterozygotes. I expected to detect 
that 25% of the embryos display an altered expression if psmc2 mRNA is disrupted 
in the mutants. I observed a similar expression pattern to that of the wik embryos 
(n=20), and no apparent change in the expression of psmc2 at 24 hpf in #249 
embryos tested (10/40 were expected to show a change if psmc2 mRNA is affected) 
(Fig 3.18 C-C’). A possibility could be that the mutation only affects protein 
synthesis. Another possibility is that mRNA in the mutants did not undergo 
nonsense-mediated RNA decay (NMD). Nonsense-mediated RNA decay is a 
mechanism that prevents truncated protein synthesis by eliminating mRNA 
transcripts containing pre-mature stop codons (Brogna & Wen 2009). NMD in the 






Fig  3.18  Expression  of  psmc2  gene  is  during  embryonic  development.  (A)  The  
amino   acid   sequence   of   psmc2   shows   high   conservation   with   psmc2   of   other  
species   (DANRE   –   zebrafish;;   XENLA   –   Xenopus   laevis).   (B)   Examples   of  psmc2  
expression  in  24  hpf  wik  embryos.  Lateral  views  of  embryos  are  shown,  rostral  is  left,  
dorsal  is  up.  (n  =  20;;  N  =  2).  (C)  Examples  of  psmc2   in  situ  in  #249  embryo  pools.  
Embryos  tested  showed  similar  expression  pattern  to  that  of  the  wik  embryos  and  no  
obvious  changes  in  psmc2  expression.  (B’,C’)  Higher  magnification  of  areas  boxed  
in   (B,C)   indicates   prominent   expression   in   somites.   (B’’,C’’)   Cross   sections   are  
shown,  spinal  cord  and  notochord  are  indicated  by  lines;;  dorsal  is  up.  Scale  bars:  B  




3.2.4.3   Overexpression   of  psmc2  mRNA   leads   to   ectopic   dorsal   axon  
outgrowth  and  improved  morphology  in  #249  mutants  
Functional analysis such as a gain-of-function and loss-of-function approaches are 
often used to further confirm whether the phenotype of interest is caused by the 
candidate gene. A gain-of-function study is an attempt to rescue the mutant 
phenotype by over-expressing wild type mRNA. Theoretically, a phenotype caused 
by a disrupted allele can be functionally complemented and genetically rescued by 
expressing a wild-type endogenous allele of the mutated gene (Schneeberger 
2014). Another common approach is a loss-of-function study to knock-down/out 
target gene for the purpose of mimicking the phenotype observed in the mutant, and 
therefore confirm the function of the gene (Puliti et al. 2007). 
 
To determine whether psmc2 is the affected gene causing motor axon outgrowth 
defects in #249 mutants, I first carried out a rescue experiment by 
overexpressing psmc2 mRNA. I amplified full-length psmc2 cDNA from wild-type 
whole-embryo RNA and inserted the product into a pCSP2 vector for in vitro 
transcription of mRNA. psmc2 mRNA was injected into wild-type embryos to test 
the toxicity at a range of concentrations of 50 ng/µl, 100 ng/µl and 150 ng/µl. 
Injected embryos showed no developmental abnormalities in the concentrations 
tested. To overexpress psmc2, embryos collected from single pairs of heterozygous 
#249 mutants were divided into an un-injected control group and an injected group. 
Approximately 1.67nL in volume of mRNA (150 ng/µl) were injected into one-cell 
stage embryos and phenotypic examination was conducted at 3 dpf. In the un-
injected control group, islet-1:GFP axons had extended dorsally in the phenotypically 
wild-type embryos at 3 dpf (Fig 3.19 A,A’), and un-injected control mutants showed 
a failure in islet-1:GFP axon outgrowth (Fig 3.19 C’). However, in the psmc2 
mRNA-injected group, mutants showed ectopic GFP positive dorsal projections, and 
an improvement in gross morphology such as eye sizes and more absorbed yolk sac 
(Fig 3.19 B,B’). Follow-up to 4 dpf, most un-injected mutants (13/18) have died, and 
the remaining (5/18) showed curved body axis and signs of degeneration (Fig 3.19 F). 
All mRNA-injected mutants (n=16) survived at 4 dpf (Fig 3.19 E). Control embryos 




evidences suggest overexpressing psmc2 mRNA can partially rescue the axonal and 
morphology phenotypes in #249 mutant. This supports psmc2 as a causative gene for 
#249 mutant phenotype. To examine if there is complete rescue in some embryos, 




Fig  3.19  psmc2  mRNA  overexpression   results   in  ectopic  dorsal  axon  growth  
and  morphological   improvement.  Lateral  views  of  embryos  are  shown,  rostral   is  
left,  dorsal  is  up.  (A-­C)  Examples  of  an  un-­injected  control  sibling,  a  psmc2  mRNA-­
injected  mutant   and   an   un-­injected  mutant   at   3   dpf.  Mutant   displayed   small   sized  




(arrow)   in  the  brain  (B),  compared  with  un-­injected  control  (A).  The  mRNA-­injected  
mutant  showed  an  improvement  in  eye  size  (dashed  circle  line),  more  absorbed  yolk  
sac   (arrowhead),   and   no   sign   of   haemorrhage   (C),   compared   with   un-­injected  
mutant  (B).  (A’-­C’)  Higher  magnification  of  the  areas  boxed  in  (A-­C),  are  shown.  (A’)  
Un-­injected   phenotypically   wild-­type   control   has   developed   islet-­1:GFP+   dorsal  
projections  at  3  dpf  (arrow).  Injection  of  psmc2  mRNA  in  the  mutant  induces  ectopic  
projection  of  GFP  expressing  dorsal  axons  (arrows,  B’).  Un-­injected  mutant  showed  
a   failure   in   islet-­1:GFP+  motor  axon  outgrowth.   (D-­F)  Follow-­up  embryos  at  4  dpf.  
Inflated   swimming   bladder   (arrow)   can   be   observed   in   4   dpf   control   embryo   (D).  
Maximum  intensity  projections  are  shown.  Scale  bars:  500  µm  in  A  for  B,C;;  100  µm  
in  A’  for  B’,C’;;  500  µm  in  D  for  E,F.  
 
 
3.2.5  Characterization  of  mutant  line  #151  
3.2.5.1   Mutation   affects   motor   neuron   generation   and   motor   axon  
outgrowth  
To verify the isle-t:GFP motor neuron phenotype in #151 mutant, I analysed the 
number of motor neurons including primary and secondary motor neurons in the 
mutants (Fig 3.20). To do this, I used three different markers: HB9, Islet-1 and ChAT 
to detect numbers of motor neurons in the spinal cord. Endogenous islet-1 is 
expressed in RoP, MiP primary motor neurons as well as secondary motor neurons 
(Appel et al. 1995; Inoue et al. 1994), whereas in islet-1:GPF transgenic animals, 
GFP is expressed in the secondary dorsal subtype of motor neurons (Higashijima et 
al. 2000). hb9 (also known as Mnx1) is a member of mnx family genes that is 
expressed in early developing primary motor neurons as well as in a sub-population 
of VeLD interneurons (ventral longitudinal interneuron) (Seredick et al. 2012). It is 
known that anti-HB9 labels early born primary motor neurons and a small percentage 
of vsx1:GFP+ V2 interneurons that derived from P2 progenitor zone (Mysiak 2015). 
ChAT expression in cholinergic motor neurons is used as a marker for terminally 
differentiated motor neurons (Reimer et al. 2008).  
 
At 3 dpf, there were 8.21 ± 0.70 of GFP+ cells in spinal cord sections of control 




spinal cord per section, 4 sections per embryo; n = 6-5; **p=0.0043; Mean ± SEM; 
Mann Whitney test, two-tailed) (Fig 3.20 B). This data suggest that numbers of islet-
1:GFP+ motor neurons are significantly reduced in the mutants. #151 mutants 
showed 34% fewer numbers of mature motor neurons labelled by choline 
acetyltransferase (ChAT) compared with control group (Control: 19.45 ± 1.18, 
Mutant: 6.89 ± 1.54; Mean ± SEM; ****p<0.0001; 14 µm spinal cord section, 4 
sections per embryo; n = 15-13; Unpaired t test, two-tailed) (Fig 3.20 D). I also used 
anti-HB9 to examine the numbers of early-born motor neurons and anti-Islet-1 to 
investigate the late-born motor neurons. I found that mutants have 19% fewer HB9 
immuno-labelled cells and 17% fewer Islet-1 immuno-labelled cells than the control 
group (Fig 3.20 F,H). (Anti-HB9 cells: Control = 14.67 ± 1.79, Mutant = 11.95 ± 
0.82; 14 µm spinal cord per section, 4 sections per embryo; **p=0.0087; Mean ± 
SEM; n = 6-5; Mann Whitney test, two-tailed) (Anti-Islet-1 cells: Control = 115.3 ± 
3.88, Mutant = 96.31 ± 1.33; 60 µm spinal cord; n = 12-13; ****p<0.0001; Mean ± 
SEM; Unpaired t test, two-tailed). These data suggest that the production of motor 
neurons was decreased in the mutants. Particularly, the generation of late-born islet-







Fig   3.20  Motor   neuron   number   is   reduced   in   the   #151  mutants.   (A,A’)  Cross  
sections  of  the  spinal  cord  show  islet-­1:GFP+  cells.  (B)  Quantifications  show  fewer  
numbers   of   islet-­1:GFP+   cells   in   the   mutants   compared   with   control   group  
(**p=0.0043;;  Mann  Whitney  test).  (C,C’)  Cross  sections  of  the  spinal  cord  show  anti-­
ChAT   labelling.   (D)  Mutants  have   fewer  ChAT  positive  cells  compared  with  control  
group  (****p<0.0001;;  Unpaired  t  test).  (E,E;;)  Cross  sections  of  the  spinal  cord  show  
motor   neuron   marker   HB9   labelled   cells.   (F)   Mutants   show   significantly   fewer  
numbers  of  HB9  immuno-­labelled  cells  in  control  group  (**p=0.0087;;  Mann  Whitney  
test).  (G,G’)  Lateral  views  of  embryos  are  shown;;  rostral  is  left;;  dorsal  is  up.  Islet-­1  
immuno-­labelling  in  the  control  sibling  and  mutant.  (H)  Fewer  numbers  of  anti-­Islet-­1  
labelled  motor  neurons  in  the  mutants,  compared  with  control  siblings  (****p<0.0001;;  
Unpaired  t  test).  Scale  bars:  A’  =  20  µm  for  A;;  C’  =  25  µm  for  C;;  E’  =  20  µm  for  E;;  G’  




I analysed the presence of motor axons in different pathways in the #151 mutant. At 
3 dpf, islet-1:GFP+ motor neurons and their dorsal extensions are present in the 
control embryos, whereas in #151 mutants no GFP+ motor neuron axon projections 
were present (Fig 3.21 A,B). I used an antibody that binds acetylated a-tubulin to 
label both primary and secondary motor axons, and antibody zn-8, which is specific 
to secondary motor axons. In the acetylated a-tubulin staining, both dorsal and 
ventral axons were present in the mutants (Fig 3.21 B’’). However, I did not observe 
RoP primary motor axons in acetylated a-tubulin labelled mutant embryos (Control 
n=10; Mutant n=12). zn-8 staining confirmed absence of dorsal secondary motor 
axons in the mutant (Fig 3.21 B’) already seen in the islet-1:GFP transgenic fish. The 
secondary axons projecting ventro-laterally in the RoP pathway were also missing in 
the mutant group (Control n=8; Mutant n=8). These data suggest that in addition to 
the generation of motor neurons, rostral primary motor axons, as well as secondary 
motor axons that project in rostral and dorsal pathways are affected in the #151 






Fig   3.21   #151   mutant   showed   secondary   motor   axons   defects.   (A-­A’’)   islet-­
1:GFP+   motor   neurons   and   their   dorsal   extensions   (arrowhead)   in   the   control  
embryo   at   3   dpf   (A).   zn-­8   and   Acetylated   a-­tubulin   staining   revealed   dorsal  
(arrowhead  in  A’,A’’)  and  ventral  axon    (arrow  in  A’,A’’)  projections  in  control  siblings.  
Selectively   stacked   sections   of   a   rostral   projection   (asterisk)   is   shown   in   (A’’’)   to  
clearly  reveal  the  rostrally  projecting  motor  axon.  (B-­B’’’)  #151  mutant  showed  fewer  
islet-­1:GFP+  motor  neurons  (indicated  with  arrowhead)  at   the  same  stage  (B).   (B’)  
Mutant   also   showed   an   absence   of   zn-­8+   dorsal   (arrowheads)   projections.   (B’’)  
Acetylated   a-­tubulin   labelling   showed   that   both   dorsal   (arrowhead)   and   ventral  
(arrow)  axons  are  present  in  the  mutant,  indicating  that  primary  motor  axons  remain  
unaffected.  RoP  primary  motor  axons  is  absent  in  mutant  embryo  (asterisk  in  B’’).  A  
single  optical  section  of  a  dorsal  projection  (arrowhead)   is  shown  in  (B’’’)   to  clearly  
reveal   the   dorsally   projecting  motor   axon.   (C)   A   schematic   of   primary  motor   axon  
(green)   and   secondary   motor   axons   (red)   in   control   animal   and   mutant.   Lateral  
views  of  embryos  are  shown;;  rostral  is  left,  dorsal  is  up.  Scale  bars:  B  =  100  μm  for  




3.2.5.2  Survival  of  motor  neuron  progenitor  cells  is  not  affected    
There are several possibilities that could result in fewer islet-1:GFP motor neurons in 
#151 mutant. For instance, progenitor cells undergoing cell death could result in 
fewer motor neurons been produced. This can be examined by applying cell death 
detection with a progenitor marker such as olig2. Alternatively, reduced 
neurogenesis from progenitor cells could also affect the number of motor neurons. 
This hypothesis can be tested using proliferation marker to label pMN progenitor 
cells. The third possibility is that the survival and proliferation of progenitor cells are 
not affected, but the survival of motor neurons is compromised. To test this, cell 
death detection can be used in combination with motor neuron markers.  
 
To investigate whether the apoptotic cell death in motor neuron progenitor cells give 
rise to lower numbers of islet-1:GFP+ spinal motor neurons, I crossed #151 
heterozygotes with olig2:DsRed transgenic line and investigated the cell death of 
olig2:DsRed+ cells in the pMN zone of the mutants. I applied cell apoptosis 
detection at 38 hpf, when over 60% of islet-1:GFP+ motor neurons and 30% of 
hb9:GFP+ primary motor neurons are still to be born after this time; and at 48 hpf, 
when almost all motor neurons are born (Reimer et al. 2013).  
 
To test if the motor neuron progenitor domain undergoes selective cell death, I used a 
Terminal deoxynucleotidyl transferase (TdT) dUTP nick end labelling (TUNEL) 
assay (Kyrylkova et al. 2012). The TUNEL assay has been widely used in cell death 
analysis by detecting DNA under degradation. The hallmark of late cell apoptosis is 
the DNA double-strand breaks generated by DNA fragmentation. Blunt-ends DNA is 
detected by labelling its 3’-hydroxyl ends with modified dUTP and subsequently 
visualized by immunohistochemistry (Kyrylkova et al. 2012). The TUNEL assay 
also detects necrotic cell deaths, which is often caused by the deprivation of oxygen 
or toxin (Grasl-Kraupp et al. 1995). 
 
I observed no significant increase in the number of TUNEL positive cells in the 
mutants at either time points examined. At 38 hpf, mutants can be identified from 




TUNEL+/DsRed+ double labelled cells in control group, which is comparable with 
the mutants 0.13 ± 0.35 cells (P>0.9999; 100 µm spinal cord; n = 8-8; Mean ± SEM; 
Mann Whitney test, two-tailed) (Fig 3.22 A-C). Both control group and mutants 
showed no detectable TUNEL+/DsRed+ cell death at 48 hpf (P>0.9999; 100 µm 
spinal cord; n = 6-6; Mean ± SEM; Mann Whitney test, two-tailed) (Fig 3.22 D-F). 
However, apoptotic cells engulfed by macrophages disappear quickly in a few hours 
(Abrams et al. 1993). TUNEL-stained cells in fixed tissues allow only a snapshot of 
cell death at a time point. Also, to exclude that no detectable TUNEL+ cells at 48 hpf 
is not due to poor antibody penetration, I performed an in vivo cell death detection to 







Fig   3.22   No   increased   TUNEL   positive   olig2:DsRed   cells   in   mutants.   (A,B)  
Lateral   views   are   shown;;   rostral   is   left,   dorsal   is   up.   TUNEL+/   DsRed+   double  
labelled  cells  are  indicated  by  arrowheads.  (A’-­B’’’)  Single  optical  sections  at  higher  
magnification   show   a   TUNEL+   and   DsRed+   cell   (arrowheads   in   A,   B).   (C)   No  
significant  increase  in  number  of  TUNEL+  cells  at  38  hpf  (P>0.9999,  Mann  Whitney  
test).  (D,E)  TUNEL+  cells  were  not  detected  in  control  sibling  and  #151  mutant  at  48  
hpf.  (F)  Quantification  shows  no  increase  in  numbers  of  cell  death  in  #151  mutants  
at  48  hpf,  compared  with  control  (P>0.9999,  Mann  Whitney  test).  Scale  bars:  50  μm  




The study of in vivo apoptotic cell death detection was elucidated by Abrams et al 
(1993) by using a vital dye acridine orange (AO) in live Drosophila embryos and 
demonstrated that AO staining is specific for apoptotic cells. AO is cell permeable 
and statins individual cells that undergo phagocytes engulfment (Abrams et al. 1993). 
In my study, I incubated 38 hpf and 48 hpf embryos in 10ng/µl AO solution in the 
dark for 20 min, followed by washes in E3 embryonic medium (courtesy of Kelda 
Chia, protocol modified based on the methods of Barrallo-Gimeno et al. (2004)). The 
staining was visualized and documented using a confocal microscopy. At 38 hpf, no 
apparent increase of AO+/DsRed+ double stained cells was observed in the mutant 
group (Control: 0.43 ± 0.17, Mutant: 0.50 ± 0.17; Mean ± SEM; P=0.7730; 100 µm 
spinal cord; n = 14-14; Unpaired t test, two-tailed) (Fig 3.23 A-C). Similarly, 
statistical analysis revealed that no significant difference in numbers of DsRed+ cells 
stained with AO between control group and mutant group (Control: 0.11 ± 0.11, 
Mutant: 0.33 ± 0.23; Mean ± SEM; P=0.7353; 100 µm spinal cord; n = 9-9; Mann 
Whitney test, two-tailed) (Fig 3.23 D-F). As the olig2:DsRed line labels both 
progenitor cells and motor neurons, both TUNEL staining and AO staining suggest 
that the pMN progenitor cells did not undergo increased apoptotic cell death, and 






Fig   3.23  No   increase   in   apoptotic   pMN   cells   and  motor   neurons   detected   in  
vivo.  (A,B)  Lateral  views  of  live  embryos  are  shown;;  rostral  is  left,  dorsal  is  up.  AO+  
and  DsRed+  cells  are  indicated  by  arrows.  (A’-­B’’’)  Single  optical  sections  at  higher  
magnification   show   a  DsRed+/AO+   double   labelled   cell   (arrows   in   A,   B).   (C)   The  
number  of  olig2:DsRed+  cells  that  take  up  AO  is  not  increased  in  mutants  compared  
to   control   siblings   at   38   hpf   (P=0.7730,   Unpaired   t   test).   (D,E)   AO   detected   cell  
death  in  control  sibling  and  #151  mutant  at  48  hpf.  (F)  The  number  of  olig2:DsRed+  
cells  that  take  up  AO  is  not  increased  in  mutants  compared  to  control  siblings  at  48  
hpf  (P=0.7353,  Mann  Whitney  test).  Scale  bars:  100  μm  in  A  for  B;;  15  μm  in  A’  for  




3.2.5.3   Fewer   numbers   of   olig2:DsRed+   cells   are   produced   in   #151  
mutants  
As no apparent increase of cell death was observed in olig2:DsRed+ cells, I 
investigate the possibility that whether fewer motor neurons are due to fewer 
progenitor cells produced. I counted the number of olig2:DsRed+ cells in the AO 
treated samples presented and described above. At both 38 and 48 hpf, mutants 
showed fewer olig2:DsRed+ cells than the control group (Fig 3.24). At 38 hpf, there 
were 69.57 ± 1.61 olig2:DsRed+ cells in the control group, compared with 61.57 ± 
2.65 in the mutant group (Mean ± SEM; *P=0.0160; 100 µm spinal cord; n = 14-14; 
Unpaired t test, two-tailed). At 48 hpf, there were 103.7 ± 3.66 olig2:DsRed+ cells in 
control group, whereas mutant group has 85.22 ± 2.11 olig2:DsRed+ cells  (Mean ± 
SEM; ***P=0.0005; 100 µm spinal cord; n = 9-9; Unpaired t test, two-tailed). This 
suggests that decreased production of progenitor cells give rise to fewer numbers of 




Fig  3.24  Reduced  number  of  olig2:DsRed+  cells  in  #151  mutant.  In  the  left  panel,  
quantification  shows  fewer  numbers  of  olig2:DsRed+  cells  in  the  mutants  compared  
with  control   siblings  at  38  hpf   (*P=0.0160,  Unpaired   t   test).  The   right  panel  shows  
that  at  48  hpf,  the  number  of  olig2:DsRed+  cells  in  the  mutant  group  is  significantly  
fewer  then  the  control  group  (***P=0.0005,  Unpaired  t  test).  
 
I examined the proliferation of olig2:DsRed+ progenitor cells in the mutant pMN at 
38 hpf using a proliferation marker PH3 to label cells in M phase of their cell cycle. I 
observed lower numbers of olig2:DsRed+/PH3+ double labelled proliferating 
progenitor cells in the mutant group compared with control group (Control: 7.33 ± 




6-7; Mann Whitney test, two-tailed) (Fig 3.25). This is probably due to fewer pMN 




Fig  3.25  #151  mutants  show  fewer  proliferating  pMN  cells.   (A,B)  Lateral  views  
are   shown;;   rostral   is   left,   dorsal   is   up.   PH3+   and   DsRed+   cells   are   indicated   by  
arrows.  (A’-­B’’’)  Single  optical  sections  at  higher  magnification  show  a  DsRed+/AO+  
double   labelled   pMN   progenitor   cell   (indicated   by   asterisks   in   A,   B).   (C)  
Quantification  showed  lower  numbers  of  olig2:DsRed+/PH3+  cells  in  the  pMN  zone  
of  the  mutants  compared  with  control  siblings  at  38  hpf  (*P=0.0414,  Mann  Whitney  
test).  Scale  bars:  50  μm  in  A  for  B;;  20  μm  in  A’  for  A’’-­B’’’.  
 
 
3.2.5.4  #151  mutants  display  defects  in  other  systems  
To investigate the impact of the gene mutation in the #151 mutant, I adopted similar 
approaches to that used in the analysis of the #249 mutant to examine myelin 
formation, muscle morphologies as well as interneuron generation in #151 mutants. 




failure in forming myelin sheath in the mutants (Fig 3.26) indicating the gene may 




Fig  3.26  #151  Mutants  failed  to  form  myelin  at  3  dpf.  (A)  Anti-­Claudin  K  labelled  
myelin  sheath  in  the  control  sibling.  (B)  #151  mutant  showed  an  absence  of  myelin  
sheath  (indicated  with  asterisk)  at  72  hpf.  Cross  sections  of  the  spinal  cord,  dorsal  is  
up  (14  μm  per  section,  4  sections  per  embryo,  n  =  5-­5).  Scale  bar:  A  =  25  μm  for  B.  
 
 
To examine the muscle morphology in #151 mutants, I performed IHC labelling in 
fast muscle fibres and slow muscle fibres at various time points. Mutants display 
disorganized muscle fibres in both muscle types at 28 hpf, 48 hpf and 72hpf (Fig 







Fig   3.27   Muscle   morphology   is   abnormal   in   #151   mutants   at   different   time  
points.  (A-­C’)  Phalloidin  labelled  fast  muscles  at  28  hpf,  48  hpf  and  72  hpf.  Mutants  
showed  disorganized  (A’-­C’)  fast  muscle  fibres,  compared  with  control  siblings  (A-­C).  
(D-­F’)   F59   labelled   slow  muscles   revealed   abnormal   slow  muscle   development   in  
mutants   (D’-­F’).   Lateral   views   of   embryos   are   shown;;   rostral   is   left;;   dorsal   is   up.  
Scale  bars:  A  =  50  μm  for  A-­C’;;  D  =  50  μm  D-­F’.  
  
Next, I investigated the interneuron generation using anti-Pax2 to label a sub-class of 
interneurons followed by IHC. In the mutant group, I observed 41.23 ± 2.52 of 
Pax2+ cells at 3 dpf, which showed 27% fewer cells than the control sibling group 
56.75 ± 4.33 (Fig 3.28) (**P=0.0044; 60 µm spinal cord; n = 12-13; Mean ± SEM; 
Unpaired t test, two-tailed). The result suggests the Pax2+ interneuron generation is 




Fig  3.28  Generation  of  Pax2+   interneurons  are  affected.   (A,B)  Lateral  views  of  
embryos   are   shown,   rostral   is   left,   dorsal   is   up.   (C)   Quantification   shows   fewer  
numbers   of   Pax2   immuno-­labelled   interneurons   in   the   mutants   compared   with  
control  siblings  (Unpaired  t  test,  **P=0.0044).  Scale  bar  =  60  µm.  
 
 
3.2.5  #151  candidate  gene  identification  
From Next Generation Sequencing (Edinburgh Genomic) and bioinformatics 
analysis of the sequencing data (courtesy of Dr. Richard Poole), 14 protein-coding 
genes on chromosome 19 were identified as potential candidate genes that may be 




gene for further confirmation, I first selected candidates that causing a nonsense 
mutation, as a premature stop codon in protein coding sequence could lead to 
truncated or non-functional protein product. I then looked at the function of the gene 
through the literature: whether it is known to be involved in pathways that might 
explain the phenotype. I then designed a genotyping assay to check if only the 
mutants have the mutation. A SNP causing a nonsense mutation at 32244010 on 
chromosome 19 in the transcript ENSDART00000130326, coding for Rbbp4 
(retinoblastoma-binding protein 4) protein was identified as a potential phenotypic 
causing mutation for #151 mutant. Rbbp4 is a component of the Nucleosome 
Remodeling and Deacetylase (NuRD) complex (Pfefferli et al. 2014). It has found 
that rbbp4 is involved in fin regeneration in adult and zebrafish embryos (Pfefferli et 
al. 2014). Knock-down of rbbp4 leads to reduced proliferation of blastema 
progenitor cells and re-differentiation of their daughter cells, which are the cells 
required during regenerative outgrowth and patterning of the fin (Pfefferli et al. 
2014). The study also showed that rbbp4 knock-down impairs blastemal proliferation 
without inducing cell deaths (Pfefferli et al. 2014). Therefore, rbbp4 is a reasonable 
choice for further analysis. 
 
In order to verify the possible involvement of rbbp4, I first validated whether the 
mutation appears in the gDNA of #151 mutants. In the rbbp4 gene, a G-to-T 
substitute result in a pre-mature termination codon in exon 13 of rbbp4-201 
transcript (Ensembl). The nucleotide change leads to a loss of restriction enzyme site 
BtsCI in the mutants. Therefore, I designed primers to amplify a fraction of gDNA 
(100 bp) flanking the mutation site, and analysed PCR products with restriction 
enzyme digestion using BtsCI enzyme for both individual control siblings (n = 12) 
and mutants (n = 11). The digestion results were visualised in analytical gel. In this 
case, both gDNA strand of a wild-type embryo will be cleaved by BtsCI (Fig 3.29 B, 
+/+), whereas the mutant gDNA fragment without the BtsCI site would appear as 
“uncut” on the gel (Fig 3.29 B, m/m). In heterozygous embryos, only one strand will 
be cleaved by BtsCI and therefore appear as two bands on an analytical gel (Fig 3.29 








Fig   3.29   #151   mutant   has   a   pre-­mature   stop   codon   in   candidate   gene  
transcript  rbbp4-­201.  (A)  Illustration  of  the  reversed  strand  of  rbbp4-­201  transcript.  
G   to   T   (C/A   in   the   reversed   strand)   mutation   caused   a   one-­base   change   in   the  
rbbp4-­201   mRNA   and   protein   sequence   that   results   in   a   pre-­mature   stop   codon  
(underline).  (B)  12  phenotypically  wild-­type  siblings  and  11  mutants  were  genotyped  
individually  using  restriction  enzyme  digestion.  Control  refers  to  un-­digested  sample  









Full length cDNA of zebrafish rbbp4-201 transcript encodes a protein of 444 amino 
acids. In situ hybridization using RNA probe for rbbp4-201 displayed a broad 
expression of rbbp4-201 in whole-mounted wik embryos at 24 hpf (Fig 3.30). I 
examined rbbp4-201 RNA expression in a pool of embryos (+/+; +/m; m/m) from 
#151 heterozygotes, and observed similar expression pattern to that of the wik 
embryos. I also did not find apparent changes in rbbp4-201 RNA expression in #151 




Fig   3.30   rbbp4   is   widely   expressed   in   developing   embryos.   (A)   rbbp4   in   situ  
showed   a   broad   expression   in   24   hpf   embryos.   (B)   Higher  magnification   of   trunk  
area.  Lateral  views  of  embryos  are  shown,  rostral  is  left,  dorsal  is  up.  (n  =  20;;  N  =  2).  
Scale  bars:  A  =  50  µm;;  B  =  100  µm.  
 
 
To test whether overexpress rbbp4-201 mRNA could possibly rescue the observed 
islet-1:GFP motor neuron deficit in #151 mutants, I amplified full-length rbbp4-201 
cDNA from wild-type whole-embryo RNA, the product was cloned into a pCSP2 
vector and transcribed to mRNA. rbbp4-201 mRNA was injected into wild-type 
embryos to test the toxicity and showed developmental abnormalities at 500 ng/µl. 
Therefore, to overexpress rbbp4-201, I injected less than 500 ng/µl to avoid false 
results. I injected 1 nl of mRNA ranged from 50 ng/µl to 400 ng/µl into #151 
embryos at the one-cell stage and examined larvae at 3 dpf. I did not observe a rescue 
of the islet-1:GPF motor neuron defect in #151 mutants (data not shown), suggesting 
the attempted recue was unsuccessful. However, at this stage I cannot exclude the 
possibility that the injected mRNA was not expressed. Thus, it is necessary to 







In our genetic screen, I performed phenotypic characterizations in two mutant lines 
showing defects in motor neuron generation and motor axon development, and I 
started initial investigations for causative gene defects. In this part, I will discuss 
what has been achieved during the ENU screen and I will make suggestions for 
further work.  
 
In #249, phenotypical analysis showed no apparent abnormalities at early stages of 
development, including the development of primary ventral motor axons (See Table 
3.1). In 3 dpf #249 mutants, secondary ventral motor axons (CaP pathway) as well as 
primary motor axons project normally (Table 3.2). However, most islet-1:GFP motor 
neurons were present but failed to grow their dorsal projections (MiP pathway). The 
mutants also showed accumulated secondary axons ventro-medially, suggesting a 
subset of secondary motor axons projecting in RoP pathway could also be affected. 
In the islet-1:GPF transgenic line, GFP is expressed in the dorsal subtype of 
secondary motor neurons, whereas endogenous islet-1 mRNA is expressed in the 
RoP and MiP primary motor neurons and secondary motor neurons (Appel et al. 
1995; Inoue et al. 1994). By using Islet-1 marker, I found a small percentage of 
reduction in the numbers of Islet-1 immuno-labelled motor neurons (14-34%) in the 
mutants at 3 dpf. Interestingly, the generation of Pax2 interneurons are not affected 
in the mutants, hinting that motor neurons are probably more vulnerable to the 
mutation. Phenotypic examination of #249 mutants also displayed defects in 
myelination, reduced labelling intensity and disrupted muscle fibres in both fast and 
slow muscle types. These observations suggest that the impact of the gene is not 
specific to motor neurons and secondary dorsal motor axons. However, the critical 
question remains whether the gene acts in differentiation of islet-1:GFP transgenic 
neurons cell-autonomously, or whether the altered environment, such as defective 
muscles prevented axons from growing out of the spinal cord. Answering this 
question requires confirmation of the causative mutation, and to use cell 
transplantation to assess whether the mutant phenotype of interest is caused by the 
defects of the gene on motor neurons or the surrounding environment. For instance, 




or wild-type cell transplanted into mutant embryos are not influenced by the 
surrounding mutant cells and develop properly to extend dorsal projections, the gene 
is considered to be required only by the cells of interest. However, if wild-type cells 
fail to grow dorsal projections in the mutant environment regardless of their 
genotype, or mutant cells are able to develop properly by the influence of wild-type 
environment, means the gene acts non-cell autonomously. 
 
Additionally, I examined numbers of proliferating cells in the pMN domain of #249 
mutants in order to test whether the failure of the dorsal axon outgrowth was linked 
to the reduced proliferation of progenitor cells. I did not detect a significant decrease 
of proliferating progenitor cells. However, an increased sample size is required to 
increase the statistical power of the results, and to answer the question whether the 
olig2:GFP proliferation is reduced in #249 mutants. Also, it is not clear whether the 
reduced number of differentiating secondary motor neurons is due to the selective 




























Primary  motor  axons  
CaP   Present  
MiP   Present  
RoP   Present  
  
  










Accumulated  axons  above  
the  HM  
  
Motor  neurons    
islet-­1:GFP+  neurons   34%  Reduction  
Anti-­Islet-­1  labelled  neurons   14%  Reduction  
Anti-­ChAT  labelled  neurons   30%  Reduction  





olig2:Dsred  cell  proliferation    
(51  &  72  hpf)  
No   significant   reduction  
(Statistical   power   51%;;  
Bigger   sample   size  
required)    
Myelination   Anti-­Claudin   K   labelled   myelin  
sheaths  
No  myelin  detected  
Muscle  fibres   Fast  muscle  fibres   Affected  
Slow  muscle  fibres   Affected  
 
 
The approach of candidate gene identification involves the prioritisation of a suitable 
candidate gene that may be relevant to motor neuron or motor axon development, the 
determination of the existence of the mutation that may results in altered protein 
function, and the functional tests of the candidate gene in motor neuron development 
and motor axon outgrowth.  
 
I have initiated candidate gene verification for mutant #249 by first investigating the 
possible involvement of the gene psmc2. The one-base nucleotide substitute in psmc2 
resulted in a premature stop codon, which could lead to a non-functional protein 




high similarity across species, suggesting the gene’s function maybe conserved. 
Psmc2 is a 26S proteasome sub-unit that belongs to the ubiquitin proteasome system 
(UPS). It is also known as 26S proteasome AAA-ATPase subunit (Rpt1) in mammals. 
A major role of UPS is to control intracellular protein degeneration (Korhonen & 
Lindholm 2004). UPS degenerates proteins through two major processes: Enzymes-
mediated process to target mis-folded protein, and 26S proteasome complex 
regulated degeneration (Korhonen & Lindholm 2004). In UPS, E1 (ubiquitin 
activation enzyme) activates a small protein ubiquitin (Ub) in an ATP-dependent 
manner and transfer it to E2 (ubiquitin conjugation), E2 transfers activated Ub to E3 
(ubiquitin protein ligases), which ligates Ub into lysine residues on target protein and 
then degenerated by 26S proteasome (Hamilton & Zito 2013) (Figure 3.31 A). The 
26S proteasome consists one 20S core and two 19S regulatory particles. The 19S 
regulatory particle is composed of a base subcomplex (PSMC1 – PSMC6) and a lid 
subcomplex (PSMD1 – PSMD14) (Figure 3.31 B)  (Bedford et al. 2008). It is 
essential for unfolding the protein and opening the gate of 20S core particle to 
facilitate the translocation of protein substrates for degradation. PSMC2 belongs to 
the base subunit of the 19S regulatory particles and its expression is important for the 







Fig  3.31.   (A)  Schematic  representation  of  UPS  regulated  protein  degradation.  
In  the  ATPase  dependent  ubiquitin-­proteasome  pathway,  ubiquitin  (Ub)  is  activated  
by  E1  (ubiquitin  activation  enzyme)  and  transferred  to  E2  (ubiquitin  conjugation).  E2  
transfers  activated  Ub   to  E3   (ubiquitin   protein   ligases),  which   ligates  Ub  on   target  
protein.  In  the  26S  proteasome,  ATPases  within  the  19S  regulatory  particle  (lid  and  
base)  unfold  the  target  protein  substrate  and  translocate  it  into  the  20S  catalytic  core  
(a and β  rings),  which  cleaves  protein  substrate  to  small  peptides.  (B)  A  diagram  of  
the  structure  of  26S  proteasome  complex.  The  26S  proteasome  complex  is  made  
up   of   one   20S   core   and   two   19S   regulatory   particles.  The   19S   regulatory   particle  
consists   of   a   base   subunit   (PSMC1   –   PSMC6)   and   a   lid   subunit   (PSMD1   –  




UPS has shown to be involved in neurodegenerative diseases such as Amyotrophic 
lateral sclerosis (ALS) – knock-out a proteasome subunit specifically in motor 
neurons caused locomotor dysfunction and loss of motor neurons in mice; 
Parkinson’s disease (PD), in which a mutation in parkin encoded E3 ligase causes 
early on-set PD; and Huntington disease (Jansen et al. 2014). Bedford et al  (2008) 
showed that conditional knock-out of a 19S complex subunit, PSMC1 (Rpt2), results 
in 26S proteasome depletion and leads to neurodegeneration in mice brain. 
Furthermore, UPS is linked to axon outgrowth and degeneration (Hamilton & Zito 
2013; Yi & Ehlers 2007). (Korhonen & Lindholm 2004) suggested that UPS is 
essential for protein turnover and synapse maintenance in nerve endings. The 
dysfunction of the UPS could cause an aggregation of mutant proteins, which affect 
the axonal transport and neuronal connectivity, and eventually lead to axon 
degeneration. In C.elegans, a genetic screen identified an ot1 mutant encodes Lin-23, 
which belongs to E3 ubiquitin ligase complex of UPS (Mehta et al. 2004). Ot1 
mutants displayed deficit in motor axon outgrowth in two sub-classes of motor 
neurons (Mehta et al. 2004). Lewcock et al (2007) conducted a ENU mutagenesis 
screen in mice in searching for genes affect spinal motor axon path-finding. The 
study found a mutant Magellan with mis-projection and ectopic branching of motor 
axons (Lewcock et al. 2007). Genetic mapping indicated a premature stop codon in 
the phr1 gene, which encodes E3 ubiquitin ligase (Lewcock et al. 2007). The 26S 
proteasome complex also plays a role in motor neuron survival and axon outgrowth. 
For example, PSMC4 (Rpt3) is a subunit of 19S regulatory particle that belongs to 
26S proteasome complex (Tashiro et al. 2012). Conditional knock-out PSMC4 (Rpt3) 
in mice spinal motor neurons caused disrupted 26S proteasome activity, which leads 
to motor neuron loss and ALS phenotypes. Cheroni et al (2005) observed a decrease 
level of both 20S core subunit and 19S regulatory particle in spinal cord motor 
neurons in ALS mouse model SOD1G93A. In Drosophila, two mutations in 19S 
regulatory particle subunits, Mov34 and Rpn6, lead to decreased neuroblasts number 
and defected axon projection and dendrites pruning during development (Watts et al. 
2003). Moreover, Imai et al (2010) found MO knock-down psmc2, zebrafish 
embryos showed defects in lens fibre differentiation (Imai et al. 2010). These 




across species. Although UPS is expressed in various tissues, it is possible that 
mutations in the ubiquitously expressed housekeeping gene can cause specific 
phenotype. For instance, retinal inosine monophosphate dehydrogenase 1 (IMPDH1) 
is widely expressed in various tissues in human (Bowne et al. 2008). However, due 
to the unique requirement of photoreceptors for IMPDH1, it only causes 
degeneration in retina-specific photoreceptor. As PSMC2 is an essential part that 
forms the 19S regulatory particles and is important for the 26S proteasome activity 
(Nijhawan et al. 2012), it is possible that the mutation in psmc2 may lead to 26S 
proteasome dysfunction and cause motor neurons and motor axon defects. Taken 
together, psmc2 is a suitable candidate gene for further validation.  
 
In the first exon of the psmc2 gene, a one-base nucleotide substitute C to T resulted 
in a pre-mature termination codon. In situ hybridization using psmc2 RNA at 24 hpf 
wild-type embryos showed a wild expression in whole embryos, with prominent 
expression in somites. This broad expression of psmc2 showed a correlation with the 
multiple defects identified in #249 mutants. However, it is not clear if psmc2 mRNA 
is expressed in differentiating motor neurons. This can be verified by in situ 
hybridization in islet-1:GPF transgenic embryos, followed by IHC labelling of GFP 
cells with horseradish peroxidase (HRP). I examined the psmc2 mRNA expression in 
a pool of #249 embryos containing mutants, heterozygotes and wild-types, and 
observed no apparent change in psmc2 expression pattern. This suggests that mRNA 
did not undergo nonsense-mediated RNA decay in the mutants, otherwise I would 
detect low level of RNA expression in the mutant embryos. It is also possible that 
mutation only affects protein synthesis. Further investigation of changes in protein 
level can be done by using western blot.  
 
As part of the gene functional analysis, I performed a rescue experiment and 
overexpressed psmc2 mRNA in the mutants. I found psmc2 mRNA-injected mutants 
showed ectopic dorsal projections and improved morphological phenotype. This 
indicates that overexpression of psmc2 mRNA can partially recue the #249 mutant 
phenotype. To assess if a full phenotypic rescue is present, injected embryos need to 




step of gene function validation, a knock-down or knock-out experiment has to be 
carried out to study if the lack of psmc2 in wild-type embryos leads to a similar islet-
1:GPF motor axon phenotype as that observed in #249 mutant. If psmc2 is not the 
phenotype causing gene in #249 mutant, the next candidate gene can be chosen for 
further analysis is nell2b (neural epidermal growth factor-like 2) (Appendix 1). The 
one-base change in nell2b caused a missense mutation. The hydrophobic amino acid 
Isoleucine (I) is substitute by polar amino acid Asparagine (N), which could 
potentially have an effect on protein (Barnes & Gray 2003). The amino acid 
sequence of Nell2b is conserved across species (data not shown). nell2b has found to 
be specifically expressed in motor neuron and sensory neuron differentiation in chick 
(Nelson et al. 2004) 
 
In the #151 mutant line, mutants showed a 97% reduction in the number of islet-
1:GFP+ motor neurons at 3 dpf compared to control siblings (Table 3.3). 
Examination of the numbers of Islet-1 and HB9 immuno-reactive motor neurons 
revealed a 17-19% decrease in motor neuron numbers. These results indicate that the 
majority of motor neurons were generated, but the production of the late-born islet-
1:GFP+ motor neurons were severely affected. Immuno-labelling of motor axons 
showed unaffected primary motor axons such as CaP and MiP, and secondary motor 
axons that project ventrally in the CaP pathways. However, the rostral primary axons 
(RoP) that extend ventro-laterally, as well as dorsal secondary motor axon 
projections (MiP pathway) are absent. Together with the neuronal cell counts, these 
results hint that the generation of primary ventral and dorsal motor neurons and 
ventral subtype of secondary motor neurons are likely to be normal, but that the 
rostral primary motor neurons and the secondary motor neurons with dorsal 
projections (MiP pathways) and lateral projections (RoP pathway) are not formed. 
To study the possible causes for the lack of these motor neurons in #151 mutants, I 
examined the survival and differentiation of motor neuron progenitor cells. To 
investigate whether fewer islet-1:GFP motor neurons were due to the selective cell 
death in olig2:Dsred labelled progenitor cells and motor neurons, I applied cell death 
detection in both fixed tissues and in live embryos at 38 hpf and 48 hpf. I observed 




motor neuron progenitor cells and differentiated motor neurons are not compromised. 
I investigated whether fewer motor neurons were due to reduced progenitor cell 
proliferation, and observed a decrease in olig2:DsRed proliferation in the mutants. I 
detected proliferating olig2-expressing progenitor cells in #151mutants using PH3 to 
label cells in M phase, and observed a reduction in PH3 labelled olig2:DsRed cells in 
the mutant embryos. These results indicate that the proliferation of progenitor cells is 
compromised in the mutants. In addition to a reduced number of islet-1:GFP motor 
neurons, #151 mutants also showed other defects. For example, I found a failure in 
myelination and disorganized muscle fibres from early developmental stages. The 
generation of Pax2 interneurons is also affected in the mutant. These data suggest 
that the gene may have a significant impact on the generation of different neuronal 
types such as olig2:DsRed+ progenitor cells, islet-1:GFP+ motor neurons and Pax2+ 
interneurons. However, it is not clear whether the lack of motor neurons is secondary 
to the altered surrounding environment. Therefore, similar to #249, it is essential to 


























Primary  motor  axons  
CaP   Present  
MiP   Present  
RoP   Absent  
  
Secondary   motor  
axons    
CaP  pathway   Present  
MiP  pathway   Absent  
RoP  pathway   Absent  
  
  
Motor  neurons    
islet-­1:GFP+  neurons   97%  Reduction  
Anti-­Islet-­1  labelled  neurons   17%  Reduction  
Anti-­Hb9  labelled  neurons   19%  Reduction  
Anti-­ChAT  labelled  neurons   34%  Reduction  




Numbers  of  olig2:Dsred  cells    
38  &  48  hpf  
11%   &   18%  
Reduction  
Proliferation   of   olig2   progenitor   cell  
(38hpf)  
41%  Reduction  
Cell  death    
38  &  48  hpf  
Acridine  orange   No  increase  
TUNEL   No  increase  
Myelination   Anti-­claudin  K  labelled  myelin  sheaths   No   myelin  
detected  
Muscle  fibres   Fast  muscle  fibres   Affected  
Slow  muscle  fibres   Affected  
 
 
For #151 mutant, I investigated a candidate gene rbbp4 annotated from genome 
sequencing and bioinformatics analysis. A G-to-T substitute occurred in exon 13 of 
rbbp4-201 transcript give rise to a pre-mature termination codon in coding sequence. 
I detected the expression of rbbp4-201 mRNA and observed a broad expression 
pattern at 24 hpf wild-type embryos. I found no apparent changes in rbbp4-201 
mRNA expression examined in a pool of #151 embryos (+/+; +/m; m/m). Similar to 
#249, it could be that the mutation only affects protein synthesis, and western blot 
can be used to detect the change in protein level. Also, it is essential to apply in situ 
hybridization in olig2:GFP and Hb9:GFP transgenic embryos to evaluate whether 




differentiating motor neurons. In order to demonstrate that rbbp4-201 is the causative 
mutation of the phenotype, I performed a gain-of-function experiment. However, by 
overexpressing rbbp4-201 mRNA did not rescue the islet-1:GPF+ motor neuron 
phenotype in #151 mutant. The Failure of the rescue could be due to multiple reasons. 
For instance, it could be that rbbp4-201 is not the phenotypic causative gene of #151 
mutants. As the mutation occurs at the end of the last exon 13, it is possible that the 
mutation did not cause functional protein change that could contribute to a severe 
motor neuron phenotype. Also, some genes are expressed in a tissue specific manner. 
Rescue could fail because injected mRNA is ubiquitously expressed and prior to the 
endogenous RNA expression, which may not be transcribed and translated in 
accordance with the way that endogenous mRNA does. This inappropriate 
expression can lead to failure of the rescue. Therefore, to further verify the function 
of rbbp4-201 in motor neuron generation, it is critical to conduct a loss-of-function 
experiment by using either CRISPR/Cas9 to knock-out or morpholino to knock-
down rbbp4-201. Moreover, it is important to verify the other candidate gene 
identified. For example, a pre-mature stop codon is also occurred in another 
candidate gene ankmy2b (ankyrin repeat and MYND domain containing 2b) in the 
transcript ENSDART00000143494. Studies in mice have found that ankmy2 
regulates the Shh pathway through the interaction with another gene FKBP38 (Saita 
et al. 2014). Shh is a secreted morphogen that plays a key role in embryonic 
development including central nervous system (Chen et al. 2001). It is required for 
both primary motor neuron and secondary motor neuron development. Preliminary 
results by genotyping #151 mutants and their siblings confirmed the existence of the 
nucleotide substitution (data not shown). To confirm if ankmy2b is causative 
mutation in #151, a loss-of-function experiment to either knock-down or knock-out 
the gene, and attempted rescue of the motor neuron phenotype by gain-of-function 
experiment have to be conducted.  
 
As briefly discussed above, once the phenotype causing genes for both mutant lines 
are confirmed, a key study remains to test whether the genes are acting on the cell-
autonomous or non-cell autonomous manner. Cell-autonomous function of the gene 




cells independent from the surrounding environment (Li et al. 2011). Non-cell 
autonomous is the defect of neighbouring cells cause cells of interested to develop 
abnormally and therefore lead to a mutant phenotype (Li et al. 2011). To distinguish 
the two scenarios, a classic cell transplantation can be performed between mutants 
and wild-type embryos. Labelled donor cells from the mutant can be pulled and 
injected into wild type embryos, and vice versa, wild-type cells can be transplanted 
into mutant embryos. If mutant cells display a mutant phenotype regarding the wild-
type environment, and wild-type cells remain their identity and grow normally, the 
gene is required in the cells of interest and considered to functions cell-autonomously. 
On the contrary, if wild-type cells are affected by the mutant environment, and 
mutant cells are able to develop properly by the influence of surrounding wild-type 
cells, means the gene is required not only in the cells of interest but also other cell 
types. In this situation, the gene acts non-cell autonomously. In the case of my 
research, cell transplantation could answer the question whether impaired dorsal 
axon growth in #249 is due to lack of ability in motor neurons or an unsupportive 
muscle environment. Similarly, in #151 mutant, whether the wild-type progenitor 
cells would be affected by the mutant environment, and fail to differentiate and grow 
motor axons.  
 
3.4  Conclusion  
I carried out a phenotype-driven screen and effectively screened 178 mutagenized 
genomes of the 222 genomes represented in the 111 F2 families. We successfully 
identified 6 mutants that display lack of islet-1:GFP motor neurons and/or their 
axons. I performed further phenotypic characterization for mutant #249, which 
showed a failure in dorsal islet-1:GFP+ motor axon outgrowth; and mutant #151, 
which displayed selective lack of  islet-1:GFP+ motor neurons. For both mutants, 
functional analyses are necessary to determine genes that are responsible for the 
observed motor neuron and motor axon phenotypes. Genes identified from the screen 
will provide opportunities to dissect the mechanisms underlying the generation of 
motor neurons and path-finding of the motor axons, as well as the signalling pathway 





Chapter   4         Spinal   motor   neurons   are   regenerated  
after  mechanical  lesion  in  zebrafish  larvae    
 
4.1  Introduction  
4.1.1   Larval   lesion   induces   local   regeneration   of   motor   neurons   and  
shares  similar  mechanisms  to  that  of  the  adult  
In adult zebrafish, a mechanical lesion to the spinal cord leads to the proliferation of 
ependymo-radial glial cells (ERGs) which give rise to new born motor neurons, 
indicating a high degree of plasticity of spinal progenitors. The regeneration process 
has been found to be regulated by signals such as notch (Dias et al., 2012), serotonin 
(Barreiro-Iglesias et al., 2015) and dopamine signalling acting through its D4a 
receptor on the sonic hedgehog pathway (Reimer et al., 2013). From the previous 
study of my research group, Dr. Jochen Ohnmacht found that in zebrafish larvae, 
targeted ablation of motor neurons using metronidazole (MTZ) treatment, leads to 
motor neuron regeneration (Ohnmacht, Yang et al., 2016). Metronidazole is a 
prodrug that can be catalysed by bacterial Nitroreductase (NTR) to produce a 
cytotoxic product (Curado et al. 2008). This cytotoxic product interacts with DNA 
and induces cell death. In a zebrafish transgenic line expressing NTR under the hb9 
promotor, MTZ induces cell death exclusively within the NTR+ motor neurons. Dr. 
Ohnmacht also initiated the study of motor neuron regeneration in larvae and 
provided evidence that regenerative motor neurogenesis can be triggered by a 
mechanical lesion in the larval spinal cord at 3 dpf.  
 
I continued the study of lesion-induced motor neuron regeneration in larvae and 
addressed the following questions: (1) whether motor neuron regeneration occurs at 
later stages in larvae after a lesion. This is interesting because the larval stage begins 
at 5dpf, which is also the time point that spinal progenitor proliferation and 
differentiation decrease to a level that remains stable for weeks (Park et al., 2007). 
Therefore, injury induced neurogenesis in larvae after 5 dpf would require 
progenitors to be reactivated. As the production of motor neurons concludes at 
around 51 hpf (Reimer et al., 2013), while oligodendrocytes are still being generated 




oligodendrogenesis to motor neurogenesis after a mechanical injury; Also, given that 
a mechanical injury is sufficient to trigger pMN to regenerate motor neurons, I asked 
(3) whether a lesion is able to induce other progenitor cells to produce new neurons 
such as interneurons. Our findings were combined in the publication by Ohnmacht*, 
Yang* et al., 2016 (Development, * co-first authors) and are described below.  
 
It has been shown that in zebrafish embryos, motor neurons are born from 9 hpf 
onwards, almost all motor neurons are generated from the motor neuron progenitor 
(pMN) domain up to 48-51 hpf and that progenitor cells remain relative quiescent at 
the adult stage (Reimer et al., 2013). Oligodendrocytes are also born from same 
olig2-expressing pMN progenitor zone, indicating pMN progenitor cells are 
multipotent. Oligodendrocyte progenitor cells are first specified at around 36 hpf 
(Kirby et al. 2006). Dr. Jochen Ohnmacht and Gianna Maurer first determined if 
motor neurons can be regenerated in larvae zebrafish, when their developmental 
generation has been completed. A mechanical lesion was inflicted on the larval 
spinal cord at 3 days post-fertilization (dpf), with the notochord and major blood 
vessels left intact. The proliferation marker EdU (5-ethynyl-2´-deoxyuridine) was 
injected into Hb9:GFP (also known as mnx1:GFP) transgenic animals directly after 
the lesion to label new-born motor neurons. Lesioned larvae showed a strong 
increase in the numbers of Hb9:GFP+/EdU+ cells at 5 dpf close to (<50 µm rostral 
and caudal), but not far from (100 µm>×>50 µm rostral and caudal) the lesion site. 
Injured larvae also showed an improvement of tissue integrity around the wound. 
This indicates that motor neuron regeneration is extremely quick in larvae compared 
to the adult, in which regenerative neurogenesis occurs at 2 weeks after a spinal cord 
lesion, and locomotor function recovers at 6 weeks post lesion (Reimer et al. 2008; 
Becker et al. 2004). The swim recovery was found correlate with regenerated axons 
across the spinal transection site (Becker et al. 2004). 
 
During regeneration, embryonic signals such as sonic hedgehog and serotonin can 
be re-deployed within a period of time (Reimer et al., 2013; Barreiro-Iglesias et al., 
2015). For example, Reimer et al. (2013) revealed dopamine synthesized by the rate 




development in embryos as well as spinal motor neuron regeneration in adults. The 
study also shown TH1-positive axons from the diencephalon are the only detectable 
source of dopaminergic innervation in the spinal cord of embryos, and its projections 
into the spinal cord can be first be detected by immunohistochemistry at 33 hpf. To 
identify whether larval regeneration shares similar mechanisms with adult 
regeneration, Dr. Barreiro-Iglesias and Gianna Maurer analysed dopamine signalling 
by detecting the descending immunoreactive TH1+ axons. Results showed that 
lesioned larvae presented TH1+ axons rostral, but not caudal to the lesion site. 
Descending TH1+ axons were detected in control unlesioned larvae along the spinal 
cord, indicating dopaminergic innervation in the unlesioned spinal cord. 
 
In adults, the dopamine agonist pergolide was found to accelerate pMN progenitor 
proliferation (Reimer et al. 2013). Therefore, we wondered whether larvae share 
similar mechanisms to that of the adult and would react to the dopamine agonist. 
Further study done by Gianna Maurer using pergolide incubation revealed a 
significant increase of numbers of newly generated Hb9:GFP+ motor neurons 
marked by EdU, suggest that motor neuron regeneration can be studied in larvae, as 
motor neuron regeneration in larval pMN reacts to similar signals to the adult after a 
lesion.  
 
In adult fish, free swimming motor behaviour is largely restored 6 weeks after the 
lesion (Becker et al., 2004). To investigate if swimming capacity was recovered in 
lesioned larvae, my colleague Dr. Daniel Wehner measured the total distance moved 
after tail touch stimuli, as embryos remain immobile most of the time before they 
develop into activate predators at 5 dpf. Results showed a complete immobility 
immediately after the lesion at 3 dpf. However, touch stimulated swimming 
behaviour was quickly restored within 48 h after the injury, with the similar 
swimming distances as unlesioned control larvae, indicates the motor functional 
recovery is considerably faster at the larval stage than at the adult stage.  
 
In Ohnmacht, Yang et al. (2016), my colleague Themis Tsarouchas also elucidated 




macrophages to concentrate around the lesion site. However, suppression of the 
immune system led to decreased numbers of regenerated motor neurons, indicating a 
positive impact of the immune system on motor neuron regeneration.  
 
4.1.2  Neuron-­glia  switch  in  the  developing  spinal  cord  
In ventral spinal cord, pMN progenitor cells that express Olig2 transcription factor 
generate first motor neurons and then oligodendrocytes. pMN progenitor cells give 
rise to motor neurons from 9 hpf to up to 51 hpf (Reimer et al., 2013). Co-expression 
of olig2 and nkx2.2 in progenitor cells induces sox10 to specify oligodendrocytes 
precursor cells (OPCs) at 36 hpf, which later mature into oligodendrocytes and 
migrate to distribute in the spinal cord (Fig 4.1 A) (Kirby et al. 2006; Ravanelli & 
Appel 2015; Sun et al. 2001). Unlike motor neurons, generation of oligodendrocytes 
starts late during embryonic development and continues through larvae stages to 
adulthood (Park et al., 2007). In the spinal cord, P2 progenitor domain sits dorsally 
adjacent to the pMN domain and produces V2 interneurons (Stifani 2014). An olig2-/- 
mutant showed an expanded P2 domain and increased numbers of V2 interneurons 
instead of motor neurons and oligodendrocytes (Rowitch 2004). The switch in pMN 
progenitor cells from generating motor neurons to generating oligodendrocytes has 
been extensively studied (Kessaris et al., 2001; Rowitch 2004; Park et al., 2002; 
Anderson 1995; Ravanelli & Appel 2015; Zhou et al., 2001). Two model theories 
have been proposed (Fig 4.1 B): one is the “switching model”, in which motor 
neurons and oligodendrocytes are derived from common Olig2+ progenitors, 
meaning the same neuroglioblasts divide asymmetrically to make first motor neurons 
and then OPCs (Rowitch 2004). For example, Park et al. (2002) used photoactivated 
fluorescein in combination with olig2 in situ hybridization, and the photoactivated 
fluorescein analysed was restricted to olig2-exprssing cells. They found 
photoactivated fluorescein in islet-1 marked early born motor neurons at 19 hpf and 
sox10 expressing oligodendrocytes progenitor cells at 48 hpf, suggesting that olig2-
exprssing cells give rise to motor neurons or oligodendrocytes. Another theory is 
motor neurons and oligodendrocytes arise from fate-restricted progenitors, such as 
neuroblasts and glioblasts (Rowitch 2004). In this case, a subset of precursors 




precursors develops into OPCs and then differentiates to mature oligodendrocytes. 
Ravanelli & Appel (2015) suggested that motor neurons and oligodendrocytes are 
generated from distinct lineage cells from pMN. By using time-lapse video their 
study found Olig2+ progenitor cells divide symmetrically to motor neurons without 
further dividing to oligodendrocytes progenitor cells, supporting the second “model” 
(Ravanelli & Appel 2015). In our larvae lesion paradigm, a mechanical lesion 
induces a re-production of motor neurons even after neurogenesis has largely ceased, 
while oligodendrocytes are still being generated. I would like to address the question 
whether pMN progenitors can switch from making oligodendrocytes to new motor 
neurons, by investigating the reaction of oligodendrocytes and their precursors after a 
lesion.  
 
Fig   4.1   Illustrations   of   neuron-­glia   switch   models.   (A)   Time   points   of  
neurogenesis   and   gliogenesis.   (B)   Two   models   of   motor   neuron   and  
oligodendrocyte   specification   in   ventral   spinal   cord.   Adapted   and   modified   from  








4.2.1  Regenerative  neurogenesis  also  occurs  at  later  stage  in  larvae  
It has been found previously in our group that larvae zebrafish are able to produce 
new motor neurons after a mechanical lesion within 48 h. The lesion was done at 3 
dpf, at which time developmental motor neuron generation had been completed. I 
was interested in testing whether motor neurons could also be regenerated if the 
lesion was inflicted at later stages, for instance, at the stage when larvae are behaving 
as predators. To do this, I shifted the injury paradigm to 5 dpf in Hb9:GFP transgenic 
larvae. In order to test whether new motor neurons were being produced, I needed to 
label the larvae spinal cord with markers for evidence of the generation of new cells. 
I used EdU as a cell proliferation marker in my study. Based on previously 
established lesion protocol, I applied EdU injection into the yolk sac of the larvae 
immediately after the spinal cord injury. Larvae were analysed 2 days post-lesion at 
7 dpf and new born Hb9+ cells were detected by immunohistochemistry. 
 
EdU is a modified thymidine analogue which incorporates into newly synthesized 
DNA during S phase. The labelling can be visualized with a florescence dye, with 
greater efficiency than the traditionally used BrdU (5–bromo–2′–deoxyuridine), for 
which a harsher treatment to denature the DNA is required (Kaiser et al. 2009). It is 
to be noted that the bioavailability (transportation and clearance in the body) of EdU 
has not been well established in zebrafish. Previous research of Zeng et al. (2010) 
injected EdU into adult mouse brains, and (Kaiser et al. 2009) injected EdU into the 
avian cochlea. These authors found EdU to incorporate into newly synthesized DNA 
during the 4-8 h following the injection. I used this time window as an indicator for 
the EdU analysis in my study.  
 
As mentioned previously, motor neurons are regenerated close to (<50 µm rostral 
and caudal), but not far from (100 µm>×>50 µm rostral and caudal) the lesion site. I 
analysed double-labelled Hb9:GFP+/EdU+ neurons, 50 µm rostral and caudal 
adjacent to the lesion site; and 100 µm of unlesioned control spinal cord, as was done 
in 3 to 5 dpf standard protocol. The analysis showed hardly any new motor neurons 




of 257% in the number of new motor neurons in lesioned animals (Fig 4.2 
Unlesioned: 1.23 ± 0.38 cells, Lesioned: 4.40 ± 0.51 cells; 100 µm spinal cord, mean 
± SEM, ****p < 0.0001; n = 13-10; Unpaired t test, two-tailed).  This supports the 
previous finding that lesion induced local regeneration of motor neurons occurs 
within 48 h after the injury. The evidence indicates larvae are also capable of 
regenerating motor neurons after a lesion at later free-swimming predator stages, 




Fig  4.2  A   lesion   leads   to  motor  neuron   regeneration  within  48  hours  at   later  
stage.  (A)  The  timeline  of  the  experiment.  (B,C)  Lateral  views  of  larvae  are  shown,  
rostral  is  left,  dorsal  is  up,  lesion  site  is  indicated  by  dashed  line.  The  number  of  EdU  
labelled  Hb9:GFP+  motor  neurons   (arrowheads)   is   strongly   increased  close   to   the  
lesion  site  (dotted  line  in  B).  (C’-­C’’’)  Single  optical  sections  of  the  areas  boxed  in  B  
and  C,   respectively,  are  shown   in  higher  magnification.   (D)  Quantification  shows  a  
significant  increase  in  motor  neuron  generation  between  5  and  7  dpf  (Unpaired  t  test,  




4.2.2   Lesion   leads   to   increased   proliferation   of   larval   pMN   progenitor  
cells  
In the pMN domain, Olig2 transcription factor plays an important role in the 
development of motor neurons (Park et al., 2002). Lesion induces motor neurons to 
regenerate suggested that there may be an increased cell proliferation in the pMN 
domain, and the new born motor neurons are likely to be derived from those pMN 
progenitor cells. To test this hypothesis, I injected EdU into olig2:DsRed transgenic 
larvae, in which pMN progenitors and motor neurons contain DsRed protein. Taking 
into account that the possible bioavailability of EdU is 4-8 h (Kaiser et al. 2009), I 
chose an injury timeline in which the lesion was performed at 3 dpf and EdU was 
injected at 4 dpf. Larvae were allowed to survive for 4 h after the injection and then 
processed for analysis (Fig 4.3 A), in order to acutely label the proliferating cells in 
the pMN domain. I found that the number of olig2:DsRed+/EdU+ cells in lesioned 
fish was 8.83 ± 0.54, in comparison with 3.33 ± 0.92 in unlesioned control group 
(100 µm spinal cord, mean ± SEM, **p = 0.0049; n = 6 vs 6; Mann–Whitney test, 
two-tailed) (Fig 4.3 B-D). The analysis showed an increase of 165% in numbers of 






Fig  4.3  The  pMN  domain  reacts  to  a  lesion  with  increased  proliferation.  Lateral  
views  are  shown;;  rostral   is  left,  dorsal  is  up.  (A)  Time  line  of  the  experiment.  (B,C)  
olig2:DsRed+   cells   (arrowheads)   in   the   pMN  domain   that   incorporated  EdU  within  
the   last   4   h.   (B’-­C’’’)   Higher   magnifications   of   single   optical   sections   of   the   cells  
indicated   by   asterisks   in  B   and  C,   respectively,   showing  double   labelling.   (D)   The  
number   of   proliferating   cells   in   the   pMN   domain   is   significantly   increased   in   the  
vicinity  of   the   lesion  site  (Mann-­Whitney   test;;  **P=0.0049).  Scale  bars:  50  μm  in  C  
for  B,C;;  20  μm  in  C’’’  for  B’’-­C’’’  and  10  μm  for  B’,C’.  Adapted  from  Ohnmacht,  Yang  









It has been found that new motor neurons are likely to be derived from Olig2+ 
expressing ERGs in the adult pMN-like domain (Reimer et al. 2008; Reimer et al., 
2009). These newly regenerated motor neurons first express the motor neuron-
specific transcription factor Hb9 and later express the mature marker choline 
acetyltransferase (ChAT). However, it was not clear whether in lesioned larval spinal 
cord, proliferating Olig2+ progenitor cells are the source of newly regenerated motor 
neurons. By using Hb9:GFP x olig2:DsRed double transgenic larvae with EdU 
labelling, my colleague Gianna Maurer assessed whether newly generated motor 
neurons in larvae were derived from the olig2-expressing cells. Newly generated 
Hb9:GFP motor neurons derived from Olig2 progenitor would retain both GPF and 
DsRed protein, and would be positive for EdU labelling. Here DsRed protein acts as 
short-term lineage tracer. Results showed all newly generated motor neurons 
(Hb9:GFP+/EdU+; 23 neurons in 4 animals) were also positive for DsRed (Fig 4.4). 
This supports our hypothesis that newly generated motor neurons originate from 
olig2-expressing pMN progenitor cells after a lesion. 
 
 
Fig   4.4   Regenerated   motor   neurons   are   derived   from   pMN   progenitor   cells  
after   a   lesion.   In  Hb9:GFP  and  olig2:DsRed  double-­transgenic   larvae   (lesion  at  3  
dpf   and   analysis   at   5   dpf),   Hb9:GFP+/EdU+   neurons   retain   DsRed   protein   are  





4.2.3  Production  of  mature  oligodendrocytes  is  affected  by  SC  lesion  
A mechanical lesion triggers motor neurons to regenerate even after developmental 
motor neuron generation has concluded. This raised another question of how would 
oligodendrocyte progenitor cells, which are still generating at the time, react to such 
an injury. To investigate if oligodendrocyte generation is altered after a lesion, I used 
the mbp:GFP transgenic line to assessed the number of newly generated 
differentiated oligodendrocytes (Almeida et al., 2011). In mbp:GFP transgenic larvae, 
oligodendrocytes are labelled under the regulatory sequences of the myelin basic 
protein a (mbpa) gene. mbp is exclusively expressed in mature oligodendrocytes and 
is an important protein for myelin formation (Zhou et al., 2001). EdU was applied 
after the lesion at 3 dpf and larvae were analysed at 5 dpf, consistent with the 
timeline of motor neuron regeneration. I observed fewer EdU double-labelled 
mbp:GFP+ cells in the lesioned group, with the mbp:GFP+/EdU+ number strongly 
reduced by 94% (unlesioned control 1.67 ± 0.37, in comparison with 0.10 ± 0.10 in 
lesioned group; mean ± SEM, ***P=0.0005; 100 µm spinal cord; n = 9-10; Mann–
Whitney test, two-tailed) (Fig 4.5). In lesioned spinal cord, myelin sheaths caudal to 
the lesion site have degenerated, presumably because the axons they myelinated were 
descending degenerating axons. The result suggests that the generation of mature 
oligodendrocytes was reduced after the lesion. This could be due to the decreased 
production of oligodendrocytes precursor cells (OPCs) consequently resulting in 







Fig  4.5  Generation  of  mature  oligodendrocytes  is  affected  by  the  lesion.  Lesion  
is  conducted  at  standard  3  to  5  dpf  timeline.  (A,B)  Lateral  views  are  shown;;  rostral  is  
left,   dorsal   is   up.   The   lesion   site   is   indicated   by   a   dashed   line.   mbp:GFP+  
oligodendrocytes   incorporate  EdU   (indicated  by  arrowheads)   in   unlesioned   larvae.  
(A’-­A’’’)  Single  optical  section  of  two  double-­labelled  neurons  indicated  in  E  showed  
in  higher  magnification.  (B)  Fewer  mbp:GFP+/EdU+  cells  are  observed  after  a  lesion.  
(C)   The   number   of   new   oligodendrocytes   is   significantly   reduced   after   a   lesion  
(Mann–Whitney  U-­test;;  ***P=0.0005).  Scale  bars:  50  μm  in  B  for  A,  B;;  20  μm  in  A’’’.  










4.2.4   Oligodendrocyte   progenitor   differentiation   is   reduced   in   the  
lesioned  spinal  cord  
Olig2 transcription factor is expressed during the early fate specification of 
oligodendrocytes which retain the expression throughout the differentiation stage 
into maturation (Liu et al., 2007). Olig2 progenitors co-express Sox10 in OPCs to 
promote oligodendrocyte differentiation (Takada et al. 2010). Therefore, Sox10 is 
used as an early marker for oligodendrocyte lineage cells. To assess whether the 
production of OPCs was altered after the lesion, I used olig2:GFP x sox10:mRFP 
double transgenic larvae. In the olig2:GFP transgenic line, GFP is expressed in pMN 
precursors including motor neurons and OPCs under the regulatory sequences of the 
olig2 gene. In sox10:mRFP larvae, the expression of membrane-tethered monomeric 
red fluorescence protein (RFP) is under control of sox10 regulatory sequence (Kirby 
et al., 2006). According to Kirby et al. (2006), the first specialization of OPCs in 
zebrafish ventral spinal cord is at 36 hpf, and myelination of axons by 
oligodendrocytes occurs at 72 hpf. Using our standard 3 to 5 dpf lesion paradigm, the 
number of olig2:GFP/sox10:mRFP/EdU triple-labelled cells was analysed. At this 
stage, triple-labelled cells are representing both newly generated oligodendrocytes 
and their precursors, hence we use the term oligodendrocyte lineage cells to indicate 
these cells. In the unlesioned group, the number of olig2:GFP+/sox10:mRFP+/EdU+ 
cells reached 9.30 ± 1.06, confirming previous evidence for continuous generation of 
oligodendrocytes in unlesioned larvae (Park et al., 2002). However, in the lesioned 
group, the number of triple labelled cells only reached 1.11 + 0.51 (mean ± SEM, 
****P<0.0001; 100 µm spinal cord; n = 9-10; Unpaired t-test, two-tailed), with a 
significant reduction of 88% compared to control group (Fig 4.6). The results 
showed fewer OPCs and oligodendrocytes were produced, which is in agreement 
with my previous result that lower numbers of differentiated oligodendrocytes were 
newly generated after a lesion, and implies a reduction in the generation of OPCs. 
These analyses suggest that the pMN domain is able to switch from generating 






Fig  4.6  Generation  of  oligodendrocytes  lineage  cells  is  reduced  after  a  spinal  
lesion.   Lateral   views   are   shown;;   rostral   is   left,   dorsal   is   up.   The   lesion   site   is  
indicated  by  a  dashed  line.    (A)  Time  line  of  the  experiment.  (B,C)  Number  of  newly  
generated  oligodendrocytes  and  their  precursors  (olig2:GFP,  sox10:mRFP  and  EdU  
triple  labelling  (asterisk)  are  reduced  in  number  after  lesion.  (B’-­B’’’’)  Single  optical  
section  of  a  triple-­labelled  cell  (indicated  with  asterisk  in  B)  at  higher  magnification.  
(D)   The   number   of   triple-­labelled   cells   is   reduced   (Unpaired   t-­test,   ****P<0.0001).  
Scale  bars:  100  μm   in  B   for  B,  C;;  20  μm   in  B’’’’   for  B’-­B’’’’.  Adapt   from  Ohnmacht,  








4.2.5  No  apoptotic  cell  death  in  oligodendrocyte  progenitor  cells    
In order to investigate whether OPCs display selective cells death in the pMN 
domain, I used olig2:GFP/sox10:mRFP double-transgenic larvae. A standard 3 to 5 
dpf lesion paradigm was applied followed by a TUNEL assay, which labels late cell 
death by detecting fragmented DNA (Kyrylkova et al. 2012). I first assessed the cell 
death in oligodendrocyte lineage cells by counting triple labelled 
olig2:GFP+/sox10:mRFP+/TUNEL+ cells. I did not observe any 
olig2:GFP+/sox10:mRFP+ that were labelled by the TUNEL reaction, suggesting 
that lower numbers of oligodendrocyte lineage cells were not due to increased cell 
death (P>0.9999; 100 µm spinal cord; n = 13-9; Mann–Whitney test, two-tailed) (Fig 
4.7). Furthermore, I did not detect increased olig2:GFP/TUNEL double-labelled cells 
within the pMN domain, indicating that pMN progenitors did not go through 
selective cell death. Occasionally, I observed double-labelled cells outside the area of 
interest in both conditions, demonstrating that I am able to detect such cells. Taken 
together, these observations suggest that there is no increase in oligodendrocyte 





Fig  4.7  No  apoptosis  of  oligodendrocyte  generation  is  detected  after  a  spinal  
lesion.  (A)  Time  line  of  the  experiment.  (B,C)  Lateral  views  are  shown;;  rostral  is  left,  
dorsal   is   up.   The   lesion   site   is   indicated   by   a   dashed   line.   TUNEL   positive   cells  
(arrowheads).   (B’-­C’’’’)   Single   optical   sections   at   higher   magnification   show   a  
TUNEL   positive   but   olig2:GFP/sox10:mRFP   negative   cell   (indicated   with  
arrowheads   in   B,   C).   (D)   No   increase   in   numbers   of   cell   death   (Student’s   t-­test,  
P>0.9999).  Scale  bars:  100  μm  in  B  for  B,  C;;  20  μm  in  C’’’’  for  B’-­C’’’’.  Adapted  from  





4.2.6  Pax2  expressing  interneurons  are  not  regenerated  after  SC  lesion  
In adult zebrafish, a spinal cord transection triggers cell proliferation not only in the 
pMN domain but also in the other progenitors such as P2 domain, which is dorsally 
adjacent to the pMN domain, and mainly generates V2 interneurons (Kuscha et al., 
2012). Kuscha et al. (2012) found that undifferentiated V2 interneurons, marked by 
vsx1:GPF, as well as serotonergic interneurons, are regenerated at  2 weeks after a 
lesion in adult fish. The research also shown pax2a:GPF+ interneurons, which might 
be derived from a more dorsal progenitor domain distinct from the pMN domain, 
were not affected by the lesion at 2 weeks post-lesion (Kuscha et al., 2012). In larvae, 
genetic ablation of motor neurons also did not affect the generation of pax2a+ 
interneurons (Ohnmacht, Yang et al., 2016). In my study, I wanted to elucidate 
whether other progenitor cells are triggered to generate new neurons after SC lesion. 
I used pax2a:GPF transgenic larvae followed by EdU labelling and analysed the 
number of newly generated dorsal pax2a:GFP+ interneurons. The result showed low 
numbers of new born pax2a:GFP+/EdU+ cells in both unlesioned controls (0.25 ± 
0.16 cells) and lesioned larvae (0.50 ± 0.34 cells), with no statistical difference 
between two groups (P = 0.6839; 100 µm spinal cord; n = 8-6; Mann-Whitney test, 
two-tailed) (Fig 4.8). This indicates that a lesion might not be sufficient to induce 






Fig   4.8   Generation   of   pax2a:GFP+   interneurons   is   not   affected   by   a   spinal  
lesion.  Lateral  views  are  shown;;  rostral  is  left,  dorsal  is  up.  (A)  The  timeline  of  the  
experiment   is   shown.   (B,C)   EdU+/pax2a:GFP+   cells   (arrows)   are   present   in  
unlesioned  (B)  and  lesioned  (C)  larvae.  The  lesion  site  is   indicated  by  dashed  line.  
(C’-­C’’’)   Single   optical   section   of   the   areas   boxed   in   B   and   C,   respectively,   are  
shown   at   higher   magnification.   (D)   Quantification   shows   no   difference   in  
pax2a:GFP+
  
neuron   generation   between   3   and   5   dpf   (Mann-­Whitney   U   test;;   P   =  
0.6839).  Scale  bar   in  C  =  50  μm   for  B,C  and   in  C’  =  50  μm   for  B’,C’.  Own   figure  






4.3.1  Zebrafish  larvae  is  a  rapid  and  robust  model  for  the  study  of  motor  
neuron  regeneration  
Unlike mammals, the adult zebrafish is capable of regenerating its spinal cord after 
an injury. Studies have demonstrated that adult zebrafish can replace neuronal loss 
by regenerating new neurons such as motor neurons (Reimer et al., 2008) and their 
progenitor cells, interneurons (Kuscha et al., 2012) and radial glia progenitor cells 
(Briona & Dorsky 2014). Although adult zebrafish has been a well-established model 
to study regenerative neurogenesis (Becker & Becker 2015), it takes 3-4 months for 
them to reach sexual maturity, and the analysis requires subsequent intervention such 
as surgery, perfusion, dissection and section for antibody staining, all limited by the 
number of animals that can be processed at a time. Moreover, the regeneration of 
motor neurons in adult takes place at 2-6 weeks after a lesion and adult fish have a 
motor functional recovery time of 6-8 weeks (Becker et al., 2004).  
 
In contrast to adult, zebrafish larvae are transparent and small in size. Spinal cord 
transection can be inflicted with an injection needle and further analysis can be done 
in whole larvae. We have established larval zebrafish as a model for lesion induced 
motor neurogenesis, and have shown that zebrafish larvae have the ability to reclose 
the wound, regenerate motor neurons and restore swimming ability within 2 days 
post-injury (dpi), with a survival rate of 85%-90% after a lesion. We found that 
regeneration occurred at both early and relatively later stages. Our study is similar to 
a previous study of Briona & Dorsky (2014) that spinal cord injury in larvae 
displayed a neuronal replacement at 4 dpi as well as response to touch at 5 dpi. 
Lesioned larval showed a robust swimming behaviour at 9 dpi (Briona & Dorsky 
2014). Other studies from Becker et al. (1997) and Reimer et al. (2008) found adult 
fish are able to repair disconnected axons and bridge the injury site with some degree 
of re-myelination, and a similar finding was described in Bhatt et al. (2007) that 
larvae regenerate fibres across the lesion site 24 h after a lesion without additional 
intervention. Combined with our finding, this research suggest larvae is an extremely 





We also showed that there is a recapitulation of signals in larval regeneration to that 
of the adult. Our study found that similar to the adult, Olig2 progenitor domain in 
larvae is highly plastic. Similar to the adult zebrafish, Olig2 progenitor cells are able 
to increase proliferation after an injury, and newly generated motor neurons in larvae 
are derived from olig2-expressing progenitor zone. Signals like dopamine, serotonin 
and notch react to a lesion in adult spinal cord and promote the re-generation of 
motor neurons from pMN domain (Kuscha et al., 2012; Barreiro-Iglesias et al., 2015; 
Reimer et al., 2013; Dias et al., 2012). By analysing the projection of TH1+ axons, 
which are the source of dopaminergic innervation in embryonic spinal cord, we 
confirmed there are dopaminergic projections down the spinal cord in 3 dpf larvae. 
Also, a dopamine agonist boosts the number of newborn motor neurons in lesioned 
larvae, indicating larval and adult regeneration share similar mechanisms. These 
findings strengthened zebrafish larvae as a model to study motor neuron regeneration 
after SC lesion. In addition to these, larvae have great accessibility for genetic 
modification as well as the ease of high-throughput screening for drug treatment and 
behaviour in lesioned animal.  
 
Taken above, zebrafish larvae have great advantages and can be used as a model for 
the research of motor neuron regeneration. 
 
4.3.2   pMN   progenitors   can   switch   from   oligodendrogenesis   to   motor  
neurogenesis  
Neurogenesis is relatively quiescent in the adult pMN domain (Reimer et al., 2008). 
However, motor neuron regeneration can be triggered by a mechanical transection of 
the spinal cord. Similarly, I found in larvae, a mechanical lesion could reactivate 
pMN progenitors to increase proliferation, and make new motor neurons after 
neurogenesis is completed, while oligodendrogenesis is on-going. New motor 
neurons are generated from the ventral spinal cord in the vicinity of lesion site, and 
retain DsRed expression controlled by olig2 promoter, indicating they are likely to be 
derived from pMN progenitor cells. These new motor neurons could be generated 
from either a recruitment of new progenitor cells distinct from oligodendrocytes 




progenitors during the embryonic development (Park et al., 2002). Interesting, I 
found a sharp decline of the generation of oligodendrocyte lineage cells, without 
detectable cell apoptosis of Olig2+ precursors, suggesting the number of a sub-
population of Olig2+ cells are reduced. This is confirmed by my observation that 
fewer numbers of mbp+ mature oligodendrocytes are produced after a lesion. My 
findings are in favour of the first possibility, in which the lineage relationship of 
motor neuron and oligodendrocyte is “one or the other” – pMN precursors are 
required to make a decision to produce either motor neurons or oligodendrocytes. 
Here we provide evidence to show the highly plastic nature of pMN domain, and 
their progenitors are able to switch their fate from oligodendrogenesis to motor 
neuron generation after a mechanical lesion. 
 
4.3.3  Progenitor  domains  present  different  potentials  in  regeneration  
In my study, I did not detect an enhanced generation of pax2a+ interneurons. pax2a+ 
cells are mostly likely to be derived from a distinct progenitor pool dorsal to pMN 
domain (Kuscha, Frazer, et al. 2012), suggesting for some dorsal progenitor zones 
neither an ablation nor a mechanical lesion is sufficient to increase neuron generation. 
This finding is similar to the observation of Dr. Jochen Ohnmacht, in which pax2a+ 
interneurons did not regenerate after targeted motor neuron ablation in larvae. This 
shows that progenitor domains react differently to a lesion. For example, in adult fish, 
pax2a+ interneurons are newly generated after a lesion, and the generation of 
vsx1:GFP+ V2 interneurons from the P2 domain was enhanced (Kuscha et al., 2012). 
In the study of Kuscha et al. (2012), no change in numbers of dorsal 
parvalbuminergic interneurons were found up to 6 weeks post-lesion. In embryos, 
serotonin promotes motor neuron development but showed no impact on numbers of 
vsx1:GFP+ and pax2a:GFP+ interneuron produced (Barreiro-Iglesias et al., 2015). A 
dopamine agonist enhanced motor neuron generation at the expense of vsx1:GFP+ 
interneurons, while pax2a:GFP+ and glyt2:GFP+ glycinergic interneurons (Eklöf-
Ljunggren et al., 2012) were unaffected (Reimer et al., 2013). In my study, further 
experiments can be done with other types of interneurons to test the regenerative 




the potential of lesion-induced proliferation is different in progenitor domains and 
they may act on different mechanisms and signalling pathways.  
 
4.4  Conclusion  
Adult zebrafish are able to react to a lesion with increased numbers of Olig2+ 
progenitor cells to produce new motor neurons and re-gain swimming ability (Dias et 
al., 2012; Reimer et al., 2008; Becker et al., 2004). We showed that regenerative 
neurogenesis can be triggered by a mechanical lesion at the larval stage when motor 
neuron generation has ceased. pMN domain progenitors react with increased 
proliferation and differentiate into new born motor neurons. Motor neuron 
regeneration in larvae shares similar signals to that of the adult. Regeneration in 
larvae is considerably faster with both motor neuron and swimming ability 
restoration within 48 h. However, the link between new motor neurons and 
functional recovery still requires further investigation. More interestingly, we 
provide evidence that pMN domain progenitors can switch from making 
oligodendrocytes to making new motor neurons. We also showed that progenitor 
domains have different regenerative potentials after a lesion. The advantage of robust 
regenerative ability of larvae with the greater accessibilities for tools make it an 

















Chapter  5  General  discussion  
 
In my thesis I aimed to find mechanisms of motor neuron development and 
regeneration after a lesion. I will discuss in turn my efforts to find new mutants 
affecting motor neuron development (5.1) and my characterization of motor neuron 
progenitor behaviour after a spinal cord lesion in larval zebrafish (5.2). The latter 
part of my thesis has already been published with me as a co-first author (Ohnmacht 
and Yang et al., 2016) 
 
5.1   Identify   essential   genes   for   spinal   motor   neuron   and   axon  
generation  in  zebrafish  
In this part of the study, I presented an ENU-induced screen in zebrafish to identify 
genes that regulate the generation of secondary motor neurons and their axon 
development. I focused on 2 mutants discovered from the screen displaying defects 
in motor neuron generation (#151) and motor axon outgrowth (#249), and 
characterized the mutant phenotypes by using various molecular markers. I started 
the analysis of mutated genes that might be responsible for the observed phenotypes 
for both mutants, and obtained preliminary results showing that overexpression of 
the candidate gene psmc2 partially rescued the dorsal secondary motor axon 
phenotype in the #249 mutants. However, in #151 mutants, overexpression of a 
candidate gene rbbp4 did not promote islet-1:GFP motor neuron generation.  
 
For decades, ENU mutagenesis screening has been widely used for novel gene 
identification. Mullins et al (1994) and Solnica-Krezel et al (1994) first established 
methods of performing large-scale mutagenesis screen in zebrafish, and 
demonstrated two most efficient mutagenic regimes and concentration that have been 
used as standardized methods for ENU treatment. Many studies have proved the 
reliability of ENU in generating point mutations and the utility of ENU screens in 
gene discovery across species (Acevedo-Arozena et al. 2008; Driever et al. 1996; 
Balling 2001; Nagy et al. 2003). This forward genetic approach requires no prior 
knowledge of the functions of the genes, hence allowed an unbiased phenotypic 




phenotype of interest requires screening of a large numbers of animals. Therefore, 
when screening for specific phenotypes of interest, the parameters chosen for the 
screen must be robust and easy to be recognized by the investigators (Argmann et al. 
2006; Moresco et al. 2013). This could largely avoid false positive results. In our 
screen, I used islet-1:GFP transgenic line as a readout, which allowed us to screen 
~1200 embryos for motor neuron phenotype under a stereo-microscope equipped 
with a fluorescent lamp in a petri dish, and to evaluate fine motor axons of ~600-700 
of flat-mounted embryos using a fluorescence microscope each week. I looked for 
abnormalities in the GFP expressed dorsal subset of secondary motor neuron and 
axons, and discarded mutants with general deformations and early developmental 
defects in order to minimize false positives and the influences of general 
physiological impairment when it comes to interpret the phenotype.  
 
I investigated two mutant lines: #249, in which dorsal secondary motor axons were 
absent; and #151, which has fewer motor neurons. I applied neuronal, axonal and 
muscle fibre markers to further define their phenotype and found additional defects 
in muscle fibres and myelination. Therefore, it will be important to find out whether 
defects in motor neurons or their progenitors are cell-autonomous or a secondary 
consequence of the altered surrounding tissue. Understanding the cell-autonomous 
and non-cell-autonomous function of a gene could help to understand the interaction 
between genetic and environmental factors.  
 
We used Next generation sequencing (NGS) technique (outsourced to Edinburgh 
Genomic) to identify mutated genes underlying the mutant phenotypes of #249 and 
#151. The strategy is to identify a chromosome interval linked to the mutation, and 
then search for single nucleotide polymorphisms (SNPs) within this defined region as 
potential causative mutations (Henke et al. 2013). The principal of the NGS is to 
fragment genomic DNA randomly into short sequences and ligate them with 
specialized adapters (primers). The generated short reads are amplified, sequenced, 
and then aligned to a reference genome using computational bioinformatics software 
in order to identify SNP variations. As sequencing reads can contain sequence errors, 




the average number of times a base in the genome is sequenced (Sims et al. 2014). 
Reads with higher coverage contain fewer sequencing errors. However, higher 
coverage also means higher cost, therefore there is a need to balance the coverage 
and cost when it comes to NGS. A study of Voz et al. (2012) demonstrated that an 8x 
coverage of the zebrafish genome was sufficient to detect the phenotype-causing 
mutation. In our screen, we used ~19x coverage to sequence both mutants and their 
siblings. The first step for genetic mapping of a gene mutation is to create a mutant 
strain that is polymorphism to the mutagenized founder strain. This would provide 
high levels of polymorphism within the mutants to identify strain-specific variations 
and mutations. In our screen, I crossed F2 mutant carriers of #249 and # 151 with a 
mapping strain wild-type TL. The next step is to isolate mutants and their 
phenotypically wild-type siblings from the subsequent map-cross and extract gDNA 
for sequencing. It is important to ensure that mutants are phenotypically identifiable 
and no wild-type siblings were mis-sorted into the mutant pool, as it could decrease 
the homogeneity around the region containing the mutation and may yield false 
results (Henke et al. 2013). Although there is no defined rule of the numbers of 
mutants to be used, Henke et al. (2013) noted that using 20 fish and 3x coverage is 
enough to identify candidate mutations, and increasing the number of fish also 
increase the sensitivity of the mapping when sequencing with higher genome 
coverage. Voz et al. (2012) used a pool of 50 fish with 8x genome coverage for 
mutation identification. In our screen, as we are sequencing with ~19x coverage, I 
isolated 80-140 embryos for each mutant and wild-type sibling pool from each 
mutant family.  
 
In #249 mutants, gain-of-function analysis of a candidate gene psmc2 – a component 
of 26S proteasome that belongs to the Ubiquitin Proteasome System (UPS), showed 
promising preliminary results. I found that the overexpression of psmc2 in mutants 
promoted the dorsal secondary motor axon outgrowth and improved the survival of 
the mutant embryos by following up to 4 dpf. Un-injected mutant embryos did not 
survive after 3 dpf. In future experiment, it is necessary to investigate whether the 
lack of psmc2 mimic the dorsal motor axon phenotype, and whether the mutation in 




morpholino to knock-down psmc2 (Imai et al. 2010) or CRISPR/Cas9 to knock-out 
psmc2 gene. In addition, studied have shown that UPS plays a role in 
neurodegenerative diseases (Ciechanover & Kwon 2015; Kwon et al. 2013; Burnett 
et al. 2009; Tashiro et al. 2012). One could speculate that the finding may give not 
only new insights into the role of UPS in motor neuron and axon development, but 
also the link between UPS and neurodegenerative disease.  
 
Meanwhile, confirming the causative mutation of the #151mutants in future 
experiments may provide opportunities to identify key molecular players in the 
development of motor neurons. To prioritize a candidate gene, I looked at the SNP 
that results in amino acid change and leads to altered protein product, as the change 
in protein function may influence the traits of interest. In addition, a gene is 
prioritized for further confirmation based on its relevance to the biological process 
underlying the phenotype of interest by reviewing through the literature to find 
whether there were previous studies connecting the gene with similar traits and 
signalling pathways (Kwon & Goate 2000). In #151 mutants, I first investigate rbbp4 
as a potential phenotype causative gene. The single base substitution in rbbp4-201 
transcript result in a pre-mature stop in coding sequence, and study has shown that 
rbbp4 knock-down reduces blastema progenitor cell proliferation and the re-
differentiation of their daughter cells during the fin regeneration in zebrafish 
(Pfefferli et al. 2014). However, a gain-of-function experiment by overexpressing 
rbbp4-201 in the mutants did not rescue the islet-1:GFP motor neuron phenotype. As 
discussed in Chapter 3, this could be due to that rppb4 is not the gene responsible for 
#151 mutant phenotype, or the artificial overexpression of the target gene does not 
correspondent to the time and location of the endogenous mRNA expression. A loss-
of-function experiment is necessary to test whether the lack of rbbp4-201 leads to 
fewer islet-1:GPF motor neurons. In addition, a nonsense mutation was also present 
in the transcript ENSDART00000067165, coding for Ankmy2 (ankyrin repeat and 
MYND domain containing 2) protein. I have confirmed the existence of the 
nucleotide substitution in ankmy2b in #151 mutants by sequencing a fragment of 
DNA containing the mutation site. A study in mouse showed that ankmy2 plays a 




potential causative gene for further confirmation, and similarly, by using a loss-of-
function approach to either knock-down/knock-out the gene and a gain-of-function 
experiment to rescue the phenotype. 
 
5.2  Regenerative  neurogenesis  larval  zebrafish  
In mammals, loss of motor neurons and axon connections in motor neuron diseases 
and spinal cord injuries are irreversible due to their inability to repair. Zebrafish, one 
the other hand, possess an excellent capacity to regenerate neuronal cells and restore 
locomotor function. In this part of the study, I showed that in the established larval 
zebrafish model, endogenous progenitor cells were recruited to give rise to new 
motor neurons at the expense of oligodendrocytes in response to an injury. The larval 
model allows us to compare the similarities and differences between larval and adult 
regeneration for their progenitor potential, how different cell populations are 
activated, and to understand the identity of progenitor cells that give rise to new 
neurons at different stages. It also expands our experimental possibilities in many 
aspects. External development and permeability to small molecules facilitate target 
drug screening in zebrafish larvae. They are genetically tractable as transgene can be 
expressed in specific cell types of interest and visualised in the intact transparent 
larva. This makes it possible to study the mechanisms involved in the activation of 
progenitor cells, differentiation and specification of regenerated neurons.   
 
In the adult spinal cord, neurogenesis is rare across species, including primates, 
rodents, birds and fish (Alunni & Bally-Cuif 2016). A consequence of the spinal cord 
injury is the sudden loss of motor neurons and disconnection of axons. As part of the 
repair process, replenishing new motor neurons and a re-connection of axons may be 
necessary. This requires endogenous progenitors to exit from their quiescent stage to 
undergo active neurogenesis and cell proliferation. In the lesioned spinal cord of 
adult zebrafish, newly regenerated motor neurons are derived from the olig2-
expressing ependymal radial glial cells (ERGs) that line in the central canal of the 
spinal cord (Reimer et al. 2008; Reimer et al. 2009). Transcription factors that define 
the progenitor zones in the neural tube of embryos, such as Olig2, Shh, Pax6 and 




indicating that these ERGs are equivalent to pMN progenitor cells in the neural tube 
that give rise to motor neurons during the development (Reimer et al. 2009). 
Ependymal cell activation was also observed in mammals following the spinal cord 
injury, however, the newly generated ependymal cells mainly give rise to astrocytes 
that migrate to the lesion site to form the glia scar and prevent axon regeneration 
(Panayiotou & Malas 2013). Current interventions for the treatment of the spinal 
cord injury are focusing on protecting the surviving cells from secondary damage, 
replacing injured or dead cells, and promoting axon regeneration from the glial scar 
formed by reactive astrocytes that plays a crucial part in the regeneration failure. To 
achieve these goals requires to develop economical and powerful model organisms 
that could be used for real-time imaging of pathogenesis and to provide gene or drug 
target information. Similar to the adult zebrafish, neuronal replacement, axonal 
outgrowth and functional recovery also occurred in larval zebrafish. However, the 
neural repair is quicker as it happened within 48 hours as opposed to 6 weeks in 
adults. In this regard, larval zebrafish are amenable to study the intrinsic and 
extrinsic signals that control regeneration in vivo and to identify how the regenerated 
neurons integrate into the CNS circuit to restore neural function. The clinical 
relevance of the larval regeneration model is that it can be used for screening drugs 
in living animals and genetic manipulations that are not feasible in models such as 
mouse. Early drug screens for clinical use involves the identification of a protein or 
pathways that may result in a therapeutic effect, validation of the discovered 
development candidate in experimental models, and the screening of compounds that 
are likely to have activity at the target protein (Hughes et al. 2011). The transparency 
of zebrafish larvae enables small molecule screens that assay compound libraries 
against disease targets to identify drug-like compounds in vivo. The VAST 
(Vertebrate Automated Screening Technology) Biolmager system, which is designed 
for high-resolution imaging of 2-7 dpf zebrafish larvae automatically, can be used for 
chemical screening in a more efficient manner to identify “hit” molecules that may 
have an effect during successful motor neuron and axon regeneration. Zebrafish 
larvae also allow genetic manipulations such as lineage tracing, transgenesis, and 




to perform direct observation to investigate the factors that regulate cell-fate decision 
during the regeneration. 
 
5.3  Concluding  remarks  and  future  directions  
In this thesis, I presented two pieces of work to study the role of developmental cues 
in motor neurogenesis and regeneration. I conducted an ENU-mutagenesis screen in 
searching for essential genes for the generation of motor neurons and correct 
pathfinding of their motor axons. I discovered mutants with motor neuron and motor 
axon defects, carried out phenotypic characterization and started candidate gene 
investigation. I also showed that zebrafish larvae can be used as a model for studying 
regeneration of motor neurons, and other cell types in the spinal cord. Genes 
identified from the screen can be used to dissect signals and pathways involved in the 
differentiation of motor neurons and the outgrowth of motor axons into their target 
muscle fibres. The findings can also be applied to lesioned zebrafish larvae to 
investigate the genes’ potential in the promotion of the motor neuron regeneration. 
More importantly, identified mutants and the larval regeneration model offer 
opportunities for in vivo chemical compound screen for potential drugs that may 
ultimately lead to the identification of new therapeutic treatment for motor neuron 



















Appendix  1.  Candidate  gene  list  for  #249  mutant  line  
Gene  
Name  





psmc2   ENSDART00000019647     13992419   Caa/Taa   STOP  
nell2b   ENSDART00000091151     13377119   aTc/aAc   Missense  
ENSDART00000133325     13377119   aTc/aAc   Missense  
CCDC87   ENSDART00000067165   12681834   aAg/aGg   Missense  
ENSDART00000067165     12681750   aTc/aCc   Missense  
  
exoc4  
ENSDART00000101619     14724890   Cgc/Tgc   Missense  
ENSDART00000101619     14724862   ttA/ttT   Missense  
ENSDART00000101619     14724854   Cct/Tct   Missense  
mdm1   ENSDART00000102010     12622355   gAa/gGa   Missense  
ENSDART00000132971     12622355   gAa/gGa   Missense  
si:dkey-­
14k9.3  
ENSDART00000137829   13961678   atC/atG   Missense  
ENSDART00000067036     13961678   atC/atG   Missense  
plxnb2a   ENSDART00000048821     13542963   atT/atG   Missense  
  
plxnb2  
ENSDART00000145737     13711351   Aac/Tac   Missense  
ENSDART00000145737     13711341   aAt/aGt   Missense  
ENSDART00000145737     13711335   gCc/gTc   Missense  
ENSDART00000145737     13711326   aGg/aAg   Missense  
ENSDART00000067029     13711351   Aac/Tac   Missense  
ENSDART00000067029     13711341   aAt/aGt   Missense  
ENSDART00000067029     13711335   gCc/gTc   Missense  
ENSDART00000067029     13711326   aGg/aAg   Missense  
ENSDART00000145737     13711347   tCc/tTc   Missense  
ENSDART00000067029     13711347   tCc/tTc   Missense  
ENSDART00000145737     13711359   tCa/tTa   Missense  
ENSDART00000067029     13711359   tCa/tTa   Missense  
ENSDART00000145737     13711210   tAt/tTt   Missense  
ENSDART00000067029     13711210   tAt/tTt   Missense  




ENSDART00000145737     13712284   Ggg/Agg   Missense  
ENSDART00000145737     13712243   agA/agT   Missense  
ENSDART00000145737     13712238   gAc/gTc   Missense  
ENSDART00000145737     13712237   gaC/gaA   Missense  
ENSDART00000114977     13703060   Ggt/Agt   Missense  
ENSDART00000145737     13711129   gGg/gCg   Missense  
ENSDART00000067029     13711129   gGg/gCg   Missense  
ENSDART00000145737     13711632   aAc/aGc   Missense  
ENSDART00000067029     13711632   aAc/aGc   Missense  
ENSDART00000145737     13711636   Ctc/Atc   Missense  
ENSDART00000067029     13711636   Ctc/Atc   Missense  
ENSDART00000145737   13712182   Acc/Gcc   Missense  




Appendix  2.  Candidate  gene  list  for  #151  mutant  line  





rbbp4   ENSDART00000130326     32244010   tCa/tAa   STOP  
  
ankmy2b  
ENSDART00000067165     32299687   tGg/tAg   STOP  
ENSDART00000143494     32290727   Ggt/Agt   Missense  
ENSDART00000143494     32293002   Gcc/Acc   Missense  




ENSDART00000052169     32239570   gaG/gaT   Missense  
ENSDART00000134645     32239341   aGg/aAg   Missense  
ENSDART00000052169     32239341   aGg/aAg   Missense  
ENSDART00000134645     32238882   gAg/gGg   Missense  
ENSDART00000052169     32238882   gAg/gGg   Missense  
meox2b   ENSDART00000088618     32429268   Cct/Tct   Missense  
eif3i   ENSDART00000005119     31075389   gTc/gAc   Missense  
abcf1   ENSDART00000048977     34724890   gaT/gaG   Missense  
  
  
ENSDART00000135128     31732354   Ctt/Ttt   Missense  






ENSDART00000135128     31745378   Cct/Tct   Missense  
ENSDART00000135128     31752111   gGc/gAc   Missense  
ENSDART00000088760     31752111   gGc/gAc   Missense  
ENSDART00000135128     31755649   gaA/gaC   Missense  
ENSDART00000088760   31755649   gaA/gaC   Missense  
si:ch211-­
194e15.5  
ENSDART00000137829   32142582   tGa/tAa   Silence  
ENSDART00000088573     32143584   AcT/aGt   Missense  
ENSDART00000137633     32143584   AcT/aGt   Missense  
ENSDART00000088573     32143946   atG/atT   Missense  
ENSDART00000137633     32143946   atG/atT   Missense  
scin   ENSDART00000046609     32598253   gAa/gTa   Missense  
si:dkeyp-­
120h9.1  
ENSDART00000128391     33008206   Tct/Gct   Missense  
ENSDART00000103636   33008206   Tct/Gct   Missense  
sostdc1b   ENSDART00000145971     32307181   caC/caA   Missense  
ENSDART00000145971     32307181   caC/caA   Missense  
  
pag1  
ENSDART00000078268     33308347   Gcc/Acc   Missense  
ENSDART00000078268     33319623   gCt/gTt   Missense  
ENSDART00000134934     33319623   gCt/gTt   Missense  
  
C19H6orf136  
ENSDART00000073704     31703209   Ctg/Atg   Missense  
ENSDART00000129742     31703209   Ctg/Atg   Missense  
ENSDART00000073704     31703138   aGa/aCa   Missense  
ENSDART00000129742     31703138   aGa/aCa   Missense  
FAM8A1  (2  of  
3)  
ENSDART00000022667     33451722   aGg/aAg   Missense  











A     
AC   anterior  commissure  
AO                                   Acridine  orange  
AMPA   alpha-­amino-­3-­hydroxy-­5-­methyl-­4-­isoxazole  propionic  acid  
ALA52                     Delta-­aminolevulinate  synthase  2  
ALS   Amyotrophic  lateral  sclerosis  
     
B     
bHLH                         Basic  helix-­loop-­helix  
BSA     Bulked  segregant  analysis  
βME   Beta-­mercaptoethanol  
BrdU   5–bromo–2′–deoxyuridine  
BMP   Bone  Morphogenetic  Protein  
     
C     
Calca   Calcitonin  
Chodl   Chondrolectin  
ChAT   Choline  acetyltransferase  
CNS   Central  nervous  system  
CoPA   Commissural  ascending  primary  interneurons  
CaP   caudal  primary  
     
D     
des                                   deadly  seven  
dmd                               dystrophy  
dpf                                   days  post-­fertilization  
dpi     days  post-­injury  
DoLA   dorsal  longitudinal  ascending  neuron  
DVDT   dorsal-­ventral  diencephalic  tract  
     




EdU                               5-­Ethynyl-­2´-­deoxyuridine  
ENU                             N-­ethyl-­N-­nitrosourea  
EMS                             Ethylmethanesulfonate  
ERGs                           Ependymo-­radial  glial  cells  
EtBr                               Ethidium  bromide  
     
F     
FF-­subtype   fast-­switch,  fatigable  
5-­HT                             Serotonin  
5-­HTP                         5-­hydroxytryptophan  
     
G     
GFP   Green  fluorescent  protein  
Gli3   Glioma-­associated  oncogene  homolog  3  
gDNA   genomic  DNA  
     
H     
HD   Homeodomain  
hpf                                   hours  post  fertilization  
HM   Horizontal  myoseptum  
HRP   horseradish  peroxidase  
     
I     
IHC   Immunohistochemistry  
     
M     
Mag   Myelin-­associated  glycoprotein  
mbpa   Myelin  basic  protein  a  
MiP   middle  primary  
MND   Motor  neuron  disease  
Mnx1   Motor  neuron  and  pancreas  homeobox  1  
MTZ   Metronidazole  
mRNAs   Messenger  RNAs  




     
N     
Neurog2   Neurogenin2  
NGS   Next  Generation  Sequencing  
NMD   nonsense-­mediated  RNA  decay    
NTR   Nitroreductase  
NuRD   Nucleosome  Remodeling  and  Deacetylase  complex  
     
O     
Omgp   Oligodendrocyte  myelin  glycoprotein  
OH8dG   8-­hydroxy-­2’-­deoxyguanosine  
OPCs   Oligodendrocytes  precursor  cells  
OLPs   Oligodendrocyte  progenitors  
     
P     
PD   Parkinson’s  disease  
PDE   phosphodiesterase  
PDE5   phosphodiesterase  5  
PC   posterior  commissure  
PCR   Polymerase  chain  reaction  
PH3   Phospho-­Histone  H3  
pMN   Motor  neuron  progenitor  
POC   post-­optic  commissure  
psmc2   proteasome  26S  subunit,  ATPase  2  
ptc2   patched  2  
     
R     
RA   Retinoic  Acid  
RB   Rohon-­Beard  
rbbp4   Retinoblastoma-­binding  protein  4  
RoP   rostral  primary  
     
S     




Sap   sapje  
SC   Spinal  cord  
SCI   Spinal  cord  injury  
SGZ   subgranular  zone  
shh   Sonic  hedgehog  signalling  
SMA   Spinal  muscular  atrophy  
SMN1   Survival  of  motor  neuron  1  
smo   smoothened  
SNP   Single  nucleotide  polymorphism  
SOD1   Superoxide  dismutase  1  
SVZ   subventricular  zone  
     
T     
tac1   tachykinin  1  
TdT   Terminal  deoxynucleotidyl  transferase  
TH   Tyrosine  hydroxylase  
TUNEL   Terminal  deoxynucleotidyl  transferase  dUTP  nick  end  labelling  assay  
     
U     
Ub   ubiquitin  
UPS   ubiquitin  proteasome  system  
     
V     
VeLD     ventral  longitudinal  interneuron  
     
W     
WGS   Whole  genome  sequencing  
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